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General introduction
The neonate with hemodynamic compromise is a real challenge for clinicians. 
The neonatal circulation functionally distincts itself from the pediatric and adult 
circulation in many ways as the newborn population is a rather heterogeneous 
group with a wide range in gestational and postnatal ages, all with different levels 
of maturation of the cardiovascular system. The main goals of hemodynamic 
monitoring are 1) recognition of early (compensated) stages of shock as further 
progression to uncompensated shock will result in increased morbidity and 
mortality [1-3], 2) timely initiation of therapy, 3) evaluation of the response to the 
initiated interventions and 4) gain of insight in the developmental cardiovascular 
physiology to improve treatment strategies. Every day, neonatologists struggle 
with questions whether their patient is circulatory instable (does normal blood 
pressure guarantee an adequate perfusion and oxygen delivery?), whether to start 
therapy (should every patient with hypotension be treated or is permissive 
hypotension an option?) and if so, which therapy is the best for this individual 
patient (inotropes, vasopressors or fluid administration)? Many of these questions 
remain unanswered and most of the current treatment modalities and guidelines 
are based on expert opinion rather than on evidence.
 Understanding of fetal and neonatal cardiovascular (patho)physiology is 
warranted in order to recognize hemodynamic instability in time. The developing 
cardiovascular system has significant functional alterations in preload, contractility, 
afterload, diastolic filling and intra-cardiac flow patterns compared to the 
circulation later in life [4-5]. Besides knowledge of the immature function, insight 
in the dynamic changes during transition from fetal to neonatal life is mandatory. 
Especially in preterm infants who are still developing their cardiovascular system, 
a normal fetal condition can become pathological several hours later in postnatal 
life. Furthermore, treatment decisions for many common clinical presentations 
of the (pre)term infant as sespsis, persistant pulmonary hypertension, asphyxia 
and patent ductus arteriosus rely on applying knowledge of physiology and patho-
physiology to identify optimal therapy as conclusive clinical trials are lacking 
[6-8].
 Adequate circulation can be defined as a good balance between oxygen delivery 
and oxygen consumption on both systemic and regional level. For an accurate 
circulatory assessment, monitoring of both the macro- and microcirculation is 
therefore essential. The hemodynamic status of a neonate is currently mainly 
estimated by clinical examination and routine monitoring: color, capillary refill 
time, (central-peripheral) temperature (difference) and urine output are used in 
combination with blood pressure monitoring, blood gas analyses and lactate 
levels. It became obvious that these parameters – even when used simultaneously 
502337-L-sub01-bw-Vrancken
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and repetitively – are inaccurate to detect poor perfusion [9, 10]. Despite many 
years of debate, there is still no consensus on the definition for hypotension in the 
newborn [11, 12]. Also, treatment of hypotension in the absence of other signs of 
circulatory failure might be harmful [13]. As systemic blood flow is no surrogate of 
blood pressure, information on cardiac output and vascular systemic resistance is 
required in order to adequately diagnose and treat circulatory failure.
 Cardiac output is one of the major determinants of oxygen delivery and should 
therefore ideally be monitored, preferably continuously. Functional echocardio-
graphy is mainly used in neonatal care to provide information on cardiac function 
and the presence of shunts [2, 14, 15]. Major limitations are the non-continuous 
use, the need for intensive training and the substantial inter-observer variability 
[16]. Since the introduction of the pulmonary artery catheter in the 1970’s, a whole 
arsenal of advanced cardiac output monitoring systems has been developed for 
clinical use [17, 18]. Systems are based on different techniques such as Doppler 
signals, indicator dilution and bio-impedance. Most CO monitoring devices not 
only estimate cardiac output, but also some other variables such as hemodynamic 
volumes, systemic vascular resistance and extravascular lung water [19, 20]. CO 
monitoring has become standard of care in the adult intensive care settings [21], 
but in children [22] and especially newborns, its use is still limited. The ideal 
neonatal CO monitor device should be validated against a gold standard, reliable 
with high accuracy and precision, easy applicable in every physiological condition, 
non-invasive, continuous, inexpensive and without complications [23, 24]. It might 
be clear that this ideal monitoring system does not exist. Most of the current 
available cardiac output monitor devices are not applicable in (preterm) neonates 
due to different reasons, such as technical limitations (catheter size restraints) and 
the inability to estimate CO during transition or in the presence of (intra- and 
extra-cardiac) shunts [23]. Only a few studies regarding the validation and use of 
advance CO monitoring systems have recently been published [25-29]. 
 Reliable monitoring of cardiac output provides the neonatologist with information 
to target adequate therapy and makes it possible to monitor the response to this 
initiated treatment in order to avoid under- or overtreatment. To date, the search 
for the ultimate (cardiac output) monitoring device is ongoing. Although plausible, 
no studies are available proving that CO monitoring improves outcome in neonates. 
 The main goal of this present thesis is to study the feasibility of advanced 
hemodynamic monitoring in (preterm) infants. The transpulmonary ultrasound 
dilution technique is validated against the gold standard in 2 neonatal animal 
models mimicking (patho)physiological conditions in the neonate. Its reliability 
for measuring cardiac output, detecting and quantifying cardiac shunts, estimating 
hemodynamic volumes and assessing extravascular lung water is investigated.
502337-L-sub01-bw-Vrancken
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Outline of the thesis
This thesis is divided in 3 sections.
Section I includes an overview of the unique neonatal pathophysiological cardio- 
vascular features and the use of advanced monitoring systems in newborns. 
Chapter 2 describes the developmental cardiovascular physiology with focus on 
cardiac function and cardiopulmonary interactions during and beyond transition 
from fetal to newborn life. An overview of the available neonatal hemodynamic 
monitoring systems for assessment of both the macro- and microcirculation is 
also provided. Chapter 3 presents the results of an international survey among 
neonatologists regarding the use of clinical signs, biochemical parameters and 
conventional monitoring devices to assess circulatory insufficiency in newborns, 
the application of advanced hemodynamic monitoring systems and the availability 
of treatment protocols for circulatory instability.
Section II investigates the feasibility of transpulmonary ultrasound dilution as an 
advanced hemodynamic monitoring device in neonates. In chapter 4 cardiac 
output measurement using the transpulmonary ultrasound dilution technique is 
validated against invasively measured pulmonary blood flow in an animal model 
with a left-to-right shunt. Chapter 5 reports the possibility of detecting and 
quantifying (extra)cardiac shunts with this device in the same animal model, 
while in chapter 6 changes in hemodynamic volumes measured by transpulmonary 
ultrasound dilution under different hemodynamic conditions are described. 
Chapter 7 validates the assessment of cardiac output by the transpulmonary 
ultrasound dilution technique against invasively cardiac output measurements by 
flow probes around the main pulmonary artery in an animal model with induced 
respiratory distress syndrome. In the same animal model, the feasibility of 
transpulmonary ultrasound dilution for estimating extravascular lung water is 
investigated. Comparison with both the gold standard gravimetry and the 
transpulmonary double indicator dilution method was made. Results are reported 
in chapter 8.
Section III consists of chapter 9 with a general discussion, summary, conclusions 
and suggestions for future research and chapter 10 that summarizes the most 
important findings of this thesis in Dutch. 
502337-L-sub01-bw-Vrancken
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Introduction 
Neonatal cardiovascular physiology is unique and cannot be extrapolated from 
older children and adults. Maintenance of neonatal circulatory homeostasis is a 
real challenge, due to the complex physiology during postnatal transition and the 
inherent immaturity of the cardiovascular system and other organs. Abnormal 
cardiovascular function during the neonatal period is associated with increased 
severe morbidity and mortality [1-3]. Knowledge of the functional and structural 
characteristics of the circulation in the newborn is essential, as most of the 
treatment decisions in the neonatal period are based on assumed underlying (patho)- 
physiology. 
 The clinical assessment of systemic blood flow (SBF) by indirect parameters, 
such as blood pressure, capillary refill time, heart rate, urine output and central- 
peripheral temperature difference is inaccurate [4]. As blood pressure is no 
surrogate for systemic blood flow, information on cardiac output (CO) and systemic 
vascular resistance (SVR) should be obtained in combination with an evaluation of 
end-organ perfusion. Accurate and reliable hemodynamic monitoring systems are 
required to detect inadequate tissue perfusion and oxygenation at an early stage, 
before this results in irreversible damage. Also, the hemodynamic response to the 
initiated treatment should be re-evaluated regularly as changes in cardiovascular 
function can occur quickly.
 We review new insights in the understanding of cardiovascular physiology 
(during and after transition) and discuss methods for current and future neonatal 
cardiovascular monitoring.
Developmental cardiovascular physiology 
The primary goal of blood flow is to deliver oxygen and nutrients to the cells to 
meet their metabolic demands and to remove waste products and carbon dioxide. 
There is a complex interaction between blood pressure, blood flow and systemic 
vascular resistance, which is regulated by autonomic central and peripheral nervous 
systems, the cardiovascular system (baroreceptors) and endocrine mechanisms [5]. 
 The amount of oxygen required by the tissue depends on the functional state 
of the cells. Furthermore, certain organs - the brain, heart, adrenal glands and 
renal cortex - have persistently high oxygen demands, while other organs like the 
spleen and the skin can suffice with a lower oxygen supply. The gastrointestinal 
tract and skeletal muscles have variable oxygen needs. Neuro-endocrine and local 
vascular mechanisms regulate tissue perfusion in the compensated phase of 
shock. Blood flow towards vital organs (via high priority vessels) is then preserved 
502337-L-sub01-bw-Vrancken
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by local vasodilatation while the vasculature of non-vital organs (via low priority 
vessels) tends to constrict in order to redistribute the blood mainly from the 
splanchnic vaculature. During this phase, normal blood pressure is preserved. 
When this compensatory mechanism fails, hypotension will occur and organ 
blood flow is further diminished leading to dysoxia and eventually cell death. 
Unless treated early, circulatory failure can result in organ failure and increased 
mortality and morbidity. 
 The relationship between tissue oxygen delivery (DO
2
) and oxygen consumption 
(VO
2
) is biphasic as shown in Figure 1 [6,7]. Under normal circumstances, DO
2
 
outweighs VO
2
. In critically ill neonates with cardiovascular compromise, a 
decrease in DO
2
 is compensated by an increase in oxygen extraction maintaining 
VO
2 
 (phase 1). The increase in oxygen extraction is believed to be the result of a 
recruitment of the capillaries, thereby increasing the surface for passive oxygen 
diffusion. In this way, the oxygen extraction can be augmented from +/- 30% in 
normal circumstances to 50-60% when oxygen delivery is limited. This mechanism 
is especially important for the preterm forebrain as it is speculated by some 
authors that the high-priority vascular assignment of this region is incomplete at 
birth and therefore responds with vasoconstriction when perfusion is decreased 
[8-10]. At some critical point however, this oxygen extraction ratio (OER) – defined 
as VO
2
/DO
2
 - is maximal and a further decrease in oxygen delivery will result in a 
Figure 1  Relationship between oxygen delivery and oxygen consumption
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2
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2
 oxygen delivery; SvO
2
 (mixed) venous oxygen saturation; OER oxygen extraction 
ratio. X-axis shows the gradual decrease in DO
2 
with the lowest DO
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decrease in oxygen availability and therefore consumption (phase 2), leading to 
anaerobic metabolism.
Feto-neonatal cardiovascular transition
During fetal life the circulation can be characterized as two parallel circuits with 
equal left and right ventricle pressures, right ventricle predominance (around 55% 
of combined cardiac output), low-resistance placental circulation and presence of 
shunts. Fetal animal and human studies have shown that - depending on gestational 
age – almost half of the total cardiac output flows into the placenta resulting in 
the same amount of venous return from this low resistance system. The umbilical 
venous blood passes through the ductus venosus after it has mixed with a small 
amount of blood from the portal vein. Most of the oxygenated blood in the right 
atrium is then diverted through the foramen ovale (FO) to the direction of the left 
atrium where it is being ejected into the left ventricle and ascending aorta together 
with pulmonary venous blood. The deoxygenated blood from the superior and 
inferior vena cava is preferentially directed to the right ventricle, from which 
75-90% of the output is then shunted through the ductus arteriosus into the 
descending aorta due to the high pulmonary vascular resistance in relation to a 
lower systemic vascular resistance [11,12]. Only a small part of the blood perfuses 
the lungs. With advancing gestation, changes in umbilical flow, placental 
perfusion, pulmonary resistance and hence pulmonary blood flow (PBF) occur, 
leading to a highest level of PBF around 30 weeks of gestation [13]. Umbilical cord 
clamping at delivery is followed by major cardiovascular changes within seconds 
and hours, although the final transition only finalizes within weeks. The instant 
loss of a low-resistance, high-flow placental bed results in an increase in systemic 
vascular resistance and a 30-50% decrease in venous return affecting cardiac 
output. With the onset of ventilation, pulmonary vascular resistance decreases 
and PBF increases followed by a rise in pulmonary venous return and left atrial 
pressure resulting in the functional closure of the FO and completing the transition 
from a parallel to a serial circulation. Animal and recent neonatal studies have 
shown that after an elective caesarian section, transductal blood flow changes 
from predominantly right-to-left to predominantly left-to-right within 10 minutes 
after birth, reflecting the instant changes in both systemic and pulmonary 
vascular resistance [14,15]. The ductus venosus remains patent for several days 
without any circulatory consequences [16]. Further completion of the transition is 
finalized with ductus arteriosus closure which is established by multiple 
mechanisms including an increase in arterial oxygen content, decreased 
prostaglandin levels, expression of endothelin I and its receptors and an increase 
in catecholamines [17,18]. The initial functional closure of the ductus occurs 
normally within a few hours after birth due to smooth muscle contraction, while 
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the anatomical closure with remodeling of the intima and loss of smooth muscle 
in the media might take several weeks or even months, especially in preterm 
infants [19]. The FO can be patent for some years. The neonatal circulation after 
birth as described is shown in Figure 2. Intrinsic and external factors can influence 
the transition process resulting in sustained increased vascular pulmonary 
resistance with persistent right-to-left shunt. In contrast, the gradually fall in 
pulmonary vascular resistance in combination with a higher systemic vascular 
resistance will result in left-to-right shunting when the ductus arteriosus remains 
patent (PDA). The incidence of a PDA correlates inversely with gestational age and 
weight and might increase to > 50% in preterm infants weighting 500 – 750 g [20]. 
A persistent patent ductus arteriosus is associated with increased morbidity due to 
pulmonary overflow and a subsequent decreased systemic blood flow [1,21,22]. 
After many years and many non-conclusive trials, we are still not sure whether or 
when to treat the preterm infant with PDA [23]. 
Figure 2  The neonatal circulation
RVO right ventricular output; PBF pulmonary blood flow; LVO left ventricular output; AAo blood flow in 
ascending aorta; DAo blood flow in descending aorta; DA ductus arteriosus; VCS vena cava superior; VCI 
vena cava inferior; VR venous return
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Determinants of cardiac output and oxygen delivery
Maintaining an optimal balance between oxygen delivery and oxygen consumption is 
a challenge in the transitional period and beyond. Oxygen delivery is determined 
by cardiac output and the arterial oxygen content (DO
2
 = CO x c
a
O
2
); global oxygen 
consumption can be calculated by multiplying the cardiac output by the difference 
between arterial and mixed venous oxygen content (VO
2
 = CO x c
(a-mv)
O
2
). In turn, 
arterial and mixed venous oxygen content are function of arterial and mixed 
venous oxygen saturation, arterial and venous partial oxygen pressure, and 
hemoglobin concentration (oxygen content cO
2
 = (Hb [mmol/L] x 0.98 [L O
2
/mmol/L 
Hb] x SO
2
) + (0.0004 x PO
2
 [kPa]).  
 CO is a major determinant of oxygen delivery and is defined as the product of 
heart rate (HR) and stroke volume (SV). Stroke volume is determined by preload, 
contractility and afterload, all parameters which are intertwined. During the 
time of transition substantial changes occur in preload, myocardial contractility, 
and pulmonary/systemic vascular resistance and flow. Especially in preterm 
infants with an immature cardiovascular system, adaptation to these changes can 
be difficult. 
Stroke volume and heart rate
For a long time it was considered that neonates could only increase their cardiac 
output by increasing heart rate, while stroke volume remained relatively fixed. 
However, several studies have shown that in term neonates during and after 
transition left ventricular stroke volume and output (LVO) increased, whereas 
blood pressure and heart rate remained stable or decreased. These changes were 
presumably due to an increase in left ventricular preload as a result of higher 
pulmonary blood flow in combination with ductal left-to-right shunting [24-26]. 
Also, in term newborns with hypovolemic or cardiogenic shock, changes in LVO 
after volume replacement were mainly determined by changes in stroke volume 
and not heart rate [27]. Several studies indicate that changes in systemic blood flow 
in preterm infants are mainly the result of changes in stroke volume rather than 
alterations in heart rate [2,28,29]. Furthermore, the preterm circulation is 
characterized by high resting heart rate levels resulting in a limited ability to 
increase cardiac output by just increasing heart rate. Indeed, a rise in heart rate 
can shorten the end-diastolic ventricular filling time, decreasing stroke volume 
and therefore cardiac output. Most of the inotropic agents used for the treatment 
of circulatory failure also have chronotropic properties, partially inhibiting their 
intended effect. In adult intensive care, trials with β-blockade (e.g. esmolol) have 
been shown to be beneficial in reducing heart rate, enhancing cardiac function 
and reducing the need for vasopressors in septic patients after the initial phase of 
hypovolemia [30,31]. In analogy with adults, it might also be favourable to reduce 
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heart rates in tachycardic newborns to optimize stroke volume and in addition 
cardiac output. This treatment option needs further research.
Contractility
Contractility refers to the ability of myocytes to change their contractile force 
independent of preload. Due to myocardial immaturity, both morphologically and 
functionally, the fetus and neonate have a limited capacity to increase contractility 
[32]. The immature myocardium is characterized by a lower number of myofibrils 
per cross-sectional area with a simplified internal organization, immaturity of the 
sarcoplasmatic reticulum and T tubules, altered calcium handling, lower troponin 
C levels and higher troponin T levels, all leading to less force during contraction 
[33-35]. Furthermore, contractility is impaired as a result of decreased β-adrenergic 
receptors and less sympathic innervations. The increase in contractile force (in 
association with an increase in calcium influx) is age dependent and improves 
during the early postnatal period. Schiffmann studied the myocardial function in 
the developing rabbit heart and demonstrated a significant increase in contractility 
(45%) and relaxation (75%) within the first 8 postnatal days. After administration 
of increasing dosages of inotropes, such as isoproterenol and ouabain, effects on 
contractility as well as relaxation were (significantly) lower in neonatal hearts 
compared to adult hearts [36]. Impaired myocardial function is often seen in 
neonates with asphyxia, preterm infants after ductus ligation and newborns with 
(congenital) dilated cardiomyopathy. 
Preload 
The relationship between preload and stroke volume is shown by the Frank-Starling 
curve (Figure 3). Preload refers to the ability of the heart to change its force of 
contraction - and therefore stroke volume - in response to changes in the volume of 
blood entering the heart when all other factors remain constant. It is the initial 
stretching of the cardiac muscle fibers prior to contraction (mostly referred by as 
end-diastolic ventricular volume). Preload is determined by the venous return (and 
therefore the circulating volume and the venous capacitance) and the ventricular 
compliance (myocardial distension). 
 Compliance: The compliance describes the change in volume as a result of a 
change in pressure and depends on the structural properties of the cardiac muscle. 
The alteration in cardiac compliance from fetal to adult life is not yet fully 
understood. Early studies suggested that fetal cardiac compliance is rather low 
and that there is a developmental increase in compliance during gestation [33]. In 
contrast, more recent studies have shown that the fetal heart has a higher 
compliance compared to adult heart due to the presence of specific fetal connectin 
isoforms [37,38]. Connectin is a protein that links the z-disk of the tin filament to 
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the myosin thick filament. The fetal isoform has high elastic properties, leading to 
a reduced myocardial stiffness and a low passive tension. These characteristics 
allow the fetal myocard to generate adequate cardiac output despite low filling 
pressures in utero. 
 Ventricular filling and venous return: the ventricular filling is characterized by an 
early passive filling followed by an active atrial contraction (E-wave and A-wave, 
respectively on Doppler echocardiography). The passive phase predominates in 
adults leading to an E/A-ratio >1. In contrast, in fetal diastole the active phase is 
more pronounced leading to an inverse E/A-ratio of <1 [39]. This less passive filling 
is influenced by multiple factors e.g. 1) low pulmonary venous return to the left 
atrium due to limited pulmonary blood flow, so left ventricular filling volumes 
mainly depend on blood flow through the foramen ovale and 2) the altered 
compliance: previously, the impaired passive filling was attributed to the lower 
compliance with increased myocardial stiffness. However, with the aforementioned 
new insights it can be argued that also the high compliant fetal heart might have 
a lower passive filling phase: the force generated by the connectin protein when 
restoring its so-called resting length after systolic contraction or diastolic 
distention will decrease with higher compliance [40]. At early diastole, when blood 
is effectively suctioned into the ventricles by sarcomeres restoring their resting 
length after systolic contraction, the fetal myocardium will generate less force 
leading to less passive filling and therefore a lower E/A ratio.
Figure 3  Schematic representation of the Frank-Starling curve
1 = adult cardiac function; 2 = fetal/neonatal cardiac function. A similar change in preload will result in 
a higher cardiac output/stroke volume in adults than in neonates.
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 Throughout gestation the E/A-ratio over the mitral valve will increase (but 
rarely >1) as the pulmonary venous return (PBF) will increase (peak around 30 
weeks of gestation), a process that continues after birth. Immediate cord clamping 
after birth leads to an increase in SVR and a decrease in venous return resulting in 
a low LVO. Left ventricular (LV) preload will then be restored as a result of an 
increase of PBF in combination with a decrease in pericardial pressure when 
negative intrapleural pressure and lung expansion occurs, leading to a less 
restrictive ventricular filling pattern [41]. The initial drop in LVO can partly be 
avoided if ventilation commences before the cord is clamped, since there is no loss 
in preload as venous return immediately switches from umbilical to pulmonary 
venous return upon cord clamping. Initiating ventilation before cord clamping 
can therefore mitigate the changes in cardiac output [42]. In addition, delayed cord 
clamping is associated with other benefits such as increased circulating volume, 
decreased incidence of late-onset sepsis and intracranial hemorrhage and a 
reduced need for transfusions [43]. 
 Circulating blood volume: Acute blood loss due to perinatal events (feto-maternal 
transfusion, placental abruption), extensive insensible water loss or capillary leak 
in patients with sepsis and necrotizing enterocolitis are causes of low circulating 
blood volume resulting in a reduced preload and subsequently ventricular 
dysfunction. In contrast, (abundant) fluid administration might also impair 
ventricular function and cardiac output as the heart functions near the flat part 
of the Frank-Starling curve.  
 Venous capacitance and mean systemic filling pressure (Pmsf): the veins contain about 
65% of the total blood volume. They are much more compliant than arteries, 
especially the splanchnic and cutaneous venous beds which have high concentrations 
of α1- and α2-adrenergic receptors and are therefore more sensitive to adrenergic 
stimulation. The venous system serves as a blood reservoir adjustable to blood flow 
requirements. As blood flows from the aorta into the systemic circulation, 
intravascular pressure will drop gradually to the level of the right atrium pressure 
(RAP). The mean systemic filling pressure is defined as the equilibrating pressure 
across the circulatory system during circulatory arrest. Under normal conditions 
there is one point (the pivot point) where the intravascular pressure equals the 
Pmsf. The Pmsf provides therefore a quantitative measurement of the filling 
status.
 The volume that is required to fill the vasculature without increasing the 
transmural pressure is called the unstressed volume (Figure 4). The stressed 
volume (VS) is any amount of volume that leads to an increase in transmural 
pressure, when added to the unstressed volume. Mathematically Pmsf is calculated 
as the stressed volume divided by the compliance (C) of the venous system [Pmsf = 
VS/C]. As the driving force for blood flow is supplied by a pressure gradient and 
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determined by the resistance to flow (Ohm’s law), the venous return - which must 
equal cardiac output – can be calculated by the difference between the Pmsf and 
RAP divided by the resistance (R) to venous return [VR = (Pmsf – RAP)/R]. Venous 
return is influenced by total blood volume, compliance of the venous system and 
the administration of inotropes/vasopressors (Figure 5) [44]. In addition, changes 
in venous return will reflect on ventricular function. Reports on the use and 
measurement of Pmsf are scarce in neonates [45].
Afterload
Afterload is defined as the force against which the heart must act in order to pump 
the stroke volume and largely depends on ventricular dimensions, blood pressure 
and (systemic) vascular resistance and vascular compliance. Morphologically it is 
the tension experienced by each sarcomere unit. With increasing afterload, the 
ventricular wall stress increases and the velocity of fiber shortening decreases 
resulting in a decrease in stroke volume. The rate-corrected mean velocity of fiber 
shortening (mVcfc) - end-systolic wall stress (ESS) relation is used to measure 
ventricular performance, adjusting for the influence of afterload, but independent 
of preload and heart rate. Echocardiographic studies have shown that there is an 
age-dependent mVcfc-ESS relationship suggesting that newborns have a higher 
basal contractile state and that myocardial performance is more sensitive to 
afterload in the immature heart [46,47]. As there is preload - afterload interdepen-
dence, the negative effect on stroke volume caused by an increase in afterload will 
be compensated by an increase in left atrial pressure, enhancing contractility. 
Figure 4  Intravascular volumes and pressure in the venous compartment 
Pmsf mean systemic filling pressure (see text for definition)
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High afterload can be seen in neonates shortly after transition, after ductal ligation 
and in the presence of cold shock (low CO and high SVR). Low afterload as a result 
of low vascular tone and low systemic vascular resistance is a cause of circulatory 
failure in neonates with warm shock (high CO and low SVR). It is important to 
differentiate between these different presentations of shock, as they require other 
therapeutic approaches (inotropes versus vasopressors) [48-51]. 
Central venous oxygen saturation
Mixed venous oxygen saturation (SmvO
2
) represents the oxygen reserve after tissue 
oxygen extraction. Under normal conditions the whole body extracts approximately 
25-30% of oxygen from the arterial blood resulting in a SmvO
2
 of 70-75%. Assuming 
stable hemoglobin and SaO
2
 levels, a decrease in SmvO
2 
is the result of an increase 
in oxygen consumption (stress, pain, seizures or increased metabolic demand in 
case of sepsis) or a decrease in cardiac output. Mixed venous oxygen saturation can 
only be measured from blood sampled from the main pulmonary artery, which is 
not feasible in neonates. An alternative is to sample venous blood from the right 
Figure 5  Mean systemic filling pressure: relation with volume
(Adapted from Aya [44]) Continuous line represents the baseline compliance. Point 1 = the total blood 
volume (V
1
) at Pmsf P
1
. For this curve, the volume at 0 pressure is the unstressed volume (V
1
0) and the 
stressed volume (VS) is the difference between V
1
 and V
1
0. Point 2 = an increase in pressure due to 
intravascular volume replacement. Point 3 = after blood removal: the same pressure (P
1
) can be obtained 
despite the decrease in total blood volume (V
3
) as a result of recruitment of some unstressed volume (V
3
0) 
into stressed volume by vasoconstriction. The compliance remains unchanged (parallel dashed line). 
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atrium or the caval veins (depending on the position of the central venous catheter) 
– central venous oxygen saturation (ScvO
2
). However, absolute values of SmvO
2
 and 
ScvO
2
 are not interchangeable for various reasons [52,53]: ScvO
2
 is among others 
influenced by 1) sampling site differences: under normal physiologic circumstances 
vena cava inferior oxygen saturation (SivcO
2
) is higher than vena cava superior 
oxygen saturation (SsvcO
2
) (the gut being a low oxygen extraction organ) with the 
latter being lower than the mixed venous oxygen saturation. During shock, as a 
result of redistribution phenomena, the relationship between the SsvcO
2
 and the 
SmvO
2
 might be reversed; 2) the presence of a (intracardiac) left-to-right shunt 
(which increases the SmvO
2
 but not SsvcO
2
); 3) incomplete mixing of blood: 
sampling blood from the superior or inferior vena cava might contribute to the 
higher values compared to SmvO
2
 as this latter also includes unsaturated blood 
from the coronary arteries; 4) redistribution of blood flow during shock: as cerebral 
blood flow and oxygenation is usually preserved over some period of shock, the 
drop in SsvcO
2
 is less marked and delayed compared to the drop in SmvO
2
. In 
contrast, due to redistribution and an increase in oxygen extraction in the 
splanchnic vascular bed, the SivcO
2
 will underestimate SmvO
2
; 5) the level of 
consciousness and 6) myocardial oxygen consumption can influence measurements 
of SmvO
2
. Despite these differences, absolute changes of SmvO
2
 and ScvO
2
 occur 
mostly in a parallel manner. While decreasing values of SvO
2
 mostly reflect 
inadequate oxygen delivery or increased consumption, normal or high values 
cannot be interpreted as normal tissue oxygenation. Especially in septic and 
circulatory compromised patients SvO
2
 might be high but due to mitochondrial 
dysfunction when oxygen extraction can be seriously impaired. 
Cardiopulmonary interactions
As described earlier, major changes in blood flow and blood pressure occur during 
normal transition. Sick newborns and especially preterm infants who have 
reduced respiratory drive, poor lung compliance and reduced thoracic musculature, 
often require positive pressure ventilation (immediately) after birth, adversely 
affecting cardiovascular function in different ways [54]: Increasing airway 
pressure decreases the alveolar/capillary transmural pressure gradient, squeezing 
blood out of the intra-alveolar capillaries, resulting in an increase in pulmonary 
vascular resistance and a decrease in pulmonary blood flow (Figure 6). As the left 
ventricular function is highly dependent on preload, a reduction in pulmonary 
venous return will reduce left ventricular output. Persistent increases in airway 
pressure and subsequently pulmonary vascular resistance may even potentiate the 
persistence of a possible right-to-left shunting through the ductus arteriosus. 
Furthermore, a direct compressive effect of the positive airway pressure on the 
heart hampers the left ventricular function and reduces cardiac output. Ventilation 
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strategies might not only impair cardiovascular function and systemic blood flow, 
but also influence cerebral blood flow in several ways, especially in preterm infants 
with impaired cerebral autoregulation: high positive end expiratory pressures can 
cause a significant reduction in cardiac output and similarly in superior vena cava 
blood flow (representing also blood returning from the brain); ventilation with 
high tidal volumes shortly after birth results in large fluctuations in cerebral 
blood flow and increased vascular extravasation [55,56]. These changes in cerebral 
blood flow and oxygenation are associated with an increased risk of intraventricular 
hemorrhage and long term neurodevelopmental disability or death [57,58].
Hemodynamic monitoring systems
Continuous assessment of blood pressure, heart rate and arterial oxygen saturation 
alone will not provide sufficient information to initiate or adapt cardiovascular 
interventions. Hypotension can indeed reflect high or low systemic blood flow 
depending on the degree of systemic vascular resistance and oxygen delivery 
might be impaired despite normal blood pressure in the phase of compensated 
shock. Moreover, in the preterm infant, there is a tendency to accept lower blood 
pressure (permissive hypotension) in the absence of other signs of circulatory 
Figure 6  Relationship between pulmonary vascular resistance and lung volume
RV residual volume; FRC functional residual capacity; TLC total lung capacity; grey zone optimal pulmonary
vascular resistance.
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failure [59]. The choice of treatment in the presence of hypotension can only be 
determined when additional information is gathered on cardiac function, such as 
vasopressors and inotropes that might influence systemic blood flow and blood 
pressure in different ways. Simultaneous and bedside measurements of blood 
pressure and blood flow in combination with end-organ perfusion are therefore 
required to adequately monitor changes in cardiovascular function before and 
after therapeutic interventions.
Methods for measuring systemic blood flow (cardiac output)
Cardiac output is one of the major determinants of oxygen delivery and should 
therefore be monitored continuously or at least on a regular basis. Preferably, 
neonatal CO monitor devices should fulfill the following clinically important 
conditions: they are expected to 1) be validated against a gold standard reference 
method and proven to be accurate and precise; 2) be easy applicable (bedside), 
non-invasive, practical and inexpensive; 3) provide continuous information which 
is easy to interpret and 4) be reliable during transition and in the presence of 
shunts [60]. It might be clear that such an ideal monitoring system does not exist. 
In the last decades, many techniques have become available for the measurement 
of cardiac output, based on different techniques like Doppler ultrasound, indicator 
dilution and bio-impedance. However, many of them are not applicable in (preterm) 
neonates for various reasons such as size restraints, need for dedicated catheters, 
and the inability to estimate CO in the presence of shunts (for example during 
transition or with congenital heart defects). Bedside continuous and non-invasive 
measurement methods are preferred, although they have the disadvantage of 
being less accurate and precise. 
None-invasive cardiac output measurement methods applicable in newborn infants
Functional echocardiography (fEcho), also called neonatologist-performed echo-
cardiography (npECHO) is currently the most used non-invasive technique to 
estimate CO in neonatal intensive care. The method provides extensive real-time 
hemodynamic information regarding intra- and extracardiac shunts, myocardial 
(dys)function, systemic and pulmonary blood flow and volume changes [61,62]. 
Spectral analysis of the Doppler shift will produce time-velocity waveforms. The 
velocity–time integral (VTI) is known as stroke distance, which is the distance that 
a column of blood will travel during a defined time period. Stroke volume can 
then be calculated using the cross sectional area (CSA) of the vessel or outflow tract 
(SV = VTI x CSA). When SV is multiplied by the heart rate the CO is calculated. The 
major difficulty is the estimation of the vessel dimensions for the calculation of 
the cross-sectional area (CSA) as CSA = π(D/2)2 with D the diameter of a vessel. 
Hereby, the incorrect assumption is made that these blood vessels are perfectly 
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round. Furthermore, in the presence of a patent ductus arteriosus with left-to-right 
shunting, RVO and not LVO equals systemic blood flow as RVO reflects right 
ventricular input and therefore systemic venous return. Some confounding by 
left-to-right shunting across the PFO with an increase in RVO and subsequent 
overestimation of SBF is, however,  possible [61]. Measurement of superior vena 
cava flow – which also reflects cerebral blood flow - can be used as a surrogate for 
systemic blood flow, although only from the upper body part [63]. Current recom-
mendations and guidelines to treat hypotension include fEcho to target 
cardiovascular support and monitor the response of the initiated therapy [64,65]. 
The method is bedside available and non-invasive. Despite all these advantages, 
fEcho has potential pitfalls: measurements are not continuous, intensive training 
and continuous practice is required, and even in capable hands a significant intra- 
and inter-observer variability has been observed [66]. This inaccuracy is mainly 
caused by the angle of insonation leading to errors in VTI and - as already mentioned 
- the estimation of the CSA. The clinical gold standard to measure CO in adults is 
the pulmonary artery catheter. As this method is not feasible in neonates, 2D-echo-
cardiography is regarded as best practice in neonates and used for most validation 
studies with advanced hemodynamic monitoring devices. 
 The transcutaneous Doppler technique is used in the ultrasonic cardiac 
output monitor (USCOM) – a continuous wave Doppler device that is less expensive 
than conventional ultrasound. USCOM is designed for rapid, non-invasive 
measurement of CO using a probe located at the sternal notch (aortic valve; LVO) or 
parastenally (pulmonary valve; RVO). CO is calculated from the measured flow 
across the aortic or pulmonary valve. The monitor displays the VTI without visible 
2D-information of the outflow tract. Results in neonates are somewhat conflicting: 
despite the good agreement found between RVO measurements by echocardio-
graphy and USCOM in preterm infants, precision was lacking [67]. Studies in (near) 
term newborns comparing CO estimates by USCOM and transthoracic echocardio-
graphy showed poor accuracy as well as low reliability with differences in RVO and 
LVO, irrespective of the presence of a PDA [68,69]. The authors speculated that 
these differences were caused by a systemic error in the calculation of the CSA of 
aortic and pulmonary values or by the turbulent flow in the pulmonary artery 
with erroneously high values of RVO. Although new users can be trained quickly, 
there remains a high inter-user variability. The limitations of the methods are 
mainly due to the use of normograms based on the patient’s height, weight and 
age for estimation of the valve cross-sectional area. As absolute measurements of 
echocardiography and USCOM are not interchangeable at this time, the latter 
might be used in clinical practice as a trend monitor to detect CO changes. 
 Electrical velocimetry (EV) is a non-invasive, easy applicable (four disposable 
surface electrodes) and continuous CO measurement method based on impedance 
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cardiographic technology: the difference in measured voltage - produced by a 
small electrical current – caused by the (mis)alignment of red blood cells in the 
aorta during diastole respectively systole is used to calculate stroke volume and 
cardiac output. EV uses an algorithm to estimate SV based on flow time, mean 
velocity index and body mass. Based on preliminary data for CO estimates by EV in 
(pre)term newborns, body mass calculations for neonates have been adjusted in 
the current algorithm. Afterwards, Noori found good agreement and precision 
between CO values measured by EV (Ausculon®) and LVO measured by Doppler 
echocardiography in healthy term neonates during transition [70]. Grollmuss 
presented similar results in 24 term neonates until 72 hours after an arterial 
switch operation [71]. CO estimates by EV might be influenced by changes in tissue 
water content (pulmonary edema, pleural effusion), alterations in heart rate or 
patient movement. However, the results of these studies are encouraging. A 
prospective study investigating the value of EV in assessing changes in cardiac 
output in critically ill preterm and term infants in response to initiation of 
cardiovascular supportive care is in progress [70]. 
Invasive cardiac output measurement methods
The current use of invasive CO measurement methods is limited in neonatal intensive 
care. Indicator dilution techniques estimate CO based on changes of indicator 
concentration over time following an intravenous injection. Transpulmonary 
thermodilution (using ice-cold saline as an indicator) is regarded the clinical gold 
standard for estimating CO in children. As a dedicated thermistor-tipped arterial 
3-French catheter needs to be inserted, the method is not feasible in neonates 
weighing less than 3.5 kg. 
 Transpulmonary ultrasound dilution (TPUD; COstatus®) might have potential 
for future use in (preterm) newborns (> 0.8 kg). CO is calculated from a dilution 
curve that is obtained by the decrease in ultrasound velocity of the blood after 
injection of the indicator (isotonic saline heated to body temperature). The system 
uses an extracorporeal loop which can be connected to any indwelling central 
venous and arterial catheter. The use of a non-toxic, low volume indicator makes 
the method attractive for small infants. TPUD provides information on cardiac 
output, hemodynamic volumes and the presence and magnitude of shunts [72]. 
Validation studies in newborn lambs show good agreement and precision between 
CO measured by TPUD and ultrasonic flow probes. Measurements were reliable in 
animals with a left-to-right shunt, respiratory distress syndrome, during shock 
and after fluid replacement [73-75]. A possible limitation could be the risk of fluid 
overload. Clinical studies in neonates are in progress and reports in newborns/
infants seem promising [76,77].  
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 Arterial pulse contour analysis (APCCO) continuously measures CO by 
converting the arterial pressure waves into a beat-to-beat stroke volume [78]. Several 
APCCO systems are available for adults, all with specific algorithms and assumptions 
regarding vascular resistance and compliance to translate the pressure wave form 
into stroke volume. None of them are designed taken in account the specific 
vascular properties of children. Reliability and accuracy (in children) is further 
hampered by changes in compliance and vasomotor tone, irregular heart rates, 
movement artifacts and damped wave forms as a result of small catheters. Studies 
in infants and children are somewhat conflicting, but the method lacks accuracy 
and seems not convincing [79-81]. Studies in neonates have not been published. 
 Stroke volume estimates (and in addition cardiac output) can also be obtained 
by photoelectric plethysmography as a non-invasive continuous finger arterial 
pressure measurement method in adults. The Nexfin device® has an incorporated 
arterial pulse contour cardiac output monitor device that is applicable to the 
arterial waveform from the finger artery. At present only finger cuffs for adults 
and older children are available. The method seems feasible for blood pressure 
measurements in children but further technical development is required for 
future CO measurement use in children and neonates as aforementioned [82]. 
Assessment of preload and volume responsiveness – is it possible?
Treatment of hypotension and circulatory failure in (preterm) newborns is 
challenging as interventions may be helpful but also harmful. The most common 
treatment of hypotension is the administration of a fluid bolus, although this 
might be associated with adverse cardiovascular effects or outcome when given 
unnecessary [83]. A fluid bolus will only result in an increase of preload and stroke 
volume when the myocardium functions at the steep part of the Frank-Starling 
(FS) curve (see also Figure 3). Fluid responsiveness is defined as an increase in CO 
or stroke volume of more than 10-15% after a fluid bolus. Fluid overload (including 
pulmonary edema) without an increase in cardiac output can occur if fluid is 
administered on the flat part of the FS curve. Therefore, it would be desirable if we 
could predict fluid responsiveness in our neonatal population by the use of static 
and dynamic parameters. Some interesting studies in adult and pediatric patients 
might guide us to new methods for future neonatal use.
 Static variables – based on single observations in time – include heart rate, 
arterial blood pressure and both central venous pressure (CVP) and end-diastolic 
volume estimates. Several studies in adults, children and infants (> 3kg) have 
shown that CVP is a poor predictor of preload as it is influenced by multiple factors 
such as right ventricular compliance, intra-abdominal pressure and respiratory 
pressures [84]. Although no neonatal studies have been published, CVP seems of 
limited value to predict fluid responsiveness. 
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 Collapsibility of the inferior vena cava (IVC) and left ventricular end diastolic 
volume measured by transthoracic echocardiography are often used to decide 
whether or not to give a fluid bolus. In pediatric studies the latter parameter also 
failed to demonstrate an adequate predictive value, although the results for IVC 
variations are contradictory [85,86]. 
 The TPUD method can estimate total end diastolic volume but current 
literature on its value for preload assessment is still lacking.
 Measuring mean systemic filling pressure might be useful as it provides not 
only a quantitative measurement of the filling status, but also represents an 
estimate of the venous vascular resistance when simultaneously measured with 
CVP. Also, changes in Pmsf reflect changes in stressed circulatory volume. Pmsf - 
the pressure of equilibrium when the circulation stops - can be estimated at the 
bedside by different methods in ventilated adults including the stop-flow method. 
This method estimates the arterial–venous equilibrium pressure (Pmsf) after 
occlusion (stop-flow) and is realized by inflating a cuff to a pressure above the 
systolic blood pressure for 30 seconds [87]. Despite its invasiveness – requirement 
of a peripheral arterial catheter and preferably a peripheral intravenous access in 
the same extremity to measure venous pressure – the stop-flow method might be 
applicable in (ventilated) newborns. However, the usefulness of measuring Pmsf to 
predict fluid responsiveness and guide hemodynamic therapy might be limited 
due to its static nature and has still to be proven. 
 Dynamic parameters as described below are based on the variation in preload 
and stroke volume secondary to positive pressure ventilation. Cyclic changes in 
stroke volume between inspiration and expiration are greater when the patients 
functions on the steep part of the FS curve. This variation is also observed 
downstream as variable aortic blood flow, arterial blood pressure or plethysmo-
graphic waveform amplitude. Different dynamic variables derived from arterial 
blood pressure variations have a better predictive value in adults than in children 
[84]. The method is not yet validated in ventilated neonates, but its use is 
questionable as it is likely to be influenced by physiological factors (higher thoracic 
and arterial compliance and low tidal volumes compared to adults) and low heart 
rate/respiratory rate ratio’s (physiological aliasing). The non-invasive plethysmograph 
variability index (PVI) is obtained from the pulse oximeter and reflects the 
dynamic change in perfusion index (PI) that occurs during at least one respiratory 
cycle [88]. PI is defined as the percentage ratio between the pulsatile and 
nonpulsatile infrared signal. The pulsatile signal is mainly determined by arterial 
blood flow and the nonpulsatile signal by bone, tissue, pigments, nonpulsatile 
(venous and capillary) blood and skin. Studies in children are inconclusive 
regarding the use of PVI to predict fluid responsiveness. Bagci evaluated the 
technique in hypotensive neonates during surgery and suggested that PVI may 
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predict fluid responsiveness [89]. However, as measurements are subject to the 
same factors that influence arterial blood pressure variations, we think its value 
for predicting fluid responsiveness is limited. 
Assessment of organ perfusion and oxygen delivery
As it is not only oxygen delivery that is important for preservation of tissue 
integrity but the balance between oxygen delivery and consumption on both a 
global and regional level, additional monitoring systems are required to detect 
early changes in regional blood flow and oxygen consumption/extraction. Clinical 
parameters in combination with additional blood gas analysis and measurement 
of lactate levels are mainly used to assess poor perfusion in neonates. The predictive 
value for circulatory failure of most of those (individual) indicators is rather 
limited, although changes over time or a combination of parameters may be more 
informative [90]. As previously stated, changes in central venous oxygen 
saturation can be used as a surrogate for changes in mixed venous oxygen 
saturation when interpreted with caution. Although there is no linear relationship 
between ScvO
2
 and cardiac output (children) and no correlation between ScvO
2
 
and systemic blood flow in preterm infants [91,92], there is some evidence that 
early goal-directed therapy using intermittent ScvO
2
-monitoring seems to reduce 
mortality rates and improve organ dysfunction in pediatric patients with septic 
shock [93,94]. In guidelines for the management of neonatal (catecholamine- 
resistant) septic shock, it is also advised to target repetitively ScvO
2
-values > 70% 
[65]. In contrast, 3 recent trials based on early goal directed therapy showed that 
additional continuous ScvO
2
 monitoring did not improve outcome in septic adults 
patients who were identified early and received intravenous antibiotics and fluid 
resuscitation  [95-97].
 For the assessment of peripheral perfusion and microcirculation, a number of 
methods are currently available. Laser Doppler flowmetry uses a low-intensity 
laser light to measure the flow velocity of blood cells in the skin circulation. It has 
been shown that the neonatal microcirculation is subject to developmental 
changes after birth and relates to clinical illness severity scores in preterm infants. 
Although non-invasive and feasible in neonates, the method had some considerable 
(methodological) limitations (signal processing limitations, instrument calibration 
problems, motion artifacts, and effects of probe pressure) that prevent its clinical 
use at this moment [98]. 
 Orthogonal polarization spectral (OPS) and sidestream darkfield (SDF) 
imaging are other technologies to assess microcirculation by using light waves 
within the hemoglobin absorption spectrum. Quantitative measurement of the 
diameter of vessels, the velocity of red blood cells and functional capillary density 
are made using buccal or skin measurements. OPS and SDF seem valuable clinical 
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tools for the estimation of tissue perfusion in healthy and critically ill newborns 
[99]. However, temperature, hemoglobin levels, and the use of vasopressors can 
influence the results. Although measurements can be performed non-invasively at 
the bedside, results are not yet instantly available as calculations have to been 
performed off-line and are rather time-consuming. Automated analysis will 
certainly facilitate future use.  
 Near InfraRed spectroscopy (NIRS) estimates regional blood flow, regional 
tissue oxygenation and - when simultaneous measured with arterial oxygen 
saturation - also fractional tissue oxygenation extraction, depending on the used 
NIRS technique. The technique uses infrared light to estimate tissue concentrations 
of oxy- and deoxyhemoglobin in real time. The method is non-invasive, provides 
continuous real-time information and is easy applicable even in the smallest 
preterm infants. Knowledge of regional (cerebral) blood flow and tissue oxygen 
extraction is useful during transition, in the phase of compensated shock with 
vital organ assignment (especially in the preterm where the forebrain vasculature 
does not function as a high- priority structure shortly after birth as suggested by 
some) and during periods of hypotension with possible loss of cerebral auto- 
regulation, all events with potential risk for adverse outcome. Although the 
technique is predominantly limited to clinical research, its clinical use is 
increasing. Observational studies in neonates evaluated the applicability of NIRS 
in the NICU (monitoring cerebral autoregulation, cerebral and splanchnic/renal 
monitoring during interventions) and beyond (intra-operatively, in the delivery 
room) and results are promising [100]. However, when interpreting results users 
have to consider several limitations: validation is lacking, precision is questionable, 
probe bias is considerable and some assumptions have to be made (stable 
hemoglobin concentration, venous/arterial blood ratios and cerebral metabolic 
demands are required) to use oxygen extraction as a surrogate for blood flow. 
Currently, several interventional studies evaluating the use of NIRS are in progress. 
Results of the SafeBoosC trial show that episodes of cerebral hypoxia and hyperoxia 
were significantly reduced in preterm infants monitored by NIRS and treated 
according to a dedicated guideline compared to controls without differences in 
short term outcome [101].  
Conclusions
The neonatal circulation is unique and distinguishes itself from the circulation 
later on in life in many ways. Knowledge of the immature cardiac function during 
transition is essential to understand the specific pathologies and to target 
therapeutic interventions. Adequate and objective assessment of the systemic and 
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peripheral circulation is therefore necessary, preferably in a non-invasive continuous 
way. Technical advances have broadened the arsenal of monitoring systems over 
the past years, and although some of them might have potential for neonatal use 
in the near future, most of the current hemodynamic monitoring systems are not 
yet applicable in the vulnerable newborn. Further technical improvement is 
therefore required. It is important to recognize the limitations of the monitoring 
system used: monitoring itself will not improve outcome, but rather the changes 
in therapy guided by adequate interpretation of the data obtained.
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Abstract 
Background: Monitoring and treatment of circulatory instability in neonates 
remains a real challenge. In addition to clinical evaluation and blood pressure 
monitoring, more (advanced) techniques have become available to assess systemic 
and regional blood flow.
Objectives: We investigated the current clinical use of (advanced) hemodynamic 
monitoring systems and the availability of treatment protocols for circulatory 
failure in neonatal intensive care units.
Methods: a web-based survey was distributed by neonatal intensive care societies. 
Ten questions addressed 1) the use of clinical hemodynamic variables for the 
assessment and possible subsequent treatment of circulatory failure in the 
neonate, 2) the use of hemodynamic monitoring devices and 3) the availability of 
treatment protocols.
Results: Seventy-nine neonatologists from 27 countries responded. Hemodynamic 
assessment was performed using clinical parameters, invasive blood pressure 
measurements and blood gas analysis, with sometimes additional functional 
echocardiography (fEcho). NIRS was used in 40% of the surveyed centers for the 
estimation of end-organ perfusion. Advanced hemodynamic monitoring systems 
were mainly used for research purposes. Fifty-five percent of the respondents 
indicated to have a protocol for the treatment of neonatal circulatory failure. 
Availability of protocols differed between regions. Treatment recommendations 
were mainly based on the presumed underlying pathophysiology (82%).
Conclusion: The use of advanced hemodynamic monitoring systems is limited in 
neonates. Circulatory failure is mainly estimated by clinical signs in combination 
with blood pressure. fEcho is increasingly used but not yet part of standard 
diagnostic care. Treatment of poor perfusion is based on underlying pathophysiology 
rather than guided by blood pressure alone.
Keywords: neonate, hemodynamic monitoring, survey, circulation, protocol 
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Introduction
Monitoring and treatment of a compromised hemodynamic status remains a real 
challenge in newborn infants. Detection of early stages of cardiovascular compromise 
is necessary to initiate treatment in time since circulatory failure is associated 
with increased (long-term) morbidity and mortality [1-3]. The cardiovascular 
system of the newborn (especially of the preterm) differs in many ways from the 
adult individual. The unique changes during feto-neonatal transition, the immaturity 
of the myocardium and the differences in vital organ assignment during phases of 
compensated shock in preterm infants require accurate assessment of the neonate’s 
circulatory state [4,5]. Knowledge of this cardiovascular developmental physiology is 
crucial for adequate hemodynamic management. Previously, neonatal circulatory 
evaluation was mainly based on physical examination combined with urine 
output, blood gas analysis, serum lactate levels, (intermittent non-invasive or 
continuous intra-arterial) blood pressure measurement and continuous pulse 
oxymetry and heart rate monitoring [6]. However, accurate information about 
(organ) blood flow is essential as normal blood pressure cannot be seen as a 
surrogate for normal systemic perfusion. Therefore, additional monitoring 
techniques are needed for the simultaneous assessment of blood flow and its 
distribution to different organ systems in order to optimize therapeutic 
management. The use of advanced hemodynamic monitoring systems for neonates 
has been limited due to technical and size restraints, potential toxicity of indicators 
(lithium, carbon dioxide), risk of fluid overload, difficulties in vascular access, and 
the presence of shunts (transitional circulation, congenital heart defects) [7]. 
However, innovative methods are now available thanks to advances in biomedical 
technology [8]. Functional echocardiography (fEcho) is increasingly used in neonatal 
intensive care units (nicus) [3,9,10]. Additional macro- and microcirculation monitoring 
might also contribute significantly to our understanding of the neonatal circulation. 
The aim of this survey was to investigate 1) which methods are currently used for the 
assessment of the hemo- dynamic status in neonates, 2) to what extend advanced 
hemodynamic monitoring systems are used in nicus and 3) the availability of 
treatment protocols for circulatory insufficiency in nicus.
Methods
This web-based survey addressed the current use of hemodynamic monitoring 
devices in the neonatal intensive care units worldwide. As no patient data were 
used, informed consent was not obtained. This project was supported by the 
Division of Neonatology of the Radboud University Medical Center, Nijmegen. 
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 The questionnaire was generated based on a review of the literature regarding 
the availability of hemodynamic monitoring systems in neonates, and edited to a 
web-based survey using commercially available software (Survey Monkey® – Survey 
Monkey Europe Sarl (Luxemburg)).
 The survey (appendix 1) consisted of 10 questions related to the clinical variables 
used for hemodynamic assessment and possible subsequent treatment of circulatory 
failure in neonates and the availability and use of hemodynamic monitoring systems 
in neonatal patients. Questions posed for the assessment and treatment of circulatory 
failure evaluated the use of clinical signs, biochemical parameters, (non-)invasive 
blood pressure monitoring,  pulse oximetry, perfusion index, fEcho, near infrared 
spectroscopy (NIRS) and other monitoring methods as central venous pressure 
(CVP), central venous oxygen saturation (ScvO2), heart rate variability and arterial 
pressure variations. Respondents were asked to rate these parameters on an 
ordinal scale (rating 1 – 10). They could also opt for ‘not available’. They were also 
asked to what extend they used different (advanced) hemodynamic monitoring 
devices in their unit.  Answers were formulated in a five point Likert scale (not 
available - never - in clinical research setting only - sometimes - often). Moreover, 
we investigated whether a protocol was available for hemodynamic management 
and if so, if management was based on blood pressure, flow measurements and/or 
underlying pathophysiology (dichotomous true/false questions). Five questions 
in the survey related to population and demographic information. 
 The survey was distributed by the national neonatal intensive care societies in 
Belgium and the Netherlands, and the members of the Section ‘Circulation, 
Oxygen Transport and Haematology’ of the European Society for Pediatric Research 
who were asked to further distribute it in their network. Furthermore, the 
questionnaire was shared with participants of the preconference course Neonatal 
Circulation at the European Society of Pediatric Research in Barcelona, 2014. 
Participation was voluntary and anonymous. We aimed for one response per 
center. We chose to use a (forwarded) weblink rather than addressing individual 
subjects. Participants were invited to provide some center details (hospital name, 
location). In this way, repeated responses from the same centers were avoided as 
much as possible. After six weeks a reminder was sent to the participants. The 
dataset was closed six months after the first invitation. 
 Data were analyzed using SPSS version 20.0 (IBM, Armonk NY, USA). Not normally 
distributed data were expressed as median and interquartile range. Differences 
between parameters used for hemodynamic assessment and those for possible 
subsequent treatment of circulatory failure were analyzed using a Mann–Whitney 
test. Possible regional differences of protocol availability and use were evaluated 
with a chi-square test. Two tailed p-values of 0.05 or less were considered 
statistically significant.
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Results
We received 86 responses of which 7 were excluded because of incomplete data 
(responses limited to the first 3 questions) (8%). Seventy-nine surveys were eligible 
for further analyses. Three questionnaires lacked demographic data. Table 1 shows 
the institutional demographic characteristics. Most of the respondents worked 
in a level III nicu (87%) (IIIa = all gestational ages and mechanical ventilation 29%, 
IIIb = included major surgery 36%, IIIc = included extracorporeal membrane 
oxygenation/cardiopulmonary bypass/renal replacement therapy 35%). Respondents 
originated from 27 countries. 
Parameters used for the assessment and possible treatment of circulatory instability in neonates 
(Figure 1):
Heart rate, overall clinical impression, invasive blood pressure measurement and 
blood gas analysis were most used by respondents for the assessment and possible 
treatment of poor perfusion (median value >8). Individual values of capillary refill 
time, peripheral perfusion, urine output, reactivity and color were more pivotal (8) 
than those for temperature (6), central-peripheral temperature difference (6), 
heart rate variability (7) and liver size (5). Oxygen saturation measurement and 
plasma lactate determination were also considered important parameters (8). In 
general, respondents attributed equal value for assessing poor perfusion and for 
starting subsequent therapy to most individual parameters, except for heart rate, 
SaO
2
, blood gas analysis (all p < 0,05), temperature (p < 0,01) and color and reactivity/
alertness (both p < 0,001) (Figure 1): those parameters were considered more 
important for the assessment of circulatory failure than for the initiation of 
therapy. 
Availability and use of monitoring devices in the neonatal intensive care (Figure 2):
Invasive blood pressure monitoring was the most used method to assess circulatory 
instability (by 78% frequently, by 8% sometimes), followed by fEcho. Respondents 
indicated to use functional echocardiography as an additional method to evaluate 
poor perfusion frequently or sometimes in 42% and 37%, respectively. Six percent 
of the centers did not have fEcho at their availability. The method was mainly used 
to assess volume status (e.g. inferior vena cava collapsibility, stroke volume, end 
diastolic volume) and to a somewhat lesser (10%) extend to measure systemic blood 
flow (e.g. left ventricular output, right ventricular output, superior vena cava flow, 
aortic flow) (see also Figure 1). There were no regional differences for the use of 
fEcho. For the estimation of end-organ perfusion, NIRS was used in 40% of the 
surveyed centers (16% frequently, 24% sometimes). Some respondents used central 
venous pressure measurements or central venous oxygen saturation to be informed 
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about the hemodynamic status of their patients (34% respectively 29%). Advanced 
hemodynamic monitoring systems, especially those for measuring cardiac output, 
were mainly used in research settings. Most of the respondents had no availability 
of advanced cardiac output measuring methods (> 81%). 
Availability of a protocol for the treatment of circulatory instability (Table 2): 
Overall, only 55% of the respondents indicated to have a protocol for the treatment 
of circulatory instability in neonates, but there were some regional differences: in 
Western Europe 83% of the respondents had a protocol available, while in Northern 
Europe and especially in the other regions the existence of a protocol was 
substantially lower (55% and 36% respectively) (chi-square < 0.05). In case there was 
a protocol available, treatment of circulatory insufficiency was mainly based on 
the underlying disease (82%), often in combination with blood flow assessment 
(25%) or blood pressure measurement (22%). Surprisingly, in contrast to our 
expectations, only 10% of the respondents reported protocols driven by blood 
pressure alone. There were no differences between the type of protocol used in the 
different regions. If no protocol was available, respondents treated circulatory 
failure based on individual preference or local practices (equally distributed). No 
information was gathered on the kind of treatment strategy if no protocol was 
available.
Table 1  Institutional demographics of survey centers
Characteristics  
(total number of respondents) 
Number 
(%) 
Level of care  (n=78) Level 1
Level 2 
Level 3
1 (1%)
8 (10%)
69 (87%) 
27 
11 
11 
30 
16 
4 
Northern Europe 
Eastern Europe 
Southern Europe 
Western Europe 
Others 
Unknown 
Number of beds (n=78) <6
6-10
11-15
16-20
20-30
>30 
2 (3%)
12 (15%)
13 (17%)
15 (19%)
18 (23%)
18 (23%) 
Number of annual  admissions 
(n=78) 
0-50
51-200
201-500
501-1000
>1000 
4 (5%)
9 (12%)
35 (45%)
26 (33%)
4 (5%) 
Care for ELBW infants 69 (90%) 
ELBW = extremely low birth weight. Circular diagram: origin of respondents (%)
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Discussion
The major findings of this international survey are: 1) neonatal hemodynamics are 
assessed by clinical signs such as heart rate and ‘overall clinical impression’ in 
combination with invasive blood pressure and blood gas analysis, 2) functional 
Table 2   Availability and use of protocols to treat neonatal hemodynamic 
instability in different regions
Protocol * if protocol available then (mainly)
NA available Pressure  
driven
Flow  
driven
Pathophysiology 
driven
Western Europe 17.6% 82.4% 10.5% 5.3% 84.2%
Northern Europe 45% 55% 0% 10% 90%
Others 63.6% 36.4% 16.7% 8.2% 75.1%
NA = not available; Northern Europe = Denmark, Finland, Iceland, Ireland, Norway, United Kingdom, 
Sweden; Western Europe = Belgium, France, Germany, Netherlands, Switzerland; Others = Eastern 
Europe (Bulgaria, Estonia, Latvia, Lithuania, Romania), Southern Europe (Greece, Italy, Malta, Spain, 
Turkey), North America  (United States, Canada), Oceania (New Zealand,  Australia) and South Africa. 
*Statistical difference between different regions and the availability of protocols (chi-square < 0.05)
Figure 2   Availability of monitoring devices in the neonatal intensive care  
(% of 79 respondents) 
CO = cardiac output; NIRS = near infrared spectroscopy; others = medstorm stress detector, microcirculation 
assessment (laser doppler spectroscopy, videomicroscopy), perfusion index, aortic blood flow variations.
0 20 40 60 80 100 
Invasive arterial blood pressure monitoring 
CO by transthoracic echocardiography 
NIRS cerebral 
Central venous pressure monitoring 
Central venous oxygen saturation 
CO by transcutaneous echocardiography 
NIRS somatic 
Others 
CO by bioimpedance 
CO by oxygen Fick 
CO by arterial pulse contour 
CO by transpulmonary indicator dilution 
% of respondents 
frequently sometimes sporadically research never not available 
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echocardiography is the most common additionally used monitoring system, but 
is not yet integrated in standard care, 3) other advanced hemodynamic monitoring 
devices are mainly limited to research practices and 4) if available, protocols to 
treat circulatory insufficiency are mainly based on the underlying pathology 
rather than on blood pressure alone.
 New insights into the developmental physiology are changing our views on 
neonatal hemodynamic monitoring.  Reliable assessment of both blood pressure 
and (systemic and organ) blood flow is necessary in order to optimize treatment of 
circulatory instability. 
 We found that clinical evaluation in combination with blood gas analyses, 
lactate levels and (invasive) blood pressure measurements is still considered the 
most important method to assess neonatal hemodynamic instability. Single 
clinical parameters have substantial shortcomings in their ability to estimate 
circulatory failure or low systemic blood flow. However, the combination of several 
clinical variables might improve the predictive value for detecting hemodynamic 
instability [6]. Heart rate was considered the most important parameter to assess 
hemodynamic instability by our respondents (median value 9). As an individual 
clinical parameter, heart rate poorly reflects low systemic blood flow, but there is 
evidence that decreased heart rate variability (HRV) precedes clinical deterioration 
in sepsis or necrotizing enterocolitis and might be helpful in the early detection of 
these events [11,12]. Seventy-eight percent of the respondents indicated to use HRV 
in clinical practice. Invasively measured blood pressure is preferably used as a 
(surrogate) marker for perfusion by neonatologists.  As systemic vascular resistance 
highly influences systemic blood flow, decisions to treat circulatory instability in 
(preterm) neonates should not be based on (low) blood pressure alone [13]. 
Hypotension can occur with high or low systemic blood flow depending on the 
degree of systemic vascular resistance and may therefore need different therapeutic 
approaches [14-16]. Cardiac output (systemic blood flow) – one of the main 
determinants of systemic oxygen delivery – should therefore be monitored at 
the same time. While a decade ago CO measurements in neonatal patients were 
rather uncommon [17], fEcho is currently applied to some extent by 79% of the 
neonatologists to measure stroke volume, ventricular output or superior vena cava 
flow. These findings are similar to those from a recent international survey 
investigating the diagnosis and treatment of hypotension in extremely preterm 
infants where 75% of the respondents relied on fEcho to estimate hemodynamic 
compromise [18]. Echocardiography provides intermittent extensive real-time 
hemodynamic information but there are some important pitfalls [19,20]. The ideal 
neonatal cardiac output monitoring device is continuous, easy applicable, reliable 
during transition and preferably non-invasive.  Current studies demonstrate that 
non-invasive methods have reduced accuracy and precision to estimate systemic 
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blood flow compared to functional echocardiography, although they might be 
used for trend monitoring [21-23]. Their clinical application is therefore still very 
limited: transcutaneous echocardiography (USCOM®) is currently used by 20% of 
the respondents, bio-impedance technology (Aesculon®, Nicom®) by 9%. Invasive 
CO measurement methods as pulse contour analysis, transpulmonary ultrasound 
dilution and Fick method are mainly used for research purposes. 
 Acid-base status and lactate levels - indirectly reflecting a mismatch between 
oxygen delivery and oxygen consumption - were highly valued by the respondents. 
However, pH and base excess are poor predictors of circulatory insufficiency [24]. 
Increased lactate levels have more predictive value regarding adverse outcome, 
especially when serial measurements are used [25,26]. 
 Central venous oxygen saturation was not highly rated as an assessment of 
circulatory instability or for the initiation of therapy. ScvO2 can be used as a 
surrogate for mixed venous saturation which represents global tissue oxygenation 
after oxygen extraction, although values are not interchangeable (agreement 
depends among others on sampling size and the possible presence of shunts). 
Moreover, normal values can be registered when oxygen extraction is impaired by 
mitochondrial dysfunction which can occur in septic patients. One should be 
cautious when interpreting these values. In current neonatal practice, the use of 
ScvO2 seems limited, although trend monitoring could be of some interest.
 Central venous pressure was also not highly rated to assess poor perfusion or 
start treatment, but the method is still used in 34% of the respondents, mainly 
working in units with major surgery or extracorporeal life support (80%). However, 
the role of CVP measurements in circulatory failure is questionable and evidence 
that CVP indeed can accurately predict fluid responsiveness is lacking [27]. 
 Except for near infrared spectroscopy, monitoring systems detecting changes 
in regional blood flow or microcirculation, such as laser Doppler spectroscopy 
and sidestream dark field imaging, seem not to have found their way in to neonatal 
practice. Although rated by a mean value of 7 to assess circulatory instability, 
respondents did not give a high value to NIRS for initiating therapy. Many 
observational studies demonstrated the use of NIRS for (cerebral) oxygenation 
monitoring in the (preterm) newborn in different clinical settings (delivery 
room, nicu, peri-operatively) [28]. However, the technique has some substantial 
limitations, which might explain the lower value attributed by the respondents 
to rely on changes in NIRS-parameters to initiate treatment. The limited use 
of NIRS reported in the earlier mentioned survey (15%) contrasts with the 
substantial applicability of the method to 40% shown in our questionnaire 
(Figure 2) [18]. 
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 Therapeutic approaches of neonatal circulatory insufficiency changed over 
time as insights in the (patho)physiology improved. Treatment of cardiovascular 
compromise is not merely targeting (low) blood pressure alone, but is more and 
more cause orientated. Recommendations and guidelines integrate blood pressure, 
flow and pathophysiology to treat hypotension in the critically ill newborn [15,29]. 
A narrow majority of our overall respondents indicated to have a protocol for 
the management of circulatory instability in neonates, although there were 
(significant) regional differences in availability. It seems that the majority of these 
protocols are in line with the suggested guidelines.
 Limitations: The results in this survey may not be entirely representative 
for current international neonatal hemodynamic practices for several reasons: 1) 
the number of respondents is limited. 2) There might be a non-response bias: 
neonatologists were mainly approached by a forwarded weblink and not by 
personal email so the exact number of potential participants and therefore the 
exact response rate is not known. Respondents mainly originated from (Northern 
and Western) European countries so current practices in other regions might 
prove different. 3) As the questionnaire was partially distributed by members of 
the section ‘Circulation, Oxygen Transport and Haematology’ there is a potential 
selection bias and overrepresentation of neonatal intensive care units with special 
interest in neonatal hemodynamics might have occurred. 4) the survey response 
could be subject to personal preferences and may not reflect unit practice. 
Nevertheless, despite the aforementioned limitations we believe that this survey 
shows interesting issues of current hemodynamic monitoring practices and 
insights in circulatory care in neonatal intensive care units worldwide.
Conclusion
The use of advanced hemodynamic monitoring systems to assess systemic blood 
flow or end-organ perfusion is limited. Estimation of poor perfusion in the neonate 
is still mainly based on clinical estimation in combination with invasive blood 
pressure measurement, blood gas analysis and lactate. Functional echocardiogra-
phy is increasingly used as part of hemodynamic assessment. The availability of 
protocols regarding circulatory failure is region dependent and primarily based 
on underlying cardiovascular (patho)physiology. Although no monitoring system 
has ever proven to improve outcome by itself, a comprehensive monitoring 
approach might enable us to further increase our understanding of the complexity 
of neonatal hemodynamics, adapt our treatment strategies and perhaps change 
outcomes. Interventional studies using advanced hemodynamic monitoring systems 
are required.
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Appendix 1: Survey distributed to the participants
Please indicate the relative importance you attribute to the following parameters when 
assessing the haemodynamic status of a neonate in your NICU, using a scale from 0 -
10. (0 = no importance, 10 = extremely important ) 
1 2 3 4 5 6 7 8 9 10
Not
available
in our 
setting
Colour
Heart rate
Urine output
Capillary refill time
Peripheral perfusion
Temperature
Temperature gap (central vs 
peripheral)
Reactivity/alertness
Liver size and/or liver 
pressure test (to predict fluid 
responsiveness)
Overal clinical impression
Non-invasive blood pressure 
(non-continuous)
Invasive blood pressure
Pulse oximetry oxygen 
saturation (including pre-
/postductal values)
Plethysmography signal / 
perfusion index
Blood gas analysis
Plasma lactate
Serum hemoglobin
Central venous pressure
Central venous oxygen 
saturation
Near Infrared Spectroscopy 
(NIRS)
Echocardiographic
assessment of volume status 
(e.g. VCI, SV, EDV,...)
Cardiac output (by 
transthoracic
echocardiography e.g. LVO, 
RVO, SVC flow, aortic flow)
Heart rate variability
Arterial pressure variations
Other (please specify and attribute a score as above) 
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Please indicate which of the following hemodynamic monitoring devices or techniques 
are available in your neonatal intensive care unit. 
frequently sometimes sporadically
in clinical 
research context 
only
never not available
1. Invasive arterial blood pressure 
monitoring

2. Central venous pressure monitoring
3. Central venous oxygen saturation
4. Cardiac output monitoring by 
transthoracic echocardiography (e.g. LVO, 
RVO, SVC flow, aortic flow)
5. Cardiac output monitoring by 
transcutaneous echocardiography (e.g. 
USCOM)
6. Cardiac output monitoring by 
bioimpedance technology (e.g. Aesculon, 
NICOM)
7. Cardiac output monitoring by 
transpulmonary indicator dilution (e.g. 
COstatus transonic)
8. Cardiac output monitoring by arterial 
pulse contour analysis (e.g. PRAM)
9. Cardiac output monitoring by oxygen 
Fick method
10. Cerebral NIRS
11. Somatic NIRS (muscle, kidney, 
intestines and/or liver)
12. Others
Other (please provide details and attribute a score as above) 
502337-L-sub01-bw-Vrancken
62
CHAPTER 3
In my neonatal intensive care setting the following different types of blood gas analysis 
are used for the interpretation of gas exchange and perfusion (more than 1 answer 
possible) : 
never used sometimes used often used preferably used
venous blood gas
capillary blood gas
arterial blood gas
central or mixed venous 
blood gas
Other (please specify) 
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Please indicate the relative importance you attribute to the following parameters when 
deciding to give a fluid bolus or start inotropes/vasopressures using a scale from 0 -10.
(0 = no importance, 10 = extremely important ) 
1 2 3 4 5 6 7 8 9 10
Not
available
in our 
setting
Colour
Heart rate
Urine output
Capillary refill time
Peripheral perfusion
Temperature
Temperature gap (central vs 
peripheral)
Reactivity/alertness
Liver size and/or liver 
pressure test (to predict fluid 
responsiveness)
Overal clinical impression
Non-invasive blood pressure 
(non-continuous)
Invasive blood pressure
Pulse oximetry oxygen 
saturation (including pre-
/postductal values)
Plethysmography signal / 
perfusion index
Blood gas analysis
Plasma lactate
Serum hemoglobin
Central venous pressure
Central venous oxygen 
saturation
Near Infrared Spectroscopy 
(NIRS)
Echocardiographic
assessment of volume status 
(e.g. VCI, SV, EDV,...)
Cardiac output (by 
transthoracic
echocardiography e.g. LVO, 
RVO, SVC flow, aortic flow)
Heart rate variability
Arterial pressure variations
Other (please specify and attribute a score as above) 
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Which of the following statements regarding a protocol for managment of 
hemodynamically instable patients is true for your neonatal intensive care department?
eslaFeurT
There is no protocol -
treatment depends on 
individual clinician

There is no protocol -
treatment according to 
local practice (similar 
among clinicians)
There is a protocol and 
this is commonly used
There is a protocol and it 
is stricly adhered to
The protocol is pressure-
based (i.e. protocol driven 
by blood pressure 
monitoring)
The protocol is pressure 
and flow-based (i.e. 
protocol driven by blood 
pressure and flow 
measurements)
The protocol is (patho)
physiology-based (i.e. 
protocol based on 
underlying disease (PDA, 
sepsis, PPHN,..))
Other (please specify) 
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How many neonatal intensive care admissions does your neonatal intensive care 
department approximately have per year?
How many beds does your neonatal intensive care department have?
Does your neonatal intensive care department care for the following patients, also after 
initial stabilization following birth. 
please tick if applicable
0 - 50
51 - 200
201 - 500
501 - 1000
> 1000
< 6
6 - 10
11 - 15
16 - 20
20 - 30
> 30
Patients born at gestational age below 24 weeks
Patients born at gestational age below 28 weeks
Patients born at gestational age below 32 weeks
Patients born at gestational age below 37 weeks
Please indicate the level of neonatal care your neonatal intensive care department 
delivers
Level I (care for infants with corrected gestational age >34 weeks or weight >1800 g)
Level IIa (care for infants with a corrected gestational age of >32 weeks or a weight of >1500 g, nasal oxygen)
Level IIb (continuous positive airway pressure, total parenteral nutrition)
Level IIIa (care for infants of all gestational ages and weights, mechanical ventilation)
Level IIIb (major surgery)
Level IIIc (extracorporeal membrane oxygenation, cardiopulmonary bypass, renal replacement therapy)
Where is your neonatal intensive care department located? 
Do you have any additional comments to this survey? If so please fill in the following 
space
Hospital:
City:
State:
Country:
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Abstract 
Background: Cardiac output monitoring remains complex in newborns as most 
of the current technologies fail to accurately measure systemic blood flow in the 
presence of shunts. We validated cardiac output measurements using transpulmonary 
ultrasound dilution (TPUD) in a neonatal lamb model with a left-to-right shunt. 
Methods: Regular arterial and central venous catheters were inserted into 7 lambs 
(mean weight 6.5 kg). A surgically constructed left-to-right aorto-pulmonary 
Gore-Tex® shunt was intermittently opened and closed whilst cardiac output was 
manipulated by creating hemorrhagic hypotension. Cardiac output measurements 
with TPUD (COtpud) were compared with those obtained by an ultrasonic 
transit-time flow probe positioned around the main pulmonary artery (COufp).
Results: 72 sessions of 3 paired cardiac output measurements were performed. 
Mean COufp was 1.00 L/min (0.47 - 1.75 L/min), mean COtpud 1.05 L/min (0.54 – 
1.87 L/min). With an open shunt mean Qp/Qs-ratio was 1.8 (1.3 – 2.6). Comparison 
between COufp and COtpud showed a mean bias (SD) of 0.03 (0.09) L/min and 0.07 
(0.10) L/min respectively for measurements with a closed and open shunt. 
Percentage error was 18% and 20% for measurements with a closed and open 
shunt. Polar plot analysis showed good trending ability for both closed and open 
shunt groups.
Conclusions: Transpulmonary ultrasound dilution is a reliable technology to 
measure cardiac output in the presence of a left-to-right shunt.
Keywords: Cardiac output, hemodynamics, monitoring, children, neonate, left-to-right 
shunt, transpulmonary ultrasound dilution.
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Introduction   
Reliable measurement of cardiac output (CO) remains challenging in the pediatric 
population [1-3].  Especially in the neonate many techniques are not suitable due to 
technical restraints, size limitations, the necessity of blood withdrawal and 
possible indicator toxicity [4]. Hence cardiac output is generally estimated from 
indirect clinical and laboratory parameters [5]. However, these variables are 
considered unreliable for assessing cardiac output [6]. Objective cardiac output 
measurements could therefore be important to newborn patients. Low cardiac 
output is proven to be associated with an increased mortality in children [7]. In 
preterm infants low systemic blood flow is associated with increased risk of 
periventricular/intraventricular hemorrhage [8], impaired neurodevelopmental 
outcome [9] and increased mortality [10]. It is plausible that cardiac output 
monitoring can prevent these risks. In addition, CO monitoring could optimize 
cardiovascular management as cardiac output and not low blood pressure will be 
targeted to start inotropic support in these critically ill newborns.
 During the period of transition patent fetal channels influence the results of 
most cardiac output measurement technologies making objective measurement 
even more complicated. Functional echocardiography is increasingly being used 
to assess cardiac output, myocardial (dys)function, intra- and extracardiac shunts 
and organ blood flow [11,12]. However, as this method is labour-intensive and 
expertise in echocardiography is required, it cannot be considered as an instant 
bedside monitoring system. Many of the other current cardiac output measurement 
techniques have not been validated in patients with shunts [13-15], with the 
exception of the modified carbon dioxide Fick method [16]. 
 Transpulmonary ultrasound dilution (TPUD) was introduced in 1995 to 
measure several hemodynamic parameters in patients during hemodialysis [17,18]. 
The technique was adapted for cardiac output measurements and tested in vitro 
[19], in animals [20-22], adults [23-25] and children [26,27], using isotonic saline at 
body temperature as an indicator, that is injected in a low volume extracorporeal 
arterio-venous (AV) tubing loop inserted between an indwelling arterial and 
central venous catheter. Recently, the method was validated in juvenile piglets and 
proven to be reproducible, accurate and safe [28,29]. 
 The aim of this study was to validate the accuracy and precision of the TPUD 
technology in a lamb model with an intermittently opened and closed left-to-right 
shunt under different hemodynamic conditions. 
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Materials and method
TRANSPULMONARY ULTRASOUND DILUTION (TPUD) - This method is based on 
the difference in ultrasound velocity in blood and the indicator (isotonic saline at 
body temperature) and uses an extracorporeal arterio-venous (AV) loop that can 
be connected to any indwelling arterial and central venous catheter (Figure 1). 
The AV-loop is flushed with heparinized saline (1 U/ml) to prevent thrombosis. 
A peristaltic pump provides stable blood flow during measurement. The indicator 
is injected into the venous limb and a venous sensor calculates the exact amount 
of injected indicator as well as the ultrasound velocity of the used saline. An 
arterial sensor measures the decrease in ultrasound velocity in blood by the 
injected saline. An ultrasound dilution curve is obtained from which cardiac 
output is calculated using the Stewart-Hamilton equation. After 2-3 measurements 
the loop is flushed and the pump stopped. The method has been described 
extensively [28]. An ultrasonic transit-time flow probe positioned around the main 
pulmonary artery was used as reference method for measurement of blood flow, 
which is considered the gold standard in an animal model [30]. 
Figure 1   Schematic setup of cardiac output measurement with transpulmonary 
ultrasound dilution (reproduced with permission19)
central  venous catheter
venous sensor
injection site
peristaltic pump 
arterial catheter 
central  venous pressure measurement
arterial sensor 
arterial pressure measurement 
CO-
status©  
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GENERAL - This experiment was performed in accordance with Dutch national 
legislation concerning guidelines for the care and use of laboratory animals and 
was approved by the Ethical Committee on Animal Research of the Radboud 
University Nijmegen (RU-DEC #2008-117) and was part of a multidisciplinary 
cardiac output study [31] performed in 7 random-bred lambs (3.5-8.3 kg) under 
general anesthesia. Ketamine (10 mg/kg), atropine (0.03 mg/kg) and midazolam (2 
mg/kg) were administered intramuscular as premedication. After intravenous 
injection of propofol (2 mg/kg) the lambs were orotracheally intubated with a 
cuffed endotracheal tube (ID 4-6 mm; Kruse, Marslev, Denmark) and mechanically 
ventilated in a pressure control mode using a Datex Ohmeda Excel 210 SE 
anesthesia machine (GE Healtcare, Waukesha, Wisconsin, USA). Anesthesia was 
maintained with inhalation of isoflurane (0.5-2.0 vol%), and with intravenous 
administration of sufentanyl (15-20 μg/kg/h), ketamine (10 mg/kg/h), midazolam 
(0.2 mg/kg/h) and pancuronium (0.02 mg/kg/h after a loading dose of 0.05 mg/kg). 
Ventilator settings were adjusted in order to maintain normoxemia (SaO
2
 90-95%) 
and normocapnia (PaCO
2
 30-45 torr [4.0-6.0 kPa]; end tidal CO
2
 30-45 torr [4.0-6.0 
kPa]). A servo-controlled heating mattress and a heating radiator were used to 
maintain a rectal temperature between 38 and 39°C. At the end of the experiment 
the animals were euthanized.
INSTRUMENTATION - Immediately after induction of anesthesia, intravascular 
catheters were surgically inserted. The tip of the arterial catheter (16 G/13 cm/1.7 
mm, 681002, Secalon TTM, Becton, Dickinson and Company, Oxford, United 
Kingdom) was positioned in the abdominal aorta via the left femoral artery and 
connected to the arterial limb of the TPUD extracorporeal circuit. This circuit was 
primed with 2.7 ml isotonic saline. A double-lumen central venous catheter (16 
G/16 cm/1.7 cm, Arrow, Arrow International, Reading, USA) was inserted via the 
right femoral vein with the position of the tip in the inferior vena cava. One of the 
lumen of this central venous catheter was connected to the venous limb of the 
AV-loop for TPUD cardiac output measurement. The other lumen was used for 
administration of fluids and medication. 
 A left-sided thoracotomy was performed and a non-stretch, thin-walled 
vascular graft (internal diameter 4 - 6 mm, Gore-Tex®, W.L. Gore & Associates Inc., 
Arizona, USA) was inserted between the descending aorta and the left pulmonary 
artery. After a loading dose of heparin (100–120 IU/kg) continuous infusion of 
heparin (50-100 IU/kg/h) was used to prevent shunt thrombosis. Adequately sized 
perivascular ultrasonic transit-time flow probes (PAX series, Transonic® Systems 
Inc, Ithaca, USA) were used to measure blood flow in the main pulmonary artery 
(COufp) and proximal (QAOpre) and distal (QAOpost) to the aorto-pulmonary shunt on 
the descending aorta. We chose to place the flow probe around the main pulmonary 
502337-L-sub01-bw-Vrancken
74
CHAPTER 4
artery and not the ascending aorta as this latter 1) does not include the coronary 
blood and 2) does not measure true systemic flow in the presence of a left-to-right 
shunt. A flow probe positioned around the main pulmonary artery (proximally to 
the shunt insertion) measures right ventricular output which reflects the systemic 
blood flow in the absence of an intracardiac shunt, irrespective of a potential 
left-to-right aorto-pulmonary shunt.  
Before each TPUD-measurement the adequacy of signal strength of the flow 
probes was checked. The flow probes were checked for zero value directly post 
mortem. 
EXPERIMENTAL PROTOCOL – Following a 15 minute stabilization period the study 
protocol was started (Figure 2). During the experiment the aorto-pulmonary shunt 
was intermittently closed and opened fully by (un)clamping. Cardiac output was 
manipulated by creating hemorrhagic hypotension by gradually withdrawing 
blood, therefore decreasing the mean arterial blood pressure by 10 mmHg over 
a period of approximately 5 minutes. Following each intervention, one session of 
TPUD measurements - consisting of three consecutive injections with 1.0 mL/kg 
isotonic saline - was performed. 
OTHER MEASUREMENTS - We used biomedical data acquisition software (Poly, 
Inspektor Research Systems BV, Amsterdam, The Netherlands) to store COufp, 
QAOpre and QAOpost  with a 200 Hz sampling rate. The difference between COtpud 
and COufp was calculated using the mean value of three consecutive TPUD 
measurements and the mean value of the three corresponding intervals measured 
by the flow probe. Qp/Qs ratio was calculated as (COufp + QAOpre – QAOpost)/COufp.
STATISTICAL ANALYSIS – The method described by Bland and Altman was used to 
assess agreement between the two methods of cardiac output measurement (for 
Figure 2   Study protocol 
Circles indicate the timing of 3 consecutive paired cardiac output measurements.
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groups with closed and open shunt) [32]. Mean bias was defined as the mean 
difference between COufp and COtpud. The mean bias was plotted against the 
mean CO ((COufp + COtpud)/2). Precision was represented by limits of agreement 
(LOA). LOA were calculated by the bias ± 1.96 x SD of the bias. As the number of 
measurement sessions per animal was almost identical we did not correct for 
repeated measurements.  The percentage bias was calculated as 100 x (mean bias/
mean COufp). The percentage error was calculated as 100 x (1.96xSD bias/mean 
COufp) as proposed by Critchley and Critchley [33]. The coefficient of variation 
(CV) for both measurement methods was calculated as 100 times (SD per session 
divided by mean CO per session). The variance of the TPUD-method as well as the 
reference method was also expressed as the coefficient of error (CE) and calculated 
as (SD per session/mean CO per session)/√3 with 3 the number of measurements in 
one session, as described by Cecconi [34]. Mean bias (with 95% confidence interval) 
and limits of agreement were also calculated for COtpud based firstly on the initial 
injection of saline and respectively the mean of the first two and all three injections 
in 1 session for the groups with closed and open shunt. The differences in bias and 
percentage error between measurements with closed and open aorto-pulmonary 
shunt were analyzed using the Mann-Whitney test. A value of 0.05 was chosen as 
the level of significance. A polar plot was used to analyze the agreement in cardiac 
output trend monitoring between the two methods as described by Critchley [35]. 
The distance from the center of the plot (vector) represents the mean change in 
cardiac output. The angle with the horizontal (0-degree radial) axis represents 
disagreement. The less the disagreement between CO measurements, the closer 
data pairs will lie along the horizontal radial axis. Good trending is defined when 
the data lay within the 10% bounderies. 
 SPSS 16.0.01 for Windows® (SPSS Inc., Chicago, USA) was used for statistical 
analysis. The polar plot was created with SigmaPlot for Windows version 7.1 (Systat 
Software, Inc, San Jose, CA).
Results
Table 1 shows the characteristics of the study population. The native ductus arteriosus 
was found to be closed in all animals. 
 A total of 72 sessions (with each 3 measurements) were performed and 
analyzed. Mean COufp was 1.00 L/min. With the shunt closed COufp ranged from 
0.61 to 1.75 L/min (mean 1.10 L/min), with the shunt open from 0.47 to 1.46 L/min 
(mean 0.91 L/min). Mean COtpud was 1.05 L/min. With the shunt closed COtpud 
ranged from 0.61 to 1.87 L/min (mean 1.13 L/min), with the shunt open from 0.54 to 1.51 
L/min (mean 0.98 L/min). With the shunt open mean Qp/Qs ratio was 1.8 (1.3 – 2.6). 
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Figure 3   Bland-Altman plot for the comparison of cardiac output measurements 
with transpulmonary ultrasound dilution (COtpud) and the flow probe 
around the pulmonary artery (COufp) 
The solid line represents mean bias and the dotted lines represent limits of agreement for all data (open 
shunt (circles) and closed shunt (squares)).
Figure 4   Polar plot representing the changes in cardiac output measured with 
transpulmonary ultrasound dilution (COtpud) and the ultrasound flow 
probe around the main pulmonary artery (COufp) with open shunt 
(circles) and closed shunt (squares) 
Dotted lines represent the 10% boundaries (i.e., 10% = 0.1 L/min as mean CO = 1.0 L/min). The distance 
from the center of the plot (vector) represents the mean change in cardiac output. The angle with the 
horizontal (0-degree radial) axis represents disagreement.
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The Bland-Altman plot is shown in Figure 3 for the combined measurements with 
open and closed shunts. Mean bias was 0.05 L/min with a precision (1.96*SD) of 
± 0.19 L/min. Mean bias (SD) was 0.03 (0.09) L/min and 0.07 (0.10) L/min for 
measurements with closed and open shunt respectively. LOA were ± 0.18 L/min and 
± 0.20 L/min for measurements with closed and open shunt respectively, resulting 
in a percentage error of 18% and 20% respectively. Percentage bias was 2.8% for 
measurements with closed shunt and 6.8% for measurements with open shunt. 
The coefficient of variation for COtpud measurements with closed shunt was 3,3%, 
for measurements with open shunt 4,6%. The CV for COufp measurements was 
1,5% for both closed and open shunt. The coefficient of error for COtpud 
measurements with the closed shunt was 1.9%, for measurements with the open 
shunt 2.6%. We noticed no significant correlation between bias and shunt fraction 
(r2 = 0.03), mean arterial blood pressure (r2 = 0.03) weight (r2 = 0.02) and heart rate 
(r2 = 0.02).
 The polar plot (Figure 4) shows good trending in every group as most of the 
data points lay inside the limits of good agreement (i.e., 10% = 0.1 L/min as mean 
CO = 1.0 L/min). Table 2 shows the mean bias and limits of agreement between 
COufp and COtpud based firstly on the initial injection of saline and respectively 
the mean of the first two injections and all three injections for measurements 
with closed and open shunt. With additional injections we noticed a slight, but not 
significant improvement in both the accuracy (bias) and the precision. 
Discussion 
Our study shows that cardiac output can reliably be measured using the TPUD in 
an animal model with a left-to-right shunt. 
 Cardiac output was measured within a large range of Qp/Qs (1.3 – 2.6). With an 
open (left-to-right) shunt accuracy and precision decreased in comparison to 
measurements with a closed shunt. Although almost statistically significant, the 
increased bias was not of any clinical relevance as the bias percentage was still low. 
The altered accuracy is the result of a change in the dilution curve in the presence 
of a left-to-right aorto-pulmonary shunt (Figure 5a and 5b). The initial height of 
the curve is somewhat lower as a smaller amount of indicator reaches the arterial 
sensor during the first pass. However, the downslope is slurred, wider and 
asymmetric due to the shunt circulation. Indicator that has shunted from the 
aorta through the shunt to the pulmonary artery appears later in the curve as it 
reaches the sensor in a delayed way. The primary curve - representing the dilution 
that would have been produced in the absence of shunt circulation - is calculated 
by the COstatus software (Figure 5c). The principle of the software algorithm is to 
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define the optimal segment for extrapolation that can eliminate the influence of 
indicator recirculation. If the elimination is accurate, agreement between the 
dilution technique measurements and the flow probe measurements should be 
close. The overestimation of cardiac output in the presence of a left-to-right shunt 
in our study is possibly due to a somewhat larger elimination of indicator 
recirculation performed by the algorithm from the COstatus. Comparison with 
other methods is hampered. Reports using lithium dilution (LidCO) excluded 
patients with shunts as cardiac output measurements were not reliable [13,14]. 
Transpulmonary thermodilution (TPTD) is widely used and accepted to measure 
cardiac output in adults and older children, but literature about the influence of 
shunts is scarce [36,37]. A recently published article shows that measuring cardiac 
output in lambs with a left-to-right shunt is feasible [31]. 
Our results also showed a subtle decrease in precision in the presence of a 
shunt. However, this finding is not significant and to our opinion merely based on 
coincidence. Despite this small decrease in precision, the percentage error for 
measurements with open shunt were within the acceptable range of less than 30% 
as proposed by Critchley and Critchley and used by others [33,38,39].  Percentage 
error in other pediatric, adult and animal studies (in patients with higher ranges 
of cardiac output and without shunts) with the transpulmonary thermodilution 
technique varies from 9.5 to 31.4% [3].
This study shows that the ultrasound dilution technique is one of the first 
technologies that can reliably measure cardiac output in the presence of a 
significant left-to-right shunt. But as Cecconi and colleagues stated, the 30% 
margin may lead to erroneous conclusions if the precision of the reference 
Figure 5   Examples of TPUD curves (grey) without (a) and with (b) a left-to-right 
shunt of lamb 6 
Notice the change in height and downslope. The pink curves represent the change in ultrasound velocity 
recorded by the venous sensor. Example of a dilution curve during left-to-right shunt (c): the continuous 
line shows the derived curve, the interrupted line (- - -) shows the primary curve after extrapolation and 
elimination of the indicator recirculation  (· · · ·).
(a)                 (b)                      (c) 
primary curve
derived curve
indicator recirculation
s s
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technique is not included [34]. The coefficient of error of our reference method was 
0.9%. The CE of TPUD was 2.6% for measurements with open shunt and 1.9% for 
measurements with closed shunt. This implies that TPUD is about 2.3 times less 
precise than our reference method. In our opinion, this is still very acceptable in 
clinical practice because 1) TPUD is compared to the gold standard for cardiac 
output measurement with excellent precision and 2) CE is equal to or lower than 
in other studies using transpulmonary thermodilution in children, even in the 
presence of a shunt [40-42]. 
 In this study we also compared changes in COufp and COtpud during 
hemorrhage because not only the absolute CO measurement, but also the capability 
to track changes in cardiac output makes a technique more valuable for clinical 
use. As shown in Figure 4 all data pairs – except one – were situated within the 10% 
boundaries. This makes the TPUD a reliable device to measure small changes in 
cardiac output, even in the presence of a shunt. 
 The TPUD technique has many benefits: it uses a non-toxic indicator at body 
temperature, which implies no (thermal) loss of indicator during the measurement 
period. There is also no loss of sampled blood, because all blood is redirected to the 
patient. Set-up time is 6 minutes; results are shown one minute after injection. 
Changes in cerebral blood flow, cerebral blood volume (measured by near infrared 
spectroscopy), heart rate and blood pressure during subsequent actions required 
for TPUD measurements were not clinical relevant in an animal model [29]. This is 
especially important regarding the use of this method in newborn infants who are 
at risk for intracranial haemorrhage as a result of fluctuations in cerebral blood 
flow. TPUD does not require specially designed catheters and can be connected to 
any indwelling catheter (peripheral arterial catheter, umbilical catheters, central 
venous catheter) used in critically ill neonates. Thrombosis of the AV-loop has not 
been reported. A possible limitation of the TUPD technique is fluid overload when 
used repeatedly (especially in neonates) as this method requires repetitive 
injections with isotonic saline. In order to prevent this fluid overload de Boode and 
co-workers advised to perform 2 consecutive measurements (instead of the 3 
advised measurements by the manufacturer), unless the difference between the 2 
measurements exceeds 10% [28]. We confirmed that with additional injections no 
clinically or statistically relevant improvement in accuracy and precision is seen, 
also in the group with open shunt (Table 2). Currently, the TPUD method only 
provides intermittent cardiac output measurements. Continuous cardiac output 
monitoring is only available in a prototype. Invasive blood pressure measurement 
is not possible during the 5-6 minutes period of CO measurements with TPUD. 
 TPUD is to our opinion a feasible method to use in newborns, including 
preterm infants. Vena cava superior flow measurements are nowadays a substitute 
for systemic blood flow in the neonatal intensive care. However, intensive training 
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to optimize measurements is necessary and even with experienced observers 
there is a large inter- and intra-observer variability [43]. Unlike the transpulmonary 
thermodilution (TPTD) method, TPUD uses an indicator at body temperature. 
Although CO measurements are feasible in presence of a left-to-right shunt with 
TPTD, the results are less precise than with TPUD [31]. Especially the necessity for 
a dedicated catheter makes the use of TPTD less attractive in newborn infants as 
this catheter cannot be used in children smaller than 3.5 kg.
 Our study has some limitations. First, we used only a small numbers of 
animals. Second, possible interatrial shunting through a patent foramen ovale 
(PFO) was not ruled out. This phenomenon is often seen in neonates with a 
(moderate to large) patent ductus arteriosus [44]. The presence of a patent foramen 
ovale can alter the effect of a ductus arteriosus by decompressing the left atrium. 
The right ventricular output then might consequently be higher than the left 
ventricular output. Although no echocardiographic studies were done, no large 
PFO was expected as QAOpre was significant higher than COufp with an open shunt. 
 We conclude that measuring cardiac output with transpulmonary ultrasound 
dilution is reliable in neonatal lambs in the presence of a significant left-to-right 
shunt covering a wide range of cardiac output. This makes the TPUD technique a 
promising method to measure cardiac output not only in critically ill children, 
but also in neonates, even during the transition from fetal to neonatal circulation. 
Table 2   Mean bias and limits of agreement (LOA) between COufp and COtpud 
based firstly on the initial injection of saline and respectively the mean 
of the first two injections and all three injections for measurements  
with closed and open shunt
Closed shunt** Open shunt**
1  
injection
2  
injections
3  
injections
1  
injection
2  
injections
3  
injections
Bias (L/min)* 0.05 0.04 0.03 0.10 0.08 0.07
LOA (L/min)* ± 0.22 ± 0.18 ± 0.17 ± 0.20 ± 0.22 ± 0.20
*No significant difference between closed and open shunt (p > 0.05); **No significant difference between 
1, 2 and 3 injections (p > 0.05); LOA = limits of agreement
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Abstract 
Objectives: We investigated the accuracy of left-to-right shunt detection using 
transpulmonary ultrasound dilution (TPUD) and compared the agreement between 
Qp/Qs measured by TPUD (Qp/Qs(tpud)) and flow probes (Qp/Qs(ufp)).
Design: A prospective, experimental animal study.
Setting: Animal laboratory. 
Participants: 7 random-bred newborn lambs.
Interventions: After general anesthesia, intravascular arterial and central venous 
catheters were inserted and connected to the TPUD monitor (COstatusTM). A Gore-Tex® 
shunt, inserted between the left pulmonary artery and descending aorta, was 
intermittently opened and closed while cardiac output was varied by blood 
withdrawals. Flow probes were placed around the main pulmonary artery (Qufp) 
and around the descending aorta, respectively proximal (Qpre) and distal (Qpost) 
to the shunt. Qp/Qs(tpud) - measured by using sessions of 3 consecutive injections 
of 1.0 mL/kg of isotonic saline at body temperature - was compared to Qp/Qs(ufp). 
Qp/Qs(ufp) was calculated as (Qufp+Qpre–Qpost)/Qufp. 
Measurements and main results: A total of 72 paired measurement sessions were 
analyzed. Shunt detection by TPUD was reliable: positive predictive value was 86%, 
negative predictive value 100%, sensitivity 100% and specificity 83%. Bland-Altman 
analysis comparing Qp/Qs(tpud) and Qp/Qs(ufp) showed an overall mean bias (SD) 
of 0.1 (0.3), limits of agreement of ± 0.6 and a percentage error of 34.8%. 
Conclusions: TPUD detects (left-to-right) shunts with high sensitivity and 
specificity. The qualitative diagnostic accuracy of TPUD for shunt detection is 
high. Modification of the algorithm seems required as shunt quantification by 
TPUD is accurate, but not yet very precise. 
Keywords: Cardiac output; ductus arteriosus, patent;  infant, newborn; left-to-right 
shunt; transpulmonary ultrasound dilution
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Introduction
Patients in neonatal intensive care units present with cardiac anomalies and/or 
intra- or extracardiac shunts. Especially in premature infants the incidence of a 
patent ductus arteriosus (PDA) with left-to-right shunt is high [1,2]. A hemodynamic 
significant patent ductus arteriosus (hsPDA) is associated with increased morbidity 
(pulmonary edema, increased risk of pulmonary hemorrhage, bronchopulmonary 
dysplasia, intraventricular hemorrhage, necrotizing enterocolitis and renal failure) 
due to an increase in pulmonary blood flow and a decrease in systemic blood flow 
caused by a steal of blood from the systemic into the pulmonary circulation [3-6]. 
Early and accurate diagnosis of hsPDA and subsequent early treatment might reduce 
these complications. However, nowadays no uniform criteria are available for 
diagnosing hsPDA. Therefore, a combination of repetitive clinical evaluation, echo- 
cardiographic studies and biochemical markers (B-type natriuretic peptide (BNP) 
and its N-terminal fragment, NT-proBNP) is used to individualize management 
[5,7,8]. Echocardiography is the clinical gold standard for the assessment of a 
hsPDA using measurements of left heart dimension, shunt directions and ductal 
diameter. A review of the literature shows a wide variety in the echocardiographic 
definition of hsPDA [9-12] and the optimal timing for screening remains unclear. 
Although there is a widespread interest in functional echocardiography among 
neonatologists, the method is not yet used as a standard diagnostic tool, is not 
always bedside available and has a considerable operator variability [13].
 Assessing the magnitude of the left-to-right shunt fraction (pulmonary over 
systemic blood flow ratio = Qp/Qs) might be preferable in order to determine if a 
PDA is hemodynamically significant as low systemic blood flow is associated with 
impaired end-organ perfusion [14]. Advanced hemodynamic monitoring using 
transpulmonary ultrasound dilution technology (TPUD) not only measures the 
actual cardiac output (systemic blood flow) and hemodynamic volumes, but also 
detect and quantifies (ductal) shunts (expressed as (Qp/Qs)). Detection and 
quantification of a left-to-right shunt could be a helpful tool in the diagnosis and 
treatment of hsPDA. TPUD is based on changes in ultrasound velocity in arterial 
blood after central venous injection of isotonic saline at body temperature [15]. As 
the technique uses an extracorporeal loop that is connected in between an 
indwelling central venous and arterial catheter of any type, TPUD is applicable in 
(preterm) neonates without technical restraints. Set up time is 6 minutes. TPUD 
technology has been validated for estimation of cardiac output in adults [16,17], 
children [18-20] and newborn lambs with and without a left-to-right shunt and 
acute lung injury [21-23]. Recently, authors demonstrated TPUD to be an accurate 
tool to detect (small) intracardiac shunts when compared with echocardiography 
peri-operatively in children [24,25].
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 The objective of this study was to analyze the sensitivity and specificity of 
shunt detection by TPUD and to compare the agreement of Qp/Qs measurement by 
TPUD (Qp/Qs(tpud)) and Qp/Qs measurement by ultrasonic transit-time flow probes 
(Qp/Qs(ufp)) – which is considered the gold standard – in an experimental neonatal 
lamb model with a artificial left-to-right shunt under different levels of cardiac 
output.
Methods
GENERAL  – The initial study protocol was designed to validate only cardiac output 
measurements using TPUD in an animal model with a left-to-right shunt under 
different hemodynamic conditions [22]. The data obtained for this study were 
collected during the initial study. The study protocol was realized in accordance 
with Dutch national legislation concerning guidelines for the care and use of 
laboratory animals, approved by the Ethical Committee on Animal Research of the 
Radboud University Nijmegen (RU-DEC #2008-117) and performed in seven 
random-bred lambs (3.5 - 8.3 kg (median 6.5 kg), 5 - 21 days (median 12 days)) under 
general terminal anesthesia. Premedication consisted of the i.m administration of 
ketamine (10 mg/kg), atropine (0.03 mg/kg), midazolam (0.2 mg/kg) and i.v 
administration of propofol (2 mg/kg). The lambs were orotracheally intubated 
(cuffed endotracheal tube (ID 4-5 mm; Kruse, Marslev, Denmark)) and the lungs 
mechanically ventilated in a pressure-controlled mode using a Datex Ohmeda 
Excel 210 SE anesthesia machine (GE Healtcare, Waukesha, Wisconsin, USA). 
Anesthesia was maintained with isoflurane inhalation (0.5-2.0 vol%) and 
continuous i.v. administration of sufentanyl (15-20 μg/kg/h), midazolam (0.2 mg/
kg/h) and pancuronium (0.02 mg/kg/h) after a loading dose of 0.05 mg/kg. The 
ventilator settings were adjusted during and after thoracotomy in order to 
maintain normoxemia (SaO
2 
90-95%) and normocapnia (PaCO
2
 4.0-6.0 kPa; 
end-tidal CO
2
 4.0-6.0 kPa). The depth of anesthesia was repeatedly assessed by 
clinical parameters (heart rate, spontaneous ventilation or elevated arterial 
pressure) and pain stimuli and was adjusted when necessary. At the end of the 
experiment the animals were euthanized using a lethal dose of pentobarbital (150 
mg/kg) intravenously. 
INSTRUMENTATION - Intravascular catheters were surgically inserted via the 
femoral vessels. A double-lumen central venous catheter (16 G/16 cm/1.7 cm, Arrow, 
Arrow International, Reading, USA) was positioned with the tip in the inferior 
vena cava. One lumen was used for connection with the venous limb of the AV-loop 
for TPUD measurement. The other lumen was used for administration of fluids 
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and medication. The tip of the arterial catheter (16 G/13 cm/1.7 mm, 681002, 
Secalon TTM, Becton, Dickinson and Company, Oxford, United Kingdom) was 
positioned in the abdominal aorta and connected with the arterial limb of the 
extracorporeal circuit for TPUD measurement. Another arterial catheter was 
inserted in the opposite femoral artery to measure blood pressure continuously. A 
non-stretch, thin-walled vascular graft (ID 4 - 6 mm, Gore-Tex®, W.L. Gore & 
Associates Inc., Arizona, USA) was then inserted between the descending aorta and 
the left pulmonary artery through a left-sided thoracotomy. The native ductus 
arteriosus was closed in all animals. After a loading dose of heparin (100–120 IU/
kg), continuous infusion of heparin (50-100 IU kg/h) was used to prevent shunt 
thrombosis. In order to measure Qp/Qs ratio and shunt flow, perivascular 
ultrasonic flow probes (PAX series, Transonic Systems Inc, Ithaca, USA) were placed 
around the main pulmonary artery (Qufp) and proximal (Qpre) and distal (Qpost) 
to the aorto-pulmonary shunt on the descending aorta. 
PROTOCOL - The study protocol was started after a stabilization period of 15 
minutes (Figure 1). During the experiment the aorto-pulmonary shunt was 
intermittently closed and opened by (un)clamping. Changes in cardiac output 
were created using hemorrhagic hypotension by successive periods of blood 
withdrawals (mean 6 ± 2 mL/kg/withdrawal, mean 19 ± 3 mL/kg in total), aiming 
for a decrease in mean arterial blood pressure by 10 mmHg over a period of 
approximately 5 minutes. Following each intervention and a stabilization period 
of 15 minutes, one session of TPUD measurements - consisting of three consecutive 
injections with 1.0 ml/kg isotonic saline - was performed. Operators performing 
TPUD measurements were not blinded for the shunt status.
Figure 1   Study protocol 
Circles indicate the timing of 3 consecutive paired hemodynamic measurements (white circles = 
measurements with shunt open, grey circles = measurements with shunt closed).
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TRANSPULMONARY ULTRASOUND DILUTION CARDIAC OUTPUT (TPUD) – TPUD 
technology is operator independent and uses an extracorporeal arteriovenous 
loop (priming volume 2.7 mL for neonates) that can be connected to any indwelling 
arterial and central venous catheter, including umbilical catheters. A peristaltic 
pump prevents stasis of blood and provides stable blood flow (6-12 mL/min) during 
measurement sessions. The technique is based on differences in ultrasound velocity 
between blood (1570-1585 m/s) and isotonic saline (used as indicator) (1533 m/s). Isotonic 
saline at body temperature is injected into the venous limb of the AV-loop and 
detected by the venous sensor situated nearby the injection site. A venous dilution 
curve (Figure 2, pink curves) is produced as a result of a decrease in blood 
ultrasound velocity. The COstatus software calculates the exact injected volume. 
The saline passes the venous catheter, mixes with blood while entering the inferior 
vena cava and the right heart, passes through the lungs and the left heart and 
finally arrives in the abdominal aorta were the arterial catheter is situated. The 
arterial sensor – positioned at the arterial side of the AV-loop –measures the 
decrease in ultrasound velocity in the blood giving the concentration of the 
injected indicator and a dilution curve is obtained (Figure 2, grey curves). After 3 
measurements the loop is flushed and the pump stopped. 
In the presence of a left-to-right shunt, part of the indicator makes an extra 
passage through the lungs before reaching the arterial catheter. This prolongs the 
disappearance time of the dilution curve. Therefore, the dilution curve has a 
normal appearance time, a decreased amplitude and an asymmetry in the down 
slope versus upslope in comparison with a dilution curve without shunts (Figure 2b). 
Detection and quantity assessment of Qp/Qs is based on a mathematical model of 
Figure 2   Examples of TPUD curves (grey) without (a) and with (b) a left-to-right 
shunt 
The initial (pink) curves represent the change in ultrasound velocity recorded by the venous sensor. 
Ta= appearance time (time from the beginning of the venous injection to the beginning of the dilution curve 
(s)), a = the upslope of the horde at half maximum height (%) and b = full width at half maximum height (s).
(a) (b)
b 
R = b/a 
a 
Ta 
s s
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proportionality of increased asymmetry, using the appearance time (Ta) (= time 
from the beginning of the venous injection to the beginning of the dilution curve (s)) 
and asymmetry of the dilution curve (= ratio of total full width at half maximum 
height (b) and the upslope of the horde at half maximum height (%) (a)) (Figure 2b) 
[26]. As the calculated area under the obtained curve is larger than the area of the 
predicted normal dilution curve in the presence of a left-to-right shunt, the Qp/Qs 
ratio will be greater than 1.
 Cardiac output, hemodynamic volumes values and – in case of a detected 
shunt – Qp/Qs ratio are displayed on the COstatusTM (Transonic Systems Inc, Ithaca, 
USA). Calculation of the cardiac output and volumes is based on the obtained 
ultrasound dilution curve(s) and generated by the CO-status software (Transonic 
Systems Inc, Ithaca, USA), first described by Krivitski et al [15].
OTHER MEASUREMENTS - We used biomedical data acquisition software (Poly, 
Inspektor Research Systems BV, Amsterdam, The Netherlands) to store Qufp, Qpre 
and Qpost with a 200 Hz sampling rate. The exact span of the TPUD measurements 
was marked in the registration. Qp/Qs ratio was calculated using the following 
equation: Qp/Qs = (Qufp+Qpre–Qpost)/Qufp. Flow probes were calibrated before 
each experiment. Before every measurement the adequacy of signal strength of 
the probes was checked. Additional acoustic gel was applied in case of decreased 
signal strength (quality < 0.7 on analog meter in “TEST” mode).
DATA ANALYSIS – Shunt detection was assessed using sensitivity and specificity. 
The positive likelihood ratio was calculated as sensitivity divided by (1 – specificity); 
the negative likelihood ratio as (1 – sensitivity) divided by specificity. The Pearson 
correlation was used to compare Qp/Qs measured by TPUD (Qp/Qs(tpud)) and 
Qp/Qs measured by flow probes (Qp/Qs(ufp)). In addition, the data were analyzed 
using the method described by Bland-Altman. Mean bias was defined as the mean 
difference between Qp/Qs(tpud) and Qp/Qs(ufp). The mean bias was plotted against 
the mean Qp/Qs ((Qp/Qs(ufp) + Qp/Qs(tpud))/2). Precision was represented by limits 
of agreement (LOA) and calculated as mean bias ± 1.96 x SD(bias). When corrected 
for repeated measurements LOA did not change [27]. Percentage error was 
calculated as 100 x (1.96 x SD(bias)/mean Qp/Qs(ufp)). Qp/Qs changes of both 
methods after shunt opening/closure and after hemorrhage were calculated. 
Correlation between changes in Qp/Qs(tpud) and Qp/Qs(ufp) was determined. 
Mean bias and limits of agreement between Qp/Qs(tpud) and Qp/Qs(ufp) were also 
calculated  based on the initial injection of saline and respectively the mean of the 
first two and all three injections in 1 session; a Kruskal-Wallis test was used to 
determine any significance (p < 0.05). SPSS 20.0 for Windows® (SPSS Inc., Chicago, 
USA) was used for statistical analysis.
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Results
A total of 72 measurement sessions were performed and analyzed. Qufp ranged 
from 0.61 to 1.75 L/min (mean 1.10 L/min) and from 0.47 to 1.46 L/min (mean 
0.91 L/min) with the shunt closed and open, respectively. With the shunt closed 
mean Qp/Qs(ufp) was 1.0 (0.8 – 1.1); with the shunt open mean Qp/Qs(ufp) was 1.8 
(1.3 – 2.6). Table 1 shows the results for shunt detection by TPUD: positive predictive 
value was 86%, negative predictive value 100%, sensitivity 100% and specificity 
83%. The positive likelihood ratio was 5.8, the negative likelihood ratio 0.0. 
Comparisons between all detected absolute values of Qp/Qs(tpud) and Qp/Qs(ufp) 
(including 6 false positive measurements) and changes in Qp/Qs after opening/
closure of the shunt and hemorrhage between the 2 methods are shown in Figure 3a 
and 3b respectively. The Pearson correlation for absolute values between the 
2 methods was r2 = 0.40 (p = 0.01); the correlation for changes r2 = 0.82 (p = 0.01). 
Bland-Altman analysis for absolute values between Qp/Qp(tpud) and Qp/Qs(ufp) 
showed an overall mean bias (SD) of  0.1 with limits of agreement of  ± 0.6 and a 
percentage error of 34.8% (Figure 4). There was no significant correlation between 
the bias in Qp/Qs measured by both methods and the cardiac output (r2 = 0.13). Bias 
and shunt size correlated negatively (r2 = 0.50). Table 2 shows the mean bias and 
limits of agreement between Qp/Qs(ufp) and Qp/Qs(tpud) based firstly on the 
initial injection of saline and respectively the mean of the first two injections and 
all three injections. With additional injections we noticed a slight, but non-signif-
icant improvement in both the accuracy and the precision (p = 0.96).
Table 1   Shunt detection using transpulmonary ultrasound dilution (TPUD)
Shunt No shunt PPV 86%
Detection 37 6 43 NPV 100%
No detection 0 29 29 Sensitivity 100%
Total 37 35 72 Specificity 83%
LR+ 5.8
LR- 0.0
PPV = positive predictive value, NPV = negative predictive value, LR+ = positive likelihood ratio, LR- = 
negative likelihood ratio.
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Figure 3   Pearson correlation between Qp/Qs(tpud) and Qp/Qs(ufp) for all detected 
measurements (A) (grey squares = false positives, white circles = Qp/
Qs(ufp) measurements with open shunt) and for changes in Qp/Qs(tpud) 
and Qp/Qs(ufp) after shunt opening/closure and hemorrhage (B)
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Discussion
Our study showed that the transpulmonary ultrasound dilution method is capable 
of detecting left-to-right shunts with a high sensitivity and specificity. Quantification 
of the shunt (expressed as Qp/Qs) correlates moderately with Qp/Qs measured by 
flow probes.
The use of algorithms and changes in dilution curves in the presence of 
cardiac shunts for the detection and quantification of shunts dates from the 1950’s 
[26,28,29]. However, TPUD is the first hemodynamic monitoring device with the 
ability to detect and quantify shunts usable in a neonatal population as it uses no 
toxic indicator and does not require specific large catheters. In neonatal intensive 
Figure 4   Bland-Altman plot for the assessment of agreement between Qp/Qs 
measured by transpulmonary ultrasound dilution ((Qp/Qs(tpud)) and Qp/
Qs measured by flow probes  ((Qp/Qs(ufp)) 
The solid line represents mean bias and the dotted lines represent limits of agreement for all data (false 
positives (grey squares), open shunt (white circles)).
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Table 2   Mean bias and limits of agreement between Qp/Qs(ufp) and Qp/Qs(tpud) 
based firstly on the initial injection of saline and respectively the mean 
of the first two and all three injections
Qp/Qs measurement sessions
1 injection 2 injections 3 injections
Qp/Qs(tpud) – Qp/Qs(ufp)* 0.11 0.08 0.07
Limits of agreement* ± 0.59 ± 0.61 ± 0.67
*= no significant difference between 1, 2 or 3 injections per session (Kruskal-Wallis, p = 0.96)
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care, patients present with a range of (congenital) cardiac anomalies, with the 
highest incidence of PDA, especially in preterm infants. 
 Early diagnosis of hsPDA is important to consider initiation of therapy and 
prevent PDA-related morbidity. As mentioned previously, the definition of hsPDA is 
not (yet) standardized. Echocardiographic parameters used for defining hsPDA are 
LA/Ao ratio and ductal diameter, sometimes in combination pulsed and color 
Doppler parameters (diastolic disturbances in main pulmonary artery, shunt 
direction, et cetera) and reversed flow in the descending aorta. Only a few studies 
mention the Qp/Qs ratio as a parameter [7,30]. Evans classified Qp/Qs-ratio < 1.5 as 
small, Qp/Qs-ratio 1.5 – 2.0 as moderate and Qp/Qs-ratio > 2 as large shunt in 
prematures < 30 weeks [7]. 
 The sensitivity of shunt detection using TPUD was 100% with a specificity of 
83% as a result of 6 false positive measurements, findings that are in agreement 
with current reports in the literature: Shih found a success rate in detecting 
intracardiac right-to-left shunts of 86% when Qp/Qs < 0.8 and 100% when Qp/Qs < 
0.5 in a piglet model using TPUD compared to UFP [31]. Boehne reported a 
sensitivity of 100% and specificity of 92.8% in 20 patients with a left-to-right shunt 
(threshold Qp/Qs > 1.3) when comparing TPUD and cardiac catheterization [32]. 
Lindberg confirmed these results in 21 children with pre-operatively intracardiac 
left-to-right shunts: sensitivity 100%, specificity 92% [24]. Although the specificity 
in our study is comparable with the mentioned studies, our false positive rate 
might even be better: despite the fact that the shunt was visibly closed in one 
measurement session, there was still a Qp/Qs(ufp) of 1.15 which was detected by 
TPUD (Figure 3A). In addition, we did not perform echocardiography to exclude 
any other anatomical intracardiac left-to-right shunts (i.e patent foramen ovale). 
These shunts could be detected by TPUD but missed with the current calculation 
of Qp/Qs(ufp). 
 In clinical practice incidence of PDA in (extremely) preterm infants varies 
between 20% and 60%. As the positive likelihood ratio in our study is 5.8, the 
posttest probability of having a left-to-right shunt with a positive test will increase 
to 59 to 89.5%. This suggests that TPUD is an accurate screening method for 
diagnosing a left-to-right shunt. A small number of patients without PDA will also 
test positive and might be unnecessary exposed to an additional echocardiography 
at that time point. However, the diagnosis of PDA by TPUD should not solely be 
based on an increased Qp/Qs ratio, but also on changes in cardiac output (systemic 
blood flow) and hemodynamic volumes: in the presence of a left-to-right shunt 
systemic blood flow will decrease (as a result of ductal steal) while total end 
diastolic volume will increase (as a result of a increased left atrium volume) [33].
 Besides detection, TPUD also quantifies the shunt fraction by calculating the 
Qp/Qs ratio. We opted to use all the detected Qp/Qs ratios (inclusively the false 
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positive ones) for further analysis as it is not possible – based on the obtained 
values of the TPUD – to clinically distinct between true and false positive 
measurements. Correlation between the detected Qp/Qs(tpud) and Qp/Qs(ufp) was 
moderate. In this study we found an overall mean bias of 0.1 with limits of 
agreement of ± 0.6 when comparing Qp/Qs(tpud) and Qp/Qs(ufp), resulting in an 
overall good accuracy and moderate precision (percentage error 34,8%). There is a 
noticeable trend  that TPUD overestimates Qp/Qs in small shunts and underestimates 
Qp/Qs in the large shunts. These finding are possibly due to an inaccuracy in the 
current algorithm which is used to predict the area under the normal dilution 
curve. This would also explain the deviation in bias in relation to the shunt size. 
Also, the lack of information on possible intracardiac shunts (i.e patent foramen 
ovale) could influence shunt flow in a dynamic manner and therefore the 
relationship between the two Qp/Qs measurements. Finally, the moderate 
precision could be influenced by the absence of actual shunt flow measurement, as 
it is not possible for flow probes to measure flow through a vascular Goretex graft. 
Flow probes were placed before and after the shunt insertion on the descending 
aorta. Subsequently, Qp/Qs(ufp) was calculated using 3 different flow probe 
measurements which might increase the chance of error. This is substantiated by 
the fact that after shunt closure Qp/Qs(ufp) ratios varied between 0.8 and 1.1, 
while they should ideally approximate 1. 
 Lindberg also determined Qp/Qs by UFP in 8 of 21 children and found a mean 
bias of -0.4 with a percentage error of 54% when comparing Qp/Qs(tpud) and Qp/
Qs(ufp) [24]. In contrast, in a group of post cardiac surgery children with very 
small residual shunts (Qp/Qs 0,8 – 1,3) quantification of shunts by TPUD was in 
agreement  with echocardiographic estimates [25]. Based on our results, we believe 
that single absolute Qp/Qs(tpud) values should not be used to quantify left-to-right 
shunts in the clinical setting. An adaptation of the algorithm for calculation Qp/
Qs by the manufacturer might possibly enhance the precision of the method. 
However, TPUD is a reliable device to detect (even small) changes in Qp/Qs as 
shown in Figure 3b.
 Despite this current lack of precision for absolute Qp/Qs estimates, we believe 
that TPUD has potential for future neonatal clinical use. Major advantage is the 
possibility of simultaneous monitoring of various hemodynamic parameters at 
bedside. Repetitive measurements could reveal changes in cardiac output, volumes 
and Qp/Qs ratios and optimize the moment for further diagnostic evaluation. 
When used in clinical practice it is obvious that a left-to-right shunt detected by 
TPUD might be caused by a PDA, but also by other intra- (open foramen ovale, 
ventricle septum defect) or extra-cardiac (aorto-pulmonary shunt) shunts. 
Therefore, echocardiography is indispensible to exclude congenital heart diseases 
before starting treatment for ductal closure. After initiating medical therapy for 
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ductal closure, repetitive measurements can provide information on the efficacy 
of therapy as TPUD might be used as a monitoring device. Further research in this 
clinical setting is warranted. 
 It might be presumed that hemodynamic monitoring using TPUD could lead 
to fluid overload when used repeatedly as this method requires 3 repetitive 
injections with 1.0 mL/kg isotonic saline per session. Especially in the preterm 
infant with hsPDA, strict fluid management is necessary. Our data show that with 
additional injections no clinically or statistically relevant improvement in 
accuracy and precision of quantifying Qp/Qs was seen (Table 2). We therefore 
advise to perform 2 consecutive measurements. Only when there is a discrepancy 
in shunt detection or a difference in cardiac output of more than 10% between 
these 2 measurements, a third measurement should be performed.  
 Limitations: Due to insertion of vascular grafts of 4 – 6 mm, we were not able 
to perform measurements with very small shunts (Qp/Qs 1.1 – 1.3) and data on 
detection and quantification of Qp/Qs by TPUD in small shunts are therefore 
lacking. A disadvantage of TPUD is that invasive blood pressure measurement is 
not possible during the 5-6 minute measurement period.
Conclusions
We conclude that transpulmonary ultrasound dilution is a hemodynamic 
monitoring device that is able to detect (left-to-right) shunts with high predictive 
value. Quantification of the shunt (expressed as Qp/Qs ratio) by TPUD is possible 
but lacks precision in its current application; on the other hand, trending ability 
to detect changes in Qp/Qs is high. We believe that the TPUD hemodynamic 
monitoring system can be used in the neonatal period as an initial screening tool 
to detect (left-to-right) shunts) and monitor ductal closure after starting initial 
medical treatment.
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Abstract 
Purpose: To analyze changes in cardiac output and hemodynamic volumes using 
transpulmonary ultrasound dilution (TPUD) in a neonatal animal model under 
different hemodynamic conditions. 
Methods: 7 lambs (3.5-8.3 kg) under general anesthesia received arterial and 
central venous catheters. A Gore-Tex® shunt was surgically inserted between the 
descending aorta and the left pulmonary artery to mimic a patent ductus 
arteriosus. After shunt opening and closure, induced hemorrhagic hypotension 
(by repetitive blood withdrawals) and repetitive volume challenges, the following 
parameters were assessed using TPUD: cardiac output (COtpud), active circulating 
volume index (ACVI), central blood volume index (CBVI) and total end-diastolic 
volume index (TEDVI). Cardiac output was also measured by an ultrasonic flow 
probe around the main pulmonary artery (COufp).
Results: 27 measurement sessions were analyzed. After shunt opening, there was 
a significant increase in TEDVI and a significant decrease in cardiac output with 
minimal change in CBVI and ACVI. With shunt closure, these results reversed. 
After progressive hemorrhage, cardiac output and all volumes decreased 
significantly, except for ACVI. Following repetitive volume resuscitation, cardiac 
output increased and all hemodynamic volumes increased significantly.
Correlations between changes in COufp and changes in hemodynamic volumes 
(ACVI 0.83; CBVI 0.84 and TEDVI 0.78 respectively) were (slightly) better than 
between changes in COufp and changes in heart rate (0.44) and central venous 
pressure (CVP) (0.7). 
Conclusion: Changes in hemodynamic volumes using TPUD were as expected 
under different conditions. Hemodynamic volumetry using TPUD might be a 
promising technique that has the potential to improve the assessment and 
interpretation of the hemodynamic status in critically ill newborns and children.
Keywords: child; infant, newborn; cardiac output; transpulmonary ultrasound 
dilution technique; ductus arteriosus; hemodynamic volumes
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Introduction 
Hemodynamic monitoring is an integral part of adult critical care and used with 
increasing interest in critically ill children [1-4]. In the last decades a range of new 
cardiac monitoring devices (e.g. methods based on Fick principle, indicator dilution, 
Doppler ultrasound, arterial pulse contour or thoracic electrical impedance) have 
been introduced to provide information about the patient’s hemodynamic state 
[1]. Most of these techniques are not applicable in neonates due to technical and/or 
vascular access restraints or potential toxicity of the indicator. Some of them have 
not (yet) been validated or are not accurate, especially in the presence of intra- or 
extracardiac shunts [5]. Transpulmonary thermodilution (TPTD) is regularly used 
in pediatric intensive care patients, but due to the necessity of a dedicated 
thermistor tipped catheter not applicable in infants < 3.5 kg. Therefore, the 
estimation of cardiac output and intravascular volume status in neonates is still 
mainly based on clinical parameters, despite their proven unreliability [6]. 
Functional echocardiography provides a lot of hemodynamic information and 
allows the monitoring of response to treatment, but is operator-dependent, 
requires training and is not always available at the bedside at any given time [7]. 
 Transpulmonary ultrasound dilution (TPUD) is a relatively new method for 
estimation of cardiac output, which has been validated in adults [8,9] and recently 
in pediatric patients [10]. The main advantage of this method is that it can be used 
with any (peripheral or umbilical) arterial and central venous catheter. The TPUD 
has proven to be easy applicable, reproducible and safe with acceptable accuracy 
and precision for measuring cardiac output, even in the presence of a significant 
left-to-right shunt in a juvenile animal model [11-13]. After injection of isotonic 
saline the ultrasound velocity in the blood will decrease and a dilution curve is 
obtained. Analysis of this dilution curve enables the calculation of cardiac output 
and several hemodynamic volumes, such as total end-diastolic volume (TEDV), 
central blood volume (CBV) and active circulation volume (ACV) [14]. TEDV is a 
surrogate for the end-diastolic heart volume (comparable to global end diastolic 
volume (GEDV) used by TPTD). CBV estimates the blood volume in the heart, lungs 
and large vessels (volume between the central venous and arterial catheter), 
resembling intrathoracic blood volume (ITBV). ACV – a new variable – differs from 
total blood volume, as it does not include the blood volume in the small peripheral 
vessels/microcirculation (‘high resistance vessels’). Several studies evaluated 
hemodynamic volumetry in pediatric animal models or critically ill children – all 
using TPTD technology - and found in agreement with studies in adult patients, 
that changes in cardiac output or stroke volume index correlated better with 
changes in GEDVI than with changes in CVP [15-18]. Although absolute values of 
GEDVI are not reliable, TPTD derived GEDVI can be used as trend monitor [19]. In 
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analogy with older children we assume it could be beneficial to use hemodynamic 
monitoring - including changes in hemodynamic volumes - in neonates to diagnose 
underlying conditions and improve or adapt treatment modalities.
 The purpose of this study was to describe the effect of hemorrhagic hypotension 
and subsequent volume resuscitation on cardiac output, TEDVI, CBVI and ACVI 
measured by TPUD in an experimental animal model with an intermittently 
opened and closed aortopulmonary shunt.
Methods
STUDY DESIGN – The initial study protocol was designed to validate cardiac output 
measurement using TPUD in an animal model with a left-to-right shunt [13]. The 
data obtained for the current study were collected during the initial study. The 
study protocol was performed in accordance with Dutch national legislation 
concerning guidelines for the care and use of laboratory animals, approved by the 
Ethical Committee on Animal Research of the Radboud University Nijmegen 
(RU-DEC #2008-117). Seven random-bred lambs (3.5 - 8.3 kg, age 5 – 21 days) were 
premedicated with an intramuscular injection of ketamine (10 mg/kg), atropine 
(0.03 mg/kg) and midazolam (0.2 mg/kg)), followed by intravenous administration 
of propofol (2 mg/kg). After orotracheal intubation (cuffed endotracheal tube (ID 
4-5 mm; Kruse, Marslev, Denmark)) they were mechanically ventilated in a 
pressure control mode using a Datex Ohmeda Excel 210 SE anesthesia machine (GE 
Healtcare, Waukesha, Wisconsin, USA) under general anesthesia (isoflurane inhalation 
(0.5-2.0 vol%), intravenous administration of fentanyl (15-20 μg/kg/h), midazolam 
(0.2 mg/kg/h) and pancuronium (0.02 mg/kg/h) after a loading dose of 0.05 mg/kg. 
The ventilator settings were adjusted during and after thoracotomy in order to 
maintain normoxemia (SaO
2
 90-95%) and normocapnia (PaCO
2
 30-45 torr [4.0-6.0 
kPa]; end-tidalCO
2
 30-45 torr [4.0-6.0 kPa]). The depth of anesthesia was repeatedly 
assessed by clinical parameters (heart rate, spontaneous ventilation or elevated 
arterial pressure) and pain stimuli and was adjusted when necessary. 
 Intravascular catheters were inserted by surgical cutdown via the femoral 
vessels. The tip of the arterial catheter (16 G/13 cm/1.7 mm, 681002, Secalon TTM, 
Becton, Dickinson and Company, Oxford, United Kingdom) was positioned in the 
abdominal aorta and connected with the arterial limb of the extracorporeal 
circuit for TPUD measurement. A double-lumen central venous catheter (16 G/16 
cm/1.7 cm, Arrow, Arrow International, Reading, USA) was positioned with the tip 
in the inferior vena cava. One lumen was used for connection with the venous 
limb of the AV-loop for TPUD measurement. The other lumen was used for 
administration of fluids and medication. Another arterial catheter was inserted in 
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the opposite femoral artery to measure blood pressure continuously. A non-stretch, 
thin-walled vascular graft (ID 4 - 6 mm, Gore-Tex®, W.L. Gore & Associates Inc., 
Arizona, USA) was then inserted between the descending aorta and the left 
pulmonary artery through a left-sided thoracotomy. After a loading dose of 
heparin (100–120 IU/kg), continuous infusion of heparin (50-100 IU/kg/h) was used 
to prevent shunt thrombosis. In order to measure the cardiac output and shunt 
fraction, we placed perivascular ultrasonic flow probes (PAX series, Transonic 
Systems Inc, Ithaca, USA) around the main pulmonary artery (COufp) and proximal 
(QAOpre) and distal (QAOpost) to the aortopulmonary shunt on the descending aorta.
STUDY PROTOCOL (Figure 1) – After a stabilization period of 15 minutes cardiac 
output and hemodynamic volumes were measured under different hemodynamic 
conditions: 1) phase 1 = normovolemia with open and closed shunt (by (un)clamping 
the aortopulmonary shunt) , 2) phase 2 = hypovolemia, which was effected by 
stepwise withdrawal of blood from the central venous catheter until a decrease in 
mean arterial blood pressure of 10 mmHg within approximately 5 minutes was 
established (total of 3 times) and 3) phase 3 = volume expansion, which was 
achieved by stepwise administration of packed red blood cells erythrocyte 
concentrate (3 times 10 mL/kg). Sessions of TPUD measurements - consisting of 
three consecutive injections of 1.0 mL/kg isotonic saline at body temperature – 
were performed after a stabilization period of fifteen minutes following each 
intervention. At the end of the experiment the animals were euthanized using a 
lethal dose of pentobarbital (150 mg/kg). 
Figure 1   (Initial) study protocol
Pink squares/black rim = TPUD measurements with closed shunt, white squares/black rim = TPUD 
measurements with open shunt. Bold squares = measurements for data analysis in this study. Interrupted 
arrows = blood withdrawal/hemorrhage, black arrows = volume resuscitation
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TRANSPULMONARY ULTRASOUND DILUTION CARDIAC OUTPUT (TPUD) – The 
dilution method is based on the physiological principle that ultrasound velocity is 
different in both blood (1570-1585 m/s) and indicator (1533 m/s). It uses a disposable 
extracorporeal arteriovenous loop (priming volume 2,7 mL), which is connected to 
the inserted catheters. A peristaltic pump (6-12 mL/min) prevents stasis of blood 
and provides stable blood flow during the 6 minute measurement sessions. Isotonic 
saline at body temperature is injected into the venous limb of the AV-loop. A venous 
sensor – situated nearby the injection site - calculates the exact volume of injected 
saline. The saline passes the venous catheter, mixes with blood while entering the 
inferior vena cava and the right heart, passes through the lungs and the left heart 
and finally arrives in the descending aorta where the arterial catheter is situated. 
In the presence of a left-to-right shunt, part of the indicator recirculates and makes 
an extra passage through the lungs before reaching the arterial catheter. The 
arterial sensor – positioned at the arterial side of the AV-loop - measures the 
decrease in ultrasound velocity of blood due to the concentration of the injected 
indicator and a dilution curve is obtained. After 3 measurements the loop is 
flushed and the pump stopped.
 Cardiac output and hemodynamic volume values (indexed by weight) are 
displayed on the CO-statusTM monitor screen (Transonic Systems Inc, Ithaca, USA). 
Calculation of the aforementioned parameters is based on the ultrasound dilution 
curve(s) and generated by the CO-status software (Transonic Systems Inc, Ithaca, 
USA), first described by Krivitski et al [14] (Figure 2). An extensive description and 
calculation of all parameters is shown in the appendix section.
OTHER MEASUREMENTS - We used biomedical data acquisition software (Poly, 
Inspektor Research Systems BV, Amsterdam, The Netherlands) to store COufp, 
QAOpre and QAOpost  with a 200 Hz sampling rate. The exact span of the TPUD 
measurements was marked in the registration. The shunt flow was calculated as 
the difference between QAOpre and QAOpost, the shunt fraction (expressed as Qp/Qs 
ratio) as (COufp + QAOpre – QAOpost)/COufp. Before every measurement the adequacy of 
signal strength of the flow probes was checked. Additional acoustic gel was applied 
in case of decreased signal strength (quality < 0.7 on analog meter in “TEST” mode). 
Continuous monitoring of heart rate, blood pressure and central venous pressure 
(CVP) was performed.
 
DATA ANALYSIS – In phase 1, the data after shunt opening and closure were 
compared. In phase 2 and 3, only the data after total hemorrhage and total volume 
resuscitation with closed shunt were analyzed. Statistical calculations were 
performed with SPSS version 18.0, using a Wilcoxon signed rank test for paired 
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comparisons of the aforementioned variables during the different phases 
(normovolemia (open versus closed shunt), hemorrhage versus normovolemia and 
hemorrhage versus volume resuscitation). Pearson’s correlation was used to 
compare changes in cardiac output measured by ultrasonic flow probe (COufp) 
between phase 1 (closed shunt) and phase 2, and between phase 2 and phase 3 
respectively with changes in hemodynamic volumes, heart rate and central venous 
pressure. Significance was set at a p-value of less than 0.05. Values were also 
indexed for body surface area using the BSA-formula for lambs (BW2/3 * 0.121) with 
BW = body weight [20].
Results
Table 1 shows the characteristics of the study population. The mean (± SD) weight 
was 6.4 (± 1.4) kg. Mean age was 12.3 (± 6) days. The native ductus arteriosus was 
closed in all animals. Lamb 1 did not receive volume expansion.
Twenty-seven measurement sessions were analyzed. Cardiac output (COtpud) 
ranged from 104 to 310 mL/kg/min; cardiac output (COufp) ranged from 104 to 284 
mL/kg/min. Mean (± SD) normovolemic values (with closed shunt) for cardiac 
output, ACVI, CBVI and TEDVI were 221 (±67) mL/kg/min, 50 (±8) mL/kg, 18 (±3) mL/
Figure 2  (a) Schematic overview of hemodynamic volumes and (b) dilution curves 
MTTa = time during which the indicator travels from the injection site (venous sensor) to the arterial 
sensor, FWHMart and FWHMven = full width at half maximum of arterial and venous curves in minutes, 
respectively; H = the concentration of injected saline becomes largely stable within 60 seconds from the 
time of injection. An explanation of the calculation of the volumes can be found in the appendix session.
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kg and 14 (±3) mL/kg respectively. Qp/Qs ratio during open shunt varied between 
1.3 and 2.2. Mean total blood withdrawal per lamb during the experiment was 19 
(± 3.5) mL/kg and mean total volume resuscitation 28 (± 4) mL/kg. Results are 
displayed in Figure 3 and Table 2.
Response to shunt closure: There was a significant increase in TEDVI and a 
significant decrease in COtpud. CBVI and ACVI hardly changed. After shunt closure 
the opposite effects were observed. 
Response to hemorrhage: COtpud and all measured hemodynamic volumes 
decreased significantly, except for ACVI.
Response to volume resuscitation: COtpud and all measured hemodynamic volumes 
increased significantly.
Figure 3  Absolute changes of cardiac output measured by transpulmonary 
ultrasound dilution COtpud (a), active circulating volume index ACVI (b), central 
blood volume index CBVI (c) and total end-diastolic blood volume index TEDVI (d) 
during different hemodynamic phases for all subjects 
Normo_O = normovolemic phase with open shunt; normo_C = normovolemic phase with closed shunt; 
volume resuscit = volume resuscitation
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Figure 4 shows correlations between changes in COufp and changes in hemo- 
dynamic volumes (ACVI, CBVI and TEDVI) and hemodynamic parameters (heart 
rate and CVP) respectively. Correlations were better for the hemodynamic volumes 
as for heart rate and CVP.
Figure 4  Pearson’s correlation between (percentage) changes in COufp and 
changes in (a) ACVI, (b) CBVI, (c) TEDVI, (d) central venous pressure (CVP) and (e) 
heart rate 
Dotted line = line of identity
(b) (a) 
(d) (c) 
(e) 
R 0,83 (p < 0,001)  
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Discussion
This is the first study describing the effect of different interventions on CO and 
hemodynamic volume changes in a neonatal (animal) population using TPUD. The 
main findings were: 1) COtpud and hemodynamic volumes all decreased after 
hemorrhage (except for ACVI) and increased after volume resuscitation, 2) opening 
of the left-to-right shunt resulted in a significant decrease in cardiac output and a 
significant increase in TEDVI, while CBVI and ACVI hardly changed. These changes 
were as physiologically expected. 
 The changes in cardiac output and hemodynamic volumes (except ACVI) 
during hemorrhage and volume resuscitation in populations without a shunt were 
also observed by others using TPTD [15,17,21]. In our study, CBVI and TEDVI both 
adequately reflected hemorrhage and volume loading. The decrease in ACVI during 
hemorrhage was less explicit, which might be due to a redistribution of blood 
from the peripheral vessels in an attempt to protect the vital organs. A study of 
hemodynamic volumes measured by TPUD in foals showed a decrease in TEDVI 
and ACVI during extensive hemorrhage (30 mL/kg) [22]. However, these authors 
found a high variability in CBVI measurements, probably due to the peripheral 
position of the arterial line which led to an excessively prolonged mean transit 
time. The position of the arterial catheter was taken into account in the algorithm 
to calculate CBVI in order to correct for this prolonged mean transit time.
 In the presence of a (significant) left-to-right shunt left ventricle end-diastolic 
volume and left ventricle output will increase. Consequently, systemic blood flow 
distal to the origin of the shunt (i.e measured cardiac output) decreases. We indeed 
noticed a significant increase in TEDVI, although this increase might – except for 
the enlargement of the left atrium - also be partially due to an increase in full 
width at half maximum of the arterial curve as a result of recirculation through 
the left-to-right shunt. CBVI did not change during shunt opening: we hypothesized 
that as the blood volume in the lungs and left ventricle increases, the blood volume 
in the aorta is slightly diminished due to lower perfusion distal to the shunt 
insertion. ACVI did not significantly change in the presence of this shunt. However, 
when left-to-right shunting exists for a longer time, fluid retention may occur due 
to decreased urine output resulting in a consequently higher ACVI. In piglets with 
right-to-left shunts (after septostomy and partial pulmonary artery occlusion) 
Shih found a significant decrease in cardiac output and CBVI, but not in TEDVI 
and ACVI using TPUD [23].
 We compared changes in cardiac output with changes in the hemodynamic 
volumes and central venous pressure and heart rate during phase 2 and 3. To rule 
out any mathematic coupling between the cardiac output measurement by TPUD 
(COtpud) and the hemodynamic volumes - both COtpud and the volumes are 
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calculated by the same dilution curve - we chose to use COufp for these analyses. 
Changes in cardiac output correlated better with changes in hemodynamic 
volumes than changes in central venous pressure and heart rate. We did not 
calculate blood pressure changes in our analyses as this parameter was used to 
determine the amount of blood withdrawal during phase 2. We expected – in 
analogy with TPTD – that TEDVI would better reflect preload conditions than CBVI 
or ACVI, but the correlation between TEDVI and COufp was slightly less when 
compared to the other mentioned volumes. This might be due to 1) the relative 
small number of measurements and 2) the presence of 1 outlier (lamb 5, phase 3) 
for which we have no clear explanation (no system warning, no inotropic use). 
When recalculating correlations without this aberrant measurement TEDVI seems 
a better predictor for preload (Pearson’s correlation for ACVI = 0,85, CBVI = 0,89 
respectively TEDVI = 0,89). In a study of 100 ventilated children the predictive 
value for fluid responsiveness (> 15% change in stroke volume after a 10 mL/kg fluid 
bolus) was poor, although slightly better for hemodynamic volumes measured by 
TPUD than for CVP [24]. 
 The changes in cardiac output and hemodynamic volumes measured by TPUD 
are in accordance with the expected physiological changes in this experimental 
setting. In our opinion hemodynamic volumetry could play – in analogy with the 
use of TPTD in adults and children - an important part in advanced hemodynamic 
monitoring of critically ill neonates as different clinical conditions may be 
associated with specific changes in cardiac output and hemodynamic volumes. We 
are aware that this current experimental model rather reflects acute hemodynamic 
changes, similar with clinical (neonatal) situations as acute (perinatal) blood loss, 
repetitive volume resuscitation during sepsis and ductal ligation. This model 
might therefore not be suitable to interpret changes in hemodynamic blood 
volumes in more chronic conditions as compensating mechanisms may alter 
blood volumes. However, we believe that combining repetitive measurements of 
CO and hemodynamic volumes and their dynamic interactions in response to 
time and treatment might be helpful in diagnosing underlying conditions and 
improving or adapting treatment modalities.
 It was not our intention in this study to validate the accuracy of the hemo- 
dynamic indices in terms of absolute values, so we do not know whether the 
measured hemodynamic volumes are comparable with normal values for infants 
and neonates. To our knowledge no studies have been published that define normal 
values for hemodynamic volumes (especially CBV and ACV) in pediatric patients. 
To compare our observed values with those found in TPTD-studies in small 
children and animals we recalculated and indexed them by body surface area [20]. 
Comparison of absolute values of hemodynamic volumes measured by TPTD and 
TPUD in juvenile animals and children reveals that GEDVI and ITBVI – although 
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proportionally smaller than in adults [15,18] - are still 1.5 to 2 times higher than 
TEDVI and CBVI [25]. Our results confirm this finding. This discrepancy is caused 
by 1) the difference in the indicator used (TPTD uses a diffusible thermal indicator), 
2) the mathematical models used for the calculation of hemodynamic values in 
TPUD and TPTD [14,26] (see also appendix) and 3) the algorithm used by TPTD for 
calculating GEDVI which is not appropriate for small children [16]. Therefore, 
volumes measured by TPUD might better reflect absolute volumes.
 In addition to the relatively scarce data, the main limitation of our study is the 
lack of concomitant right and left ventricular end-diastolic volume measurement 
by using for example 3D-echocardiography or cardiac MRI, as these latter might 
estimate the actual TEDVI. However, as mentioned earlier, this was not the aim of 
our study. Secondly, TPUD is an invasive monitoring system requiring central 
venous and arterial lines. However, in contrast to TPTD, TPUD can be used with 
any indwelling catheter inserted in term and preterm infants. Additionally, the 
use of triple injections of 1.0 mL/kg per session could lead to fluid overload in 
vulnerable neonates when used repetitively. Previously, de Boode showed that for 
cardiac output measurements 1) using 0.5 mL/kg instead of 1.0 mL/kg of isotonic 
saline per injection and 2) performing 2 consecutive measurements (instead of 3), 
unless the difference between the two measurements exceeds 10%,  is as precise 
and accurate as the recommended sessions [11]. We confirmed those findings in 
another study [13]. 
We conclude that TPUD can be used in an experimental neonatal population with 
or without a left-to-right shunt to adequately monitor changes in hemodynamic 
volumes under different hemodynamic conditions. Although its clinical utility in 
neonates is not yet proven, and absolute values of the hemodynamic volumes must 
be interpreted with caution, TPUD seems a promising technique that might 
improve the assessment and interpretation of the hemodynamic status in critically 
ill newborns and children, especially when used as a trend monitor. Validation 
studies of TPUD in neonates and children in comparison with (3D) echocardiography 
or cardiac MRI are warranted to evaluate the accuracy of these blood volume 
measurements. 
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Appendix:
Calculation of hemodynamic volumes:
Hemodynamic volumetry by TPUD (see also Figure 2) [1]
Cardiac output is calculated using the Stewart-Hamilton equation: CO = Vinj/∫Ca(t), 
with Vinj = the volume of injected saline (mL) and ∫Ca(t) = the area under the 
dilution curve (saline concentration in arterial blood (mLsaline/mLblood*minute)). 
Active circulating volume (ACV) is defined as the volume of blood in which the 
indicator mixes in a one minute time period from the time of injection. It is 
calculated using the following formula: ACV = Vinj/H, where Vinj = volume of 
injected isotonic saline (mL); H = level of isotonic saline concentration in the blood 
(mLsaline/mLblood) at the end of the first minute after venous injection as recorded 
by the arterial sensor.
Central blood volume (CBV) is calculated as CBV = CO x (MTTa-MTTv-MTTt) with CO 
cardiac output and MTTa the mean transit time, which is the time span between 
injection of the indicator (measured by the venous sensor) and the time point 
when half of the indicator has passed the detection point (arterial sensor). As the 
mean transit time actually refers to the transit time of the indicator between the 
venous and arterial catheter a correction must be made for the time the indicator 
travels from the injection site to the end of the venous catheter (MTTv) and the 
mean transit time during which the indicator travels in the loop before reaching 
the arterial sensor (MTTt). CBV might vary slightly depending on the position of 
the tip of the arterial and central venous catheter.
Total end-diastolic volume’s (TEDV) calculation is based on the assumption that 
the change in spread of the ultrasound dilution curve from the initial venous 
shape results largely from mixing of the indicator in the heart chambers. This 
spread of the curve is defined as the full width at half maximum (FWMH) (1). The 
venous injection curve is small and high (no mixing of indicator yet) resulting in a 
small FWHMven, while the arterial dilution curve is broader and less high due to 
mixing of indicator (larger FWHMart). The higher the end-diastolic volume, the 
broader the arterial curve will be. As the spread of the curve will also be influenced 
by the heart rate the formula for TEDV calculation is corrected for this: TEDV = CO 
x (1.62/HR + 0.77 x FWHMc) where CO = cardiac output (mL/min); FWHMc = (FWHMart2 
– FWHMven2)1/2; HR = heart rate (bpm); FWHMart and FWHMven = the full width 
at half maximum of the arterial and venous curves in minutes, respectively.
All the volumes are indexed by bodyweight.
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Hemodynamic volumetry by TPTD [2]
The intrathoracic blood volume (ITBV) is defined as the sum of GEDV and 
pulmonary blood volume. It is calculated based on the assumption that the blood 
volume in the lungs and the intrathoracic vessels (with the exception of heart 
volume) constitutes 25% of GEDV:
 ITBV = 1.25 x GEDV
This assumed factor of 1.25 is based on one study in adult subjects [3]. However, 
there exists a rather large intra- and interindividual variability [4, 5]. 
Global end-diastolic (GEDV) is defined as the sum of all end-diastolic volumes of 
atria and ventricles. It is calculated by subtracting the pulmonary thermal volume 
(PTV) from the intrathoracic thermal volume (ITTV):
 GEDV = ITTV – PTV (ml)
Where ITTV is the distribution of the thermal volume in the thorax and calculated 
as cardiac output multiplied by the mean transit time of the thermal indicator:
 ITTV (ml) = CO x Mtt
therm
   and
 PTV (ml) = CO x DSt x 1000/60  (DSt the downslope time of thermodilution curve)
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Abstract
Background: Transpulmonary ultrasound dilution (TPUD) is a promising method 
for cardiac output (CO) measurement in severely ill neonates. The incidence of 
lung injury in this population is high, which might influence cardiac output 
measurement using TPUD due to an altered lung perfusion. We evaluated the 
influence of lung injury on the accuracy and precision of CO measurement using 
TPUD in an animal model.
Methods: In 9 neonatal lambs central venous and arterial catheters were inserted 
and connected to the TPUD-monitor (CO-status®, Transonic Systems Inc., Ithaca, 
NY, USA). Repetitive saline lavages (NaCl 0.9%; 10-30 mL/kg) were performed to 
gradually induce lung injury. CO measurements with TPUD (COtpud) were 
compared with those obtained by an ultrasonic transit-time flow probe around the 
main pulmonary artery (COufp). An increase in oxygenation index (OI) was used as 
an indicator of induced lung injury during the experiment. Postmortem the lung 
injury was confirmed by histopathological examination.
Results: 55 sessions of three paired CO measurements were analyzed. Mean COufp 
was 1.53 L/min (0.66-2.35 L/min), mean COtpud was 1.65 L/min (0.78-2.91 L/min). 
Mean bias (SD) between the two methods was 0.13 (0.15) L/min with limits of 
agreement of ± 0.29 L/min. The overall percentage error was 19.1%. Accuracy and 
precision did not change significantly during progressive lung injury. Histopatho-
logical severity scores were consistent with heterogeneous lung injury.
Conclusion: The accuracy and precision of CO measurement using TPUD is not 
influenced in the presence of heterogeneous lung injury in an animal model.
Keywords: Cardiac output; lung injury; monitoring; children; neonate; dilution 
technique, indicator.
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Introduction 
Hemodynamic monitoring has become part of standard care in critically ill 
children [1-3]. Measurement of cardiac output (CO), hemodynamic volumes and 
extravascular lung water is increasingly used to provide information about the 
patient’s hemodynamic state and to initiate and monitor therapy in many disease 
states [4,5]. The pulmonary arterial thermodilution is regarded as gold standard 
reference method for measuring CO in the adult clinical setting, although 
nowadays it is used in selected patients only [6,7]. The limitations of this technique 
are well documented [8,9]. Transpulmonary thermodilution (TPTD) has been 
designated as the method of preference for measuring CO in pediatric critical care 
[10,11]. In neonatal intensive care however, the use of CO measurement - including 
TPTD - is still limited due to 1) technical restraints and size limitations of the 
available techniques and 2) the period of circulatory transition, when patent fetal 
channels might influence the accuracy of CO measurement [12]. Transpulmonary 
ultrasound dilution (TPUD) is based on changes in ultrasound velocity in arterial 
blood after central venous injection of isotonic saline at body temperature [13]. 
It is a promising technology for neonatal CO measurement, since no dedicated 
catheters are required. The method uses an extracorporeal arterio-venous (AV-)
loop with a peristaltic pump, which can be connected with any indwelling 
catheter, including umbilical catheters. TPUD technology has been validated in 
adults [14-16] and children [17,18] with good accuracy and precision. Neonatal and 
juvenile animal studies showed that TPUD is accurate, precise and safe regarding 
CO measurement, also in the presence of a significant left-to-right shunt [19-21]. 
 Any indicator dilution method should fulfill the following conditions to avoid 
errors in CO measurement: use of an inert, soluble indicator that quickly and 
completely mixes after injection, constant blood flow during measurement and 
preservation of indicator between the injection and detection site [22]. With regard 
to potential transpulmonary loss of indicator, Moser and Kenner found in healthy, 
anesthetized dogs that only 0.08% of the injected volume of isotonic saline is lost 
during the first pass through the pulmonary capillary bed [23]. The incidence of 
respiratory failure due to respiratory distress syndrome (RDS), meconium aspiration, 
congenital lung diseases and pneumonia is high in critically ill newborns. As these 
conditions are often associated with increased capillary permeability, lung oedema 
and a ventilation/perfusion mismatch, we hypothesized that there might be an 
absolute or relative increase of indicator loss, potentially influencing the reliability 
of cardiac output measurements. The objective of this study was to investigate 
whether gradually induced lung injury influenced the agreement between CO 
obtained by TPUD (COtupd) and an ultrasonic transit-time flow probe positioned 
around the main pulmonary artery (COufp) in an experimental lamb model.
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Material and methods
TRANSPULMONARY ULTRASOUND DILUTION (TPUD) – TPUD is based on the 
physical principle that ultrasound velocity is different in blood and isotonic saline, 
which is used as indicator. An extracorporeal arterio-venous loop is connected 
between indwelling arterial and central venous catheters. Only during 
measurement procedures blood flows through this loop that is controlled by a 
peristaltic pump to prevent stasis of blood and to provide stable blood flow. Isotonic 
saline at body temperature (1.0 mL/kg) is injected into the venous limb. A venous 
sensor, clamped on the venous limb of the loop, calculates the exact amount and 
onset of injected indicator. The saline passes the venous catheter and mixes with 
blood while entering the superior vena cava. The circulation carries the injectate 
through the heart, lungs and descending aorta where the arterial catheter is 
located. An arterial sensor, positioned downstream on the arterial limb of the 
extracorporeal loop, detects the decrease in ultrasound velocity of the blood. 
Specially designed software (CO-status®, Transonic Systems Inc., Ithaca, NY, USA) is 
used to calculate CO and hemodynamic volumes from the obtained dilution curve. 
Values are displayed on the monitor. The method has previously been described 
extensively [20]. 
GENERAL - This experiment was performed in accordance with Dutch national 
legislation concerning guidelines for the care and use of laboratory animals, 
approved by the Ethical Committee on Animal Research of the Radboud University 
Nijmegen (RU-DEC #2010-034) and performed in 11 random-bred lambs under 
terminal general anesthesia. The lambs were premedicated with an intramuscular 
injection of ketamine (10 mg/kg), atropine (0.03 mg/kg) and midazolam (0.2 mg/
kg). After placing a peripheral IV for injection of propofol (2 mg/kg) they were 
orotracheally intubated with a cuffed endotracheal tube (ID 4-6 mm; Kruse, 
Marslev, Denmark) and mechanically ventilated in a pressure control mode using 
a Datex Ohmeda Excel 210 SE anesthesia machine (GE Healtcare, Waukesha, 
Wisconsin, USA). Anesthesia was maintained with inhalation of isoflurane (0.5-2.0 
vol%), and intravenous administration of sufentanyl (15-25 μg/kg/h), midazolam 
(0.2 mg/kg/h) and pancuronium (0.02 mg/kg/h after a loading dose of 0.05 mg/kg). 
Ventilator settings were adjusted in order to approximate normoxemia (SaO
2
 
90-95%) and normocapnia (PaCO
2
 30-48 torr [4.0-6.5 kPa]). A servo-controlled 
heating mattress and a heating radiator were used to maintain a rectal temperature 
between 38 and 39°C. The animals were euthanized at the end of the experiment 
by an overdose of pentobarbital (150 mg/kg intravenously).
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INSTRUMENTATION - Immediately after induction of anesthesia, intravascular 
catheters were surgically inserted. The tip of the arterial catheter (umbilical vessel 
catheter 5 Ch/35 cm/1.7 mm, ArgyleTM, Tyco Healthcare/Kendall Ireland Limited, 
Tullamore, Ireland) was positioned in the abdominal aorta via the left femoral 
artery and connected with the arterial limb of the extracorporeal circuit for TPUD 
measurement and continuous blood pressure measurement. A double-lumen 
central venous catheter (16 G/16 cm/1.7 cm, Arrow, Arrow International, Reading, 
PA, USA) was inserted via the right jugular vein with the position of the tip in the 
superior vena cava. One of the lumina of this central venous catheter was connected 
to the venous limb of the AV-loop for TPUD measurement. The other lumen was 
used for administration of fluids and medication. 
 A left thoracotomy was performed at the left fourth intercostal space. The 
pericardium was incised and the aorta located. The ascending aorta was gently 
separated from the pulmonary artery by a blunt surgical forceps. An adequately 
sized transit-time flow probe (10 or 12A, PAX series, Transonic Systems Inc., Ithaca, 
NY, USA) was placed around the mean pulmonary artery. We chose to place the 
flow probe around the main pulmonary artery and not the ascending aorta as the 
main pulmonary flow reflects the systemic flow even in the presence of possible 
extracardiac shunts. Furthermore, a flow probe around the ascending aorta does 
not include the coronary blood flow. Acoustic gel was added between the flow 
probe and the vessel to obtain a qualitative good signal. If still open, the native 
ductus arteriosus was ligated to prevent shunting. The pericardium and thoracic 
cavity were closed and the lambs were turned into a supine position. The flow 
probe was checked for zero value directly post mortem.
INDUCTION OF LUNG INJURY – We have chosen a respiratory distress syndrome- 
model since RDS is one of the most frequently observed conditions on a neonatal 
intensive care unit. Lung injury was gradually induced by repeated (broncho-alve-
olar) saline lavages as described by Lachmann et al [24]. Lung lavage was performed 
by instilling 10–30 mL/kg warmed isotonic saline in 60 mL aliquots. After a 2 -3 
minute period the saline was drained by gravity and subsequently suctioned with 
an endotracheal suction catheter (10 Ch/60 cm, Mülly, Unomedical A/S, Denmark). 
Ventilator settings were adjusted during instillation in order to maintain tidal 
volumes of 10 mL/kg. Blood gas analyses were performed at baseline and after 
every two lavages. Lavages were repeated until a PaO
2
 <100 torr (<13.3 kPa) was 
achieved at a FiO
2
 of 1.0 [25,26]. The lambs remained in supine position during the 
experiment to obtain a bilateral washout and to guarantee an adequate flow probe 
position. 
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EXPERIMENTAL PROTOCOL – After a stabilization period of 15 minutes the study 
protocol was started. Sessions of CO measurement using TPUD (COtpud) were 
performed at baseline and after every 2 lavages. After every pair of lavages a 
stabilization period of 15 minutes was taken. Every CO measurement session 
consisted of triplicate injections with 1.0 mL/kg isotonic saline at random in the 
respiratory cycle. 
DETERMINATION OF LUNG INJURY – Oxygenation index (OI) was used as an 
indicator to assess the severity of the induced lung injury during the experiment. 
The oxygenation index was defined using the following formulas:
OI =  mP
AW
 × FiO
2
                PaO
2
(1)
  
OI = oxygenation index; mP
AW
 = mean airway pressure (cmH
2
O); FiO
2
 = oxygen fraction 
(%); PaO
2
 = partial oxygen tension (torr) and
mP
AW
 = (PIP × Tinsp) + (PEEP × Texp)
                         Tinsp + Texp
(2)
  mP
AW
 = mean airway pressure; PIP = peak inspiratory pressure (cmH
2
O); Tinsp = inspiratory 
time (sec); PEEP = positive end expiratory pressure (cmH
2
O); Texp = expiratory time (sec) 
A higher OI is indicative of more severe lung injury [27]. To confirm lung injury, 
postmortem histopathological examination was performed using scoring systems 
described previously [28,29]. The lungs were imbedded in substantial amounts of 
pleural fluid. Lung tissue from the right and left lower lobe was fixated in 4% 
buffered formalin immediately after removal. After mounting in paraffine, two 
slices of 4 μm thickness were stained with hematoxylin/eosin and PAS respectively. 
The histopathological changes in the lung tissue were scored using a semi-quanti-
tative scoring system by a pathologist. Variables scored were alveolar and 
interstitial inflammation, alveolar and interstitial hemorrhage, oedema, 
atelectasis and necrosis. Each variable was scored on a 0- to 4-point scale (0 - no 
injury; 1 - injury in 10% of the field; 2 - injury in 20% of the field; 3 - injury in 30% 
of the field; 4 - injury in > 30% of the field) (scores adapted from Hilgendorff28). 
Maximum possible score for each tissue sample was 28. Mean scores of the two 
tissue samples for every lamb were also calculated.
502337-L-sub01-bw-Vrancken
131
INFLUENCE OF LUNG INJURY ON COTPUD MEASUREMENTS
7
OTHER MEASUREMENTS - We used biomedical data acquisition software (Poly, 
Inspektor Research Systems BV, Amsterdam, The Netherlands) to store COufp with 
a 200 Hz sampling rate. The difference between COtpud and COufp was calculated 
using the mean value of three consecutive TPUD measurements and the mean 
value of the three corresponding flow probe measurements. Before every 
measurement the adequacy of signal strength of the flow probe around the main 
pulmonary artery was checked. 
STATISTICAL ANALYSIS – A Mann-Witney test was used to demonstrate any 
significant difference between the oxygenation index assessed at the begin and 
the end of the experiment. The method described by Bland and Altman for 
repeated measurements was used to assess the agreement between COtpud and 
COufp [30]. Mean bias was defined as the mean difference between COufp and 
COtpud. Mean bias was plotted against the mean CO of both methods ((COufp + 
COtpud)/2).  Precision was represented by the limits of agreement (LOA). A mixed 
effects linear model was used to estimate the variance component due to lamb 
(σ2
L
) and the residual variance (σ2
R
). The limits of agreement were then calculated as 
Mean (Bias) ± 1.96 × σ2
L 
+ σ2
R
. Percentage error was calculated as 100% x (1.96 x SD of 
the bias/mean COufp) [31]. Measurements were also grouped into different 
oxygenation index categories (OI < 10, OI 10 – 20, OI 20 – 40 and OI > 40). For each 
OI-category the median, inter-quartile range and 95% CI (confidence interval) of 
the bias were calculated and reproduced in a boxplot. To demonstrate any 
significant difference in mean bias between different OI categories a mixed effect 
linear model was used with the OI-group as fixed effect and lamb as random effect 
to deal with multiple measurement per lamb. A p-value < 0.05 was considered 
statistically significant. Percentage error was subsequently calculated in every 
OI-category. Changes in cardiac output were calculated by subtracting the 
consecutive CO measurements obtained after every two lavages for each method. 
Analysis of the agreement in cardiac output trend monitoring between the two 
methods was assessed with a polar plot [32]. Agreement by methods is shown by 
the deviation (or angle) from the polar axis (0) and magnitude of the change in CO 
by the distance from the origin (0, 0). Negative changes were converted to positive 
changes and central zone data (< 10% changes) were excluded to facilitate the 
statistical analysis. The mean polar angle (angular bias), the standard deviation of 
the polar angle and the radial limits of agreement (radial sector that contains 95% 
of the data points) were calculated. Good trending ability was defined as an 
angular bias of ± 5° and radial limits of agreement of ± 30%. 
 SPSS 16.0.01 for Windows® (SPSS Inc., Chicago, USA) was used for statistical 
analysis. The polar plot was created with SigmaPlot for Windows version 7.1 (Systat 
Software, Inc, San Jose, CA).
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Results
Two lambs died after the first lavage session due to severe hypoxemia. We excluded 
them for further analysis. Table 1 shows the characteristics of the animals studied. 
Mean weight was 8.9 kg (range 4.1 – 12.3). Postnatal age ranged from 7 to 22 days. 
In one animal the native ductus arteriosus was ligated. The number of lavages per 
animal ranged from 6 to 14. Five lambs received inotropic support (dobutamine 3 
– 6 μg/kg/min). Two additional lambs (5 and 7) died before all measurement sessions 
could be undertaken due to severe hypoxemia or hemodynamic instability. 
 There was a significant increase in oxygenation index during the experiment 
(p < 0.001). Figure 1 shows the histopathological findings. Figure 1a shows the 
 histopathological scoring system for every lamb: scores for individual tissue samples 
varied from 4 to 15 (mean scores per lamb 6.5 - 12.5) compatible with heterogeneous 
lung injury. Figure 1b and 1c illustrate the histopathological findings in lambs 2 
and 8 respectively. 
 A total of 55 measurements sessions could be analyzed, as two sessions were 
excluded due to erroneous results. COufp ranged from 0.66 to 2.35 L/min (mean 
1.53 L/min), COtpud ranged from 0.78 to 2.91 L/min (mean 1.65 L/min). 
 The Bland-Altman plot is shown in Figure 2. The overall mean bias (SD) was 
0.13 (0.15) L/min, LOA were ± 0.29 L/min with an overall percentage error of 19.1%. 
Figure 3 shows box whisker plots for the median bias between COufp and COtpud 
with increasing oxygenation index. Accuracy did not change significantly with 
increasing oxygenation index (p = 0.95). Percentage errors for OI-subgroups were 
20.0% (OI < 10), 15.1% (OI 10 - 20), 18.1% (OI 20 - 40) and 18.9% (OI > 40) respectively. 
The polar plot (Figure 4) shows moderate to good trending as the plot shows an 
angular bias of ± 8° and radial limits of agreement of 32%. 
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Discussion
This study shows that CO measurement using TPUD is reliable with acceptable 
accuracy and precision (percentage error < 20%) in an experimental neonatal lamb 
model with induced, heterogeneous lung injury.
 Lung injury is often associated with an increased pulmonary capillary 
permeability resulting in pulmonary oedema and increased extravascular lung 
water. It is well known that indicator loss can occur using transpulmonary 
thermodilution [33,34]. As the TPTD-technique uses a thermal indicator (heat), the 
volume of the distribution is not only limited to the blood vessels, but also includes 
the extravascular lung water space. As the TPUD-technique uses a non-diffusible 
indicator (normothermic isotonic saline), we assume that loss into the extravascular 
space is negligible. However, flow dynamics may alter in the injured lung: pulmonary 
arterial vessels tend to constrict in response to local hypoxia, redistributing blood 
flow away from poorly ventilated regions and toward lung regions that are well 
ventilated, optimizing local ventilation/perfusion matching and minimizing 
intrapulmonary shunting. This could lead to differentiated transit times due to 
dispersion of the indicator, a change in the shape of the dilution curve and therefore 
influencing cardiac output measurements.  
 We did not opt for a oleic acid or a lipopolysaccharide model to induce lung 
injury but chose the lavage-model as this model represents the most the RDS seen 
Figure 2   Bland-Altman plot for repeated measurements for the assessment of 
agreement between transpulmonary ultrasound dilution cardiac output 
(COtpud) and main pulmonary artery blood flow (COufp) 
The solid line represents mean bias and the dotted lines represent limits of agreement for all data (OI < 10 
(black squares), OI 10 – 20 (grey squares), OI 20 – 40 (white circles) and OI > 40 (grey triangles)).
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Figure 3   Box and whisker plots for the median bias between CO measured by 
flow probe (COufp) and transpulmonary ultrasound dilution (COtpud) 
with increasing oxygenation index (OI) 
The box represents the inter- quartile range of the bias; the whiskers express the 95% confidence 
interval of the bias (* = mixed effect linear model showed no significant difference between OI groups).
Figure 4   Half circle polar plot representing the changes in cardiac output 
measured with transpulmonary ultrasound dilution (COtpud) and the 
ultrasound flow probe around the main pulmonary artery (COufp) 
Central zone data (<10% CO) are excluded. Dashed line represents the mean radial bias (8°), dotted lines 
the 95% CI (32°). Almost all data are situated within the 30° radial limits.
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in neonatal patients. RDS is a heterogeneous disease with different gradations and 
is characterized by areas of atelectasis, inflammation, necrosis and oedema. The 
degree of inflammation is not as substantial as in the other models and the 
permeability is less effected, although some authors found prominent oedema 
indicating increased permeability [35,36]. Therefore, we have to be aware that the 
results might not be entirely representative for other neonatal lung diseases as 
meconium aspiration syndrome or neonatal pneumonia.
 We used the oxygenation index to express the lung injury during the 
experiment. The increase in OI was statistically significant. In combination with 
the hemodynamic instability severe lung injury was clinically evident. We 
preferred to use the gold standard (histopathology) to confirm the lung injury and 
used therefore a scoring system described earlier to validate the grade of RDS. 
Individual tissue scores (left versus right lung) varied between 4 and 15, consistent 
with inhomogeneous moderate lung injury (affected and non-affected areas). 
Although it is difficult to show a causal relationship between the clinical lung 
injury and the histopathology, there seems to be a trend that those lambs with the 
highest oxygenation index at the end (> 40) also had the highest mean histopatho-
logical severity scores (>8) (comparison figure 1 and table 1). 
 In this study we found an overall mean bias of 0.13 L/min with limits of 
agreement of ± 0.29 L/min when comparing COtpud and COufp. The percentage 
error of 19.1% is less than the clinically acceptable limit of 30% as defined by 
Critchley and Critchley [31]. We should notice that we compared TPUD with the 
gold standard (ultrasonic transit-time flow probe), which has a very high precision. 
Therefore clinically acceptable limits would be around 20% rather than 30%, 
making this method acceptable for measuring cardiac output in the neonatal 
population. This overall accuracy and precision is also comparable with results of 
transpulmonary thermodilution [37-42] and transpulmonary ultrasound dilution 
[17,20,21,43] cardiac output measurements in pediatric animal models and 
children without lung injury as shown in Table 2. 
 As the overall accuracy and precision is the resultant of measurements 
without and with different degrees of lung injury we also calculated bias and LOA 
for the different OI-subgroups. We found no significant change in either accuracy 
or precision in the subgroups with higher OI-scores compared to the subgroup 
with OI < 10 (measurements without lung injury). It can be noticed that the number 
of measurements in every subgroup is relatively small and therefore it might be 
possible that a statistically significant difference couldn’t be reached.  To our 
opinion this is of no clinical relevance since the percentage errors for every 
subgroup are below the 20% margin. Since there is no change in accuracy and 
precision with increasing oxygenation index (and confirmed lung injury) it can be 
presumed that indicator loss seems indeed to be unlikely. 
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When there is no obvious indicator loss there can still be a delayed pulmonary 
transit time of indicator due to an altered circulation. This could result in a change 
in the indicator dilution curve. In non-affected areas we speculate that the injected 
indicator will travel fast, passing the ultrasound sensor without delay, whereas in 
injured pulmonary areas the indicator might travel more slowly reaching the 
arterial sensor at a later time point. The expected dilution curve will be less high 
and wider compared to the initial curve. The total area under the dilution curve 
however should remain the same without hardly any change in measured cardiac 
output. Dilution curves indeed changed in some of the lambs, particularly in those 
with the highest histopathological scores (lambs 3, 5 and 8). An example of the 
change in dilution curve is shown in Figure 5. This finding supports the hypothesis 
that the delay and differentiation in transit time does not influence cardiac output 
measured by TPUD in this heterogeneous RDS-model. However, there might be a 
condition, when the indicator release from the affected lung area is such delayed, 
that the indicator passes the detection sensor after the usual detection timeframe 
(60 sec), resulting in an overestimation of cardiac output. We did not find that in 
our population.
The applicability of a cardiac output measurement technique is not only 
determined by the reliability of assessment of absolute cardiac output values, but 
also by the capability to track changes in cardiac output. We compared changes in 
cardiac output after consecutive lung lavages between TPUD and the ultrasonic 
flow probe and found that the TPUD technique has moderate to good trending 
ability in this lung injury-model as the polar plot shows an angular bias of ± 8° and 
radial limits of agreement of 32%. (Figure 4).
Figure 5   Examples of TPUD dilution curves (pink) at baseline measurement  
(left) and after lung injury (right) of lamb 3. Notice the lower maximum, 
some increase in width and an evident higher residual baseline
BASELINE LUNG INJURY
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Limitations of the study:
First, we did not rule out possible intracardiac shunts (patent foramen ovale or 
ventricular septum defects) which could interfere with cardiac output measurements. 
On the other hand, the TPUD method is relatively good in identifying shunts, and 
we did not measure any shunts in the animals using TPUD. Second, despite 
extensive surfactant lavage, signs of histopathological injury were only present in 
maximal 30% of lung tissue sample. A possible explanation for this phenomenon 
is probably the relative short time between lavages and histopathological 
examination. With a longer interval time, microscopic changes could have been 
more pronounced. However, we believe that 30% histopathological injury can be 
considered as a sign of substantial lung injury. Other authors have also found the 
same degree of lung injury after extensive surfactant wash-out [29,44]. Third, we 
did not measure intrapulmonary shunt flow during lung injury to confirm our 
hypothesis of altered lung flow. However, the changes in the dilution curves due to 
increased transit times suggest lung flow alterations.
Conclusions
We conclude that cardiac output measurement using TPUD is reliable in the 
presence of moderate to severe respiratory distress syndrome. Indicator loss is 
negligible and the delayed indicator transit time in animals with heterogeneous 
lung injury does not affect the reliability of cardiac output measured by TPUD. 
TUPD is a promising technique to measure cardiac output in critically ill newborns. 
Clinical studies in this population are warranted.
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Abstract 
Purpose: Increased extravascular lung water (EVLW) may contribute to respiratory 
failure in neonates. Accurate measurement of EVLW in these patients is limited 
due to the lack of bedside methods. The aim of this pilot study was to investigate 
the reliability of  the transpulmonary ultrasound dilution (TPUD) technique as a 
possible method for estimating EVLW in a neonatal animal model. 
Methods: Pulmonary edema was induced in 11 lambs by repeated surfactant 
lavages. In between the lavages, EVLW indexed by bodyweight was estimated by 
TPUD (EVLWItpud) and transpulmonary dye dilution (EVLWItpdd) (n=22). Final 
EVLWItpud measurements were also compared with EVLWI estimations by gold 
standard post mortem gravimetry (EVLWIgrav) (n=6). EVLWI was also measured 
in two additional lambs without pulmonary edema. 
Results: Bland-Altman plots showed a mean bias between EVLWItpud and EVLWItpdd 
of -3.4 mL/kg (LOA ± 25.8 mL/kg) and between EVLWItpud and EVLWIgrav of 1.7 mL/kg 
(LOA ± 8.3 mL/kg). The percentage errors were 109% and 43% respectively. The 
correlation between changes in EVLW measured by TPUD and TPDD was r2 = 0.22.
Conclusion: Agreement between EVLWI measurements by TPUD and TPDD was 
low. Trending ability to detect changes between these 2 methods in EVLWI was 
questionable. The accuracy of EVLWItpud was good compared to the gold standard 
gravimetric method but the TPUD lacked precision in its current prototype. Based 
on these limited data, we believe that TPUD has potential for future use to estimate 
EVLW after adaptation of the algorithm. Larger studies are needed to support our 
findings.
Keywords: Cardiac output; extravascular lung water; monitoring; children; neonate; 
dilution technique, indicator; hemodynamics.
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Introduction
Extravascular lung water (EVLW) is defined by the fluid within the lung but outside 
the vascular compartment and is the total of interstitial fluid, alveolar fluid, extra - 
vasated plasma, intracellular water, lymphatic fluid and surfactant [1]. Respiratory 
failure in critically ill newborns is mainly due to respiratory distress syndrome 
(RDS), meconium aspiration and pneumonia, conditions that are often associated 
with increased capillary permeability and EVLW. Complex systemic inflammatory 
reactions as seen during sepsis, on cardiopulmonary bypass or extracorporeal 
membrane oxygenation, can also affect the microvascular permeability in neonates 
resulting in pulmonary fluid overload with further impairment of pulmonary gas 
exchange. In critically ill adults and children, the amount of EVLW is a good 
predictor of mortality [2-5] and therapy guided by EVLW measurements seems to 
have beneficial effects on outcome [6,7]. Only a few studies investigated the role of 
EVLW in newborn infants as a prognostic factor for ventilator dependency and 
outcome [8,9]. Still, measurement of extravascular lung water could enable the 
neonatologist to optimize fluid management in order to improve the pulmonary 
function. 
 The gold standard and reference method to measure EVLW is post-mortem 
gravimetry, a method which use is mainly restricted to experimental settings. 
Measurement of the dry and wet weight of the removed lungs enables the 
calculation of EVLW [10-12]. Transpulmonary indicator dilution methods are used 
in adult and pediatric intensive care to estimate EVLW. The transpulmonary 
double dilution (TPDD) technology using ice-cold indocyanine green (ICG) is 
regarded the clinical gold standard [13-15], but the TPDD system is not longer 
commercially available. Currently, the transpulmonary single thermal indicator 
dilution (TPTD) technique using ice-cold saline is increasingly used bedside for the 
estimation of EVLW [16-18]. However, this method cannot be used  in newborn infants 
(< 3,5 kg) due to size limitations of the dedicated catheter. The transpulmonary 
ultrasound dilution (TPUD) technology utilizes pre-existing central venous and 
arterial lines and is applicable for neonatal cardiac output (CO) measurement, 
even in the presence of (extra-)cardiac shunts [19,20]. TPUD is based on changes in 
ultrasound velocity in arterial blood after central venous injection of isotonic 
saline at body temperature [21]. When used as a double indicator method with 
injection of ice-cold isotonic saline, EVLW can be calculated using the difference 
in mean transit time (MTt) between the diffusible (heat) and non-diffusable (saline) 
indicator. 
 The aim of this study was 1) to validate EVLW measurements using TPUD 
against gravimetry over a wide range of lung water values in a neonatal animal 
model and 2) to compare sequential EVLW measurements of TPUD and TPDD to 
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validate the possibility of tracking changes in EVLW measured by TPUD in the 
same model. 
Material and methods
GENERAL – This experiment was performed in accordance with Dutch national 
legislation concerning guidelines for the care and use of laboratory animals, 
approved by the Ethical Committee on Animal Research of the Radboud University 
Nijmegen (RU-DEC #2010-034 and RU-DEC #2010-034A1) and performed in 
thirteen lambs under general anesthesia. They were premedicated with an 
intramuscular injection of ketamine (10 mg/kg), atropine (0.03 mg/kg) and 
midazolam (0.2 mg/kg) and intravenous administration of propofol (2 mg/kg). 
General anesthesia was maintained with inhalation of isoflurane (0.5-2.0 vol%), 
and intravenous administration of sufentanyl (15-25 μg/kg/h), midazolam (0.2 mg/
kg/h) and pancuronium (0.02 mg/kg/h after a loading dose of 0.05 mg/kg). 
Anaesthetics were adapted if the depth of anesthesia - repeatedly assessed by pain 
stimuli and clinical parameters such as heart rate, spontaneous ventilation, and 
arterial blood pressure – was insufficient. The lambs were orotracheally intubated 
with a cuffed endotracheal tube (inner diameter 4-6 mm; Kruse, Marslev, Denmark) 
and their lungs were mechanically ventilated in a pressure control mode (Datex 
Ohmeda Excel 210 SE anesthesia machine (GE Healtcare, Waukesha, Wisconsin, 
USA)) with tidal volumes of approximately 8-10 mL/kg and inspiratory-to-expiratory 
ratio of 1:2. Normocapnia, estimated by capnography with the CO2SMO Plus 
Respiratory Profile Monitor (Model 8100; Respironics, Pittsburgh, PA), was realized 
by adjusting the minute volume ventilation to maintain an end-tidal CO
2
 between 
30 and 41 torr (4.0–5.5 kPa). In case of decreased oxygenation positive end-expiratory 
pressure (PEEP) and/or the FiO
2
 were adjusted to maintain the measured arterial 
oxygen saturation above 95%. A servo-controlled heating mattress and a heating 
radiator were used to maintain a rectal temperature between 38 and 39°C. The 
animals were euthanized at the end of the experiment by a lethal dose of 
pentobarbital (150 mg/kg intravenously).
INSTRUMENTATION – Immediately after induction of anesthesia, several intra- 
vascular catheters were inserted by surgical cut-down: 
1) a thermal-dye-dilution probe (Pulsiocath PV2023, 3F; Pulsion) equipped with a 
thermistor for detection of changes in blood temperature and a fiber optic to 
detect changes in ICG concentrations in the blood was placed in the lower 
abdominal aorta via the right femoral artery, 
2) In the contralateral femoral artery, an arterial catheter (umbilical vessel 
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catheter 5 Ch/35 cm/1.7 mm, ArgyleTM, Tyco Healthcare/Kendall Ireland 
Limited, Tullamore, Ireland) was introduced – also positioned in the abdominal 
aorta - and connected with the arterial limb of the extracorporeal circuit for 
TPUD measurements (see later). This catheter was also used for continuous 
blood pressure monitoring and blood sampling, 
3)  a central venous catheter (5F, 2 lumen, 13 cm; Arrow International, Reading, 
PA) was inserted in the ipsilateral femoral vein with regard to the ther-
mal-dye-dilution probe, with the tip located near de right atrium for the 
injection of ice-cold indocyanine green in order to avoid a cross talk 
phenomena [22] and 
4)  a double-lumen central venous catheter (16 G/16 cm/1.7 cm, Arrow, Arrow 
International, Reading, PA, USA) was inserted via the right jugular vein with 
the position of the tip in the superior vena cava. One of the lumina of this 
central venous catheter was connected to the venous limb of the AV-loop for 
TPUD measurement. The other lumen was used for administration of fluids 
and medication. 
INDUCTION OF LUNG INJURY – In 11 lambs, lung injury and pulmonary edema 
was stepwise induced using a surfactant depletion model as described by Lachmann 
et al [23]. Prior to the lavages, the lambs were pre-oxygenated with FiO
2
 1.0. 
Repetitive lung lavages were performed by instilling 10–30 mL/kg/lavage isotonic 
saline (37°C). After a 2 -3 minute period the saline was drained by gravity and 
subsequently suctioned with an endotracheal suction catheter (10 Ch/60 cm, 
Mülly, Unomedical A/S, Denmark). Ventilator settings (PEEP and minute volume 
ventilation) were adjusted in order to maintain arterial oxygen saturation and 
end-tidal CO
2
 within the target ranges. Lavages were repeated until a PaO
2
 <100 
torr (<13.3 kPa) was achieved at a FiO
2
 of 1.0 [24]. The lambs remained in supine 
position during the experiment to obtain a bilateral washout. In two additional 
lambs, only baseline measurements were performed without surfactant wash out 
to include also EVLWgrav measurements of minimal injured lungs before they 
were euthanized. 
 Oxygenation index (OI) was used as an indicator to assess the severity of the 
induced lung injury during the experiment and calculated as (mPAW × FIO
2
)/PaO
2
 
with mPAW the mean airway pressure (cm H
2
O), FIO
2 
the inspired oxygen (%) and 
PaO
2
 the partial oxygen tension (torr). mPAW was calculated as ((PIP×Tinsp) + 
(PEEP×Texp))/Tinsp + Texp where PIP is the peak inspiratory pressure (cm H
2
O), 
Tinsp the inspiratory time (s), PEEP the positive end-expiratory pressure (cm H
2
O), 
and Texp the expiratory time (s). A higher OI was indicative of more severe lung 
injury.
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TRANSPULMONARY ULTRASOUND DILUTION – TPUD uses isotonic saline at body 
temperature as an indicator to estimate cardiac output and is based on the 
principle that ultrasound velocity differs between blood (1560 – 1590 m/s) and 
isotonic saline (1533 m/s) [21]. An extracorporeal arterio-venous loop, equipped 
with ultrasound sensors on both venous (for calculating the exact amount and 
onset of injected indicator) and arterial site (for detection of changes in ultrasound 
dilution), is connected between the indwelling arterial and central venous 
catheters. Blood flows through this loop only during measurement procedures 
and is controlled by a peristaltic pump to prevent stasis of blood and provide stable 
blood flow. To measure EVLW the TPUD was converted into a double indicator 
method using ice-cold (< 10°C) isotonic saline. An additional thermistor was placed 
on the arterial side of the loop for detection of changes in blood temperature. 
Isotonic saline is considered to be non-diffusible and travels only in the 
intravascular space, including the heart, lungs, and blood vessels during its first 
pass as a consequence of an absent concentration gradient across lung capillaries 
[25]. The second indicator (heat) is diffusible and travels in both the intravascular 
space and the extravascular lung space. The difference between the mean transit 
time (MTT) of the diffusible indicator (measured by thermistor) and the 
non-diffusible indicator (measured by ultrasound sensor) was used to calculate 
EVLW. 
Calculation of lung water uses the following equation:
EVLW = CO * (MTT
ther
 – MTT
UD
) [1]
where CO is the cardiac output, MTT
ther 
is the mean transit time of the thermal 
indicator recorded by the thermistor and MTT
UD 
is the mean transit time of the 
ultrasound dilution indicator recorded by the ultrasound sensor. 
Corrections must be made for 1) the increase in ultrasound velocity during passage 
in the plastic tubing due to blood cooling from cold saline (∆t
pl
), 2) the distribution 
of temperature not only in the blood but also in the tubing walls during its passage 
(∆t
tube
) and 3) any delay of temperature transfer to the thermal sensor when the 
cooled blood arrives to the location of the thermistor (∆t
ts
).
Equation 1 is therefore revised as follows:
EVLW = CO * [(MTt
therm
 – ∆t
tube
 – ∆t
ts
) – (MTt
UD
 + ∆t
pl
)] [2]
Where  ∆t
tube 
= time delay related to heat exchange within AV loop tubing; ∆t
ts 
= time 
delay related to inertia of thermistor due to plastic surroundings and ∆t
pl 
= time 
accounting for the influence of ultrasound velocity changes in plastic tubing.
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Each EVLW measurement session consisted of two ice-cold (<10°C) isotonic saline 
injections (1 mL/kg). EVLW was determined by the average of two consecutive 
EVLW measurements by TPUD and indexed by bodyweight (EVLWItpud). Specially 
designed software (CO-status®, Transonic Systems Inc., Ithaca, NY, USA) was used to 
calculate cardiac output, hemodynamic volumes and EVLW. Values were displayed 
on the monitor.
TRANSPULMONARY DOUBLE INDICATOR DILUTION (see appendix 1) – TPDD 
measurements were performed by rapid injection of 5-mL ice-cold (< 10°C) ICG 
(1 mg/mL in glucose 5%) into the femoral venous catheter. Changes in both 
temperature and ICG concentration were detected by the thermal-dye-dilution 
probe connected to a COLD monitor (Pulsion Medical Systems, Germany). Cardiac 
output, blood volumes, and EVLW were calculated from the analysis of the dilution 
curves and measurement of the mean transit time and downslope time [26,27]. 
Before a series of measurements was performed, the central venous catheter was 
flushed with 1–2 mL of ice-cold saline. Each dilution curve was visually inspected 
for artefacts or other signs of inadequate measurement. EVLW was determined by 
the average of three consecutive EVLWI measurements by TPDD and indexed by 
bodyweight (EVLWItpdd). Unfortunately, in the last three animal experiments, 
the COLD system was defective.
GRAVIMETRIC TECHNIQUE (see appendix 2) – 50-mL of central venous blood was 
collected immediately prior to the euthanasia. Subsequently, the lungs were 
removed after median sternotomy and drained passively. The gross weight of each 
lung, with its residual blood, was determined. The lungs were homogenized with 
an equal weight of water to induce hemolysis using a commercial blender and 
homogenizer. Half of the homogenate was used to determine its wet/dry weight 
and the other half was centrifuged at 6,000 rpm for 1 hour at 4°C to separate a 
clear supernatant. Hematocrit from whole blood and hemoglobin from whole 
blood and lung supernatant were measured. The wet and dry weights of the 
samples of blood, homogenate, and supernatant were determined before 
respectively after 4 days of incubation in a heat chamber at 70°C. Post mortem 
EVLWI was calculated by the formulas as previously described (see Appendix 2) 
and also indexed by bodyweight (EVLWIgrav) [10-12].
EXPERIMENTAL PROTOCOL – After a stabilization period of 15 minutes following 
instrumentation the study protocol was started. Sessions of EVLWItpud 
measurements and blood gas analysis were performed at baseline and after a 
postlavage stabilization period of 15 minutes following  2 consecutive lavages. At 
baseline, halfway and at the end of the experiment EVLWItpdd was also estimated. 
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In all lambs, postmortem measurements of extravascular lung water were 
performed by gravimetry. The median time interval between the last EVLW 
measurement  and the euthanasia was 40 (IQR 4) minutes with a range between 15 
and 60 minutes. A blood transfusion was administered if the hemoglobin 
concentration was less than 5.6 g/dL. Inotropic support (dobutamine or epinephrine) 
was initiated in case of circulatory instability (hypotension and/or low cardiac 
output) due to hypoxia.
STATISTICS – The cardiac output values were indexed by bodyweight (mL/kg/min). 
Variables were summarized as frequencies for categorical data or means, and standard 
deviations (SD) for continuous normally distributed variables. A Mann-Witney test 
was used for comparison between initial and final oxygenation indexes and PEEP 
levels in the lambs that underwent lung lavages. Data from the different EVLWI 
measurements were compared using the method described by Bland and Altman 
[28]. The bias was defined as the difference between EVLWItpud and EVLWI 
measured by the reference method (EVLWItpdd/grav) or the difference between 
EVLWItpdd and EVLWIgrav. The bias was plotted against the mean EVLWI of both 
methods ((EVLWItpud + EVLWItpdd/grav)/2 or (EVLWItpdd + EVLWIgrav)/2). The 
limits of agreement (LOA) were calculated by multiplying the SD of the bias with 
1.96. The percentage error (PE) was calculated as 100 x ((1.96 α SD of the bias)/mean 
EVLWI(tpdd/grav) [29]. We did not correct for (unequal) repeated measurements as 
the number of paired measurements per subject was small (1–5) and less than the 
total number of subjects (13), allowing pooling of the data [30]. Comparison of bias 
of EVLWI between TPUD and the two reference methods and final PEEP, final 
oxygenation index, mean EVLWI and CO were analyzed by Spearman coefficient of 
rank correlation. Changes in EVLWI measurements by TPUD and TPDD were 
calculated by subtracting the consecutive EVLWI measurements. Comparison of 
these changes in EVLWI was analyzed by Spearman coefficient of rank correlation. 
A p-value < 0.05 was considered statistically significant. SPSS 20 for Windows® 
(SPSS Inc., Chicago, USA) was used for statistical analysis.
Results
Thirteen lambs with a mean postnatal age of 15 ± 6 days  (range 4 - 21 days) and a 
mean weight of 8.3 kg (range 4.1–12.3 kg) were studied. The characteristics and 
results of the EVLWI measurements of the lambs are shown in Table 1. EVLW could 
not be measured in one lamb due to technical problems (lamb 2). Four lambs 
(lambs 4, 7, 9 and 10) died during or after a lavage session before reliable final 
EVLWItpud measurements could be performed, leaving eight lambs to compare 
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EVLWItpud with EVLWIgrav. Mean EVLWIgrav was 19.0 mL/kg (SD 5.3 mL/kg). As 
the COLD device was out of order during the last three experiments, 9 lambs – and 
a total of 22 measurements - were eligible for comparison of EVLWItpud and 
EVLWItpdd. Comparison between EVLWItpdd and EVLWIgrav was possible in six 
animals (1, 3, 5, 6, 8, 10). In the lambs who were subjected to lung lavages, the 
initial mean EVLWtpud was 13.3 mL/kg (SD 8.0 mL/kg) which increased after 
multiple lung lavages to a final mean EVLWItpud of 23 mL/kg  (SD 6.3 mL/kg). This 
increase in lung water was accompanied by a significant increase in oxygenation 
index (p < 0.001) and PEEP levels (p < 0.001).
 Figure 1 shows the results of the EVLWI measured by TPUD (a) and TPDD (b) 
during the experiment and visualizes the final EVLWI measurements of the different 
methods (c). Bland-Altman plots for the differences between (a) EVLWItpud and 
Figure 1   Results of the extravascular lung water index (EVLWI) measured by 
transpulmonary ultrasound dilution (TPUD) (a) and transpulmonary 
double dilution (TPDD) (b) during the experiment and of the final 
EVLWI measurements by the three different methods (c)
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EVLWIgrav, (b) EVLWItpud and EVLWItpdd and (c) EVLWItpdd and EVLWIgrav are 
illustrated in Figure 2. The mean bias between (a) EVLWItpud and EVLWIgrav was 
1.7 mL/kg (LOA ± 8.3 mL/kg), (b) EVLWItpud and EVLWItpdd was -3.4 mL/kg (LOA ± 
Figure 2   Bland-Altman plots for the comparison between a extravascular lung 
water index measured by transpulmonary ultrasound dilution 
(EVLWItpud) and gravimetry (EVLWIgrav), b EVLWItpud versus 
transpulmonary double indicator dilution (EVLWItpdd) and c EVLWItpdd 
versus EVLWIgrav
The bold horizontal lines represent the mean bias; the dashed horizontal lines represent the upper 
and lower limits of agreement.
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25.8 mL/kg) and (c) EVLWItpdd and EVLWIgrav was 11.0 mL/kg (LOA ± 11.1 mL/kg). 
The percentage errors were 43%, 109% and 59%, respectively. The bias between 
EVLWItpud and EVLWIgrav was not correlated with final OI (r2 = 0.10, p = 0.54), 
mean EVLWI (r2 = 0.04, p = 0.70) or cardiac output (r2 = 0.00, p = 0.99). There was a 
weak correlation with the final PEEP (r2 = 0.36, p = 0.11). The bias between EVLWItpud 
and EVLWItpdd was not related to the mean EVLWI (r2 = 0.02, p = 0.53) but there 
was a weak correlation with the PEEP (r2 = 0.26, p = 0.01), OI (r2 = 0.24, p = 0.02) and 
cardiac output (r2 = 0.28, p = 0.01). Figure 3 shows the correlation between changes 
in EVLWI measured by TPUP and TPDD (r2 = 0.22, p = 0.11). Table 2 gives an overview 
of the studies comparing EVLWI measured by (double) dilution techniques and 
gravimetry (see discussion section).
Discussion
This is a validation study investigating the applicability of EVLWI measurements 
by the transpulmonary ultrasound dilution method. Our results show that 
measuring EVLWI using TPUD seems accurate when compared with the gold 
standard gravimetry, but the method still lacks precision. TPUD is not reliable as 
a monitoring device to track changes in EVLWI when compared with the TPDD.  
Figure 3   Correlation between the change in extravascular lung water index 
measured by transpulmonary ultrasound dilution (EVLWItpud) and 
transpulmonary double indicator dilution (EVLWItpdd) (Spearman’s  
rank correlation) 
The continuous line represent the linear regression line with regression coefficient r2.
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 Despite its accuracy compared to the gravimetric method, the precision of 
EVLWI measurements by TPUD is rather low with an error percentage of 43%. Like 
TPDD, TPUD uses a double indicator technique with temperature as a diffusible 
indicator (which equilibrates with the extravascular space) and the isotonic saline 
(TPUD) as a non-diffusible indicator. EVLW is estimated by multiplying CO and the 
difference in mean transit time by the thermal and the non-diffusible indicator. 
Various factors may influence the measurement of EVLW by indicator (dye) dilution 
techniques [31]: the effect of high PEEP is controversial resulting in both under- or 
overestimation of EVLWI as an increase in PEEP can change the distribution of 
thermal and non-diffusable indicators by effecting pulmonary blood flow; altered 
lung perfusion due to (focal) lung injury leads to underestimation of EVLW and 
cardiac output seems to relate inversely to the difference in MTt between the 
non-diffusable and the thermal indicator [32,33]; Although this study was not 
designed to evaluate the effects of these factors, the bias between EVLWItpud and 
EVLWIgrav was not related to the mean EVLWI, the wide range in cardiac output 
or the degree of lung injury (final OI) and weakly related to PEEP. The lack of 
precision for estimating EVLWItpud compared to gravimetric measurements 
might be due to several factors: 1) the limited number of data, 2) the underlying 
algorithm used for the calculation of EVLW is not accurate and might need some 
adaptation; 3) the type of lung injury model used: the surfactant wash out model 
with instilling and subsequently draining saline from the lung, results in a 
ventilation/perfusion mismatch and therefore an increase in not only the 
interstitial fluid, but also the intra-alveolar fluid. However, if we assume that there 
is a discrepancy between the intra-alveolar fluid measured by TPUD and the 
gravimetry (after drainage of the lungs) , we would have expected an overestimation 
rather than both over- and underestimation of EVLWI. 4) We conducted the 
gravimetric measurements according to published guidelines [12]. Our gravimetric 
EVLWI values were slightly higher compared to those in earlier studies (see table 2), 
probably due to the wash out model with an evident increase in alveolar fluid. The 
time-window between the last EVLWItpud and the removal of the lungs amounted 
to an average of 40 minutes. During that time, possible shifts in intra-alveolar and 
interstitial fluid might occur influencing the bias between the 2 methods.
 To validate the possibility of tracking changes in EVLWI we compared the 
TPUD with the TPDD during the experiment. Overall accuracy between EVLWItpud 
versus EVLWItpdd was good but there were wide limits of agreement resulting in 
an inacceptable high percentage error. There was a trend that the disagreement 
between EVLWItpdd and EVLWItpud widened with higher EVLW values (figure 
2b). Based on these comparative results, it seems that TPUD is not applicable as a 
EVLWI (trend) monitoring in clinical practice, also given the weak correlation 
between changes in EVLWI measured by these 2 methods (figure 3). Explanations 
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for this lack of precision might be various. First, differences in the underlying 
algorithms for the calculation of EVLW by TPDD and TPUD influencing the EVLWI 
measurements (see methods and appendix section). EVLWItpud estimates seem to 
fluctuate in some of the lambs during the experiment (figure 1b), an observation 
which might be due to the inaccuracy of the TPUD measurements (and requiring 
adaption the algorithm) or to real fluctuations in EVLWI (as the remaining 
intra-alveolar fluid after incomplete saline removal after lavages might increase 
EVLW). On the other hand, it is known that the TPDD overestimates EVLW because 
temperature exchange occurs within the cardiac structures, a phenomena which 
becomes more apparent with increasing lung water (see also Figure 1c). Second, 
one might question the reliability of the TPDD measurements as problems with 
the COLD device occurred in some lambs. We tried to eliminate this factor by 
visually inspecting each dilution curve for artefacts or other signs of inadequate 
measurement. The TPDD is considered the clinical gold standard to measure 
EVLWI based on different studies showing strong correlation between EVLWItpdd 
and EVLWIgrav [12-18,34-36]. However, as a strong correlation does not necessary 
imply good agreement between two methods [28], we reviewed some previous 
reports and (re)calculated bias and precision if the necessary data were available 
(table 2). We found that percentage errors between EVLWItpdd and gravimetric 
measurements varied considerably between 10 and 71% (mean 43%), mainly 
depending on the type of lung injury. In our study, the disagreement between the 
2 methods is rather high (percentage error 59%, figure 2c), a result that might be 
influenced by the limited number of measurements for comparison (n = 6). 
Estimates of EVLWI using TPDD (in this study) should therefore be interpreted 
with cautions, despite the acceptance of the method as the clinical gold standard. 
Based on our results, it even seems that TPUD might be a better clinical tool to 
estimate EVLW than TPDD.
 Although TPUD seems to lack some precision to estimate EVLWI in its current 
application, we think the method might have potential for future use in preterm 
and term neonates after adapting the algorithm. No bedside methods are available 
at this time to measure EVLWI in these patients. The diagnostic accuracy of 
physical examination (crackles) is poor for the detection of increased EVLW. Chest 
radiographic indices and lung ultrasound profiles can be used to estimate lung 
fluid clearance or the presence of EVLW [37,38] but fail to give absolute values of 
EVLW. Moreover, in older children no correlation was found between EVLWI 
measured by thermodilution and a radiographic scoring system [39]. Magnetic 
resonance can detect lung water content in preterm infants but the method is not 
bedside applicable.
 Our findings do need to be interpreted cautiously as they are based on a small 
data set due to the early loss of animals caused by respiratory instability during Ta
b
le
 2
   O
ve
rv
ie
w
 o
f 
st
u
d
ie
s 
co
m
p
ar
in
g 
ex
tr
av
as
cu
la
r 
lu
n
g 
w
at
er
 m
ea
su
re
d
 b
y 
(d
ou
bl
e)
 d
il
u
ti
on
 m
et
h
od
s 
an
d
 g
ra
vi
m
et
ry
.
A
u
th
o
r
M
et
h
o
d
Sp
ec
ie
s
N
u
m
b
er
 o
f 
m
ea
su
re
m
en
ts
C
o
rr
el
at
io
n
B
ia
s 
(m
L/
k
g)
LO
A
  
(m
L/
k
g)
M
ea
n
  
E
V
LW
gr
av
 
(m
L/
k
g)
Pe
rc
en
ta
ge
 
er
ro
r 
(%
)
D
o
u
b
le
 i
n
d
ic
at
o
r 
d
il
u
ti
o
n
 m
et
h
o
d
s 
ve
rs
u
s 
gr
av
im
et
ry
Pe
ar
ce
 –
 1
96
5
Is
ot
op
e 
in
d
ic
at
or
D
og
s
ed
em
a
se
ve
re
 e
d
em
a
18 5
-
-1
.2
-6
.7
2.
04
4.
24
4.
8
9.
3
43 45
H
ol
cr
of
t 
– 
19
78
(m
L.
gr
 E
D
W
L)
IC
G
ba
bb
oo
n
s
29
0.
87
0.
31
1.
4
5.
5
28
M
ih
m
 –
 1
98
7
IC
G
h
u
m
an
s
9
0.
98
3.
43
2.
99
6.
06
49
R
os
si
 –
 2
00
3
M
ol
ec
u
la
r 
 
in
d
ic
at
or
Pi
gs
sh
am
en
d
ot
ox
ae
m
ia
6 7
0.
78
0.
94
-0
.2
6
5.
82
2.
85
4.
25
6.
4
12
.6
44 34
R
oc
h
 –
 2
00
4
IC
G
Pi
gs
O
le
ic
 a
ci
d
H
C
l 
ac
id
12 24
0.
88
0.
38
-5
.2
-7
.9
1.
8
6.
5
17
.5
15
.1
10 43
M
ad
d
is
on
 –
 2
00
8
IC
G
p
ig
s
10
0.
55
-1
.0
6.
6
9.
2
71
V
ra
n
ck
en
 –
 2
01
5
TP
U
D
IC
G
la
m
bs
8 6
0.
74
0.
90
1.
7
11
8.
3
11
.1
19 22
43 50
M
ed
ia
n
0.
87
43
Si
n
gl
e 
in
d
ic
at
o
r 
d
il
u
ti
o
n
 m
et
h
o
d
 v
er
su
s 
gr
av
im
et
ry
K
at
ze
n
el
so
n
 –
 2
00
4
TP
TD
d
og
s
15
0.
97
3.
01
2.
7
17
15
K
ir
ov
 –
 2
00
4
TP
TD
sh
ee
p
18
0.
85
4.
9
5.
08
8.
7
37
R
os
si
 –
 2
00
6
TP
TD
Pi
gs
sh
am
en
d
ot
ox
ae
m
ia
6 5
- -
-5
.1
-5
.7
1.
07
4.
13
6.
6
11
.1
16 37
M
ad
d
is
on
 –
 2
00
8
TP
TD
p
ig
s
10
0.
43
8.
5
14
.5
9.
5
11
7
N
u
sm
ei
er
 –
 2
01
4
TP
TD
la
m
bs
9
0.
93
12
.2
10
.2
20
.2
50
M
ed
ia
n
0,
87
37
LO
A
 l
im
it
s 
of
 a
g
re
em
en
t;
 p
er
ce
n
ta
ge
 e
rr
or
 =
 1
0
0
* 
((1
.9
6*
SD
 o
f 
th
e 
bi
as
)/m
ea
n
E
V
LW
Ig
ra
v)
; I
C
G
 =
 i
n
d
o
cy
an
in
 g
re
en
; E
V
LW
g
ra
v 
= 
ex
tr
av
as
cu
la
r 
lu
n
g 
w
at
er
 m
ea
su
re
d
 
b
y 
g
ra
vi
m
et
ry
; T
PU
D
 =
 t
ra
n
sp
u
lm
on
ar
y 
u
lt
ra
so
u
n
d
 d
il
u
ti
on
; T
P
T
D
 =
 t
ra
n
sp
u
lm
on
ar
y 
th
er
m
o
d
il
u
ti
on
, E
V
D
W
 (e
x
tr
av
as
cu
la
r 
d
ry
 w
ei
gh
t 
of
 t
h
e 
lu
n
gs
)
502337-L-sub01-bw-Vrancken
160
CHAPTER 8
lavage sessions and technical problems with the TPDD device. We are aware that 
more data could have altered results and conclusions.  Notwithstanding this 
limitation, we think this pilot study adds new information regarding the 
possibility of EVLWI measurements by TPUD, especially for (newborn) infants.
 Other limitations: We used the surfactant lavage model to induce lung edema 
as RDS is one of the most commonly lung injury in neonatal intensive care. 
However, this model might not be totally representative for other types of 
(neonatal) lung injury (meconium aspiration syndrome, sepsis, cardiogenic shock 
with increased EVLW) as it lacks some of those specific features [24]. We did not 
rule out any intracardiac shunts that could have interfered with EVLW estimates 
(both cardiac output and mean transit times are influenced by shunt circulation). 
On the other hand, the TPUD method is adequate in identifying shunts, and we 
did not detect any shunts with TPUD in the studied animals [19].
Conclusion
EVLWI measurements using transpulmonary ultrasound dilution in a neonatal 
animal model shows low agreement with the clinically accepted transpulmonary 
double dilution method. Accuracy seems good compared to the gold standard 
gravimetric method but the method lacks precision in its current prototype. Based 
on these pilot study data, we propose that further adjustment of the algorithm is 
needed before the technique can be used for (neonatal) EVLWI measurements. 
However, larger studies are needed to support our findings. 
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Appendices
Appendix 1. Calculations of EVLW by transpulmonary double 
indicator dilution
In this double indicator dilution technique, two different indicators are injected 
simultaneously, using cold ICG. The cold equilibrates with the extravascular space, 
while the dye is rapidly bound to proteins and remains intravascular. Analysis of 
dilution curves yields the cardiac output (CO), the mean transit time (MTt) of the 
indicator, and the exponential downslope time (DSt) of the curve.
The volume of distribution for the temperature indicator corresponds to the total 
water content between the injection and detection sites and is referred to as the 
intrathoracic thermal volume (ITTV). 
Multiplication of the CO by the mean transit time of the thermal indicator (MTt
ther
) 
yields the ITTV.
ITTV = CO × MTt
ther
 (mL) [1]
The volume of distribution for the dye indicator which is strictly plasma bound 
equals the intravascular volume between the injection and detection sites and is 
referred to as intrathoracic blood volume (ITBV). 
Multiplying the CO by the mean transit time of the strictly plasma bound ICG 
(MTt
ICG
) yields the ITBV:
ITBV
TPDD
 = CO × MTt
ICG
[2]
The difference of the thermal and blood volume is the EVLW.
EVLW = ITTV - ITBV
TPDD
[3]
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Appendix 2. Formulas used for the gravimetric calculation of EVLW
Fw
s
 =  Wws – Wds
Wws
[1]
Fw
h
 =  Wwh – Wdh
Wwh
[2]
Qr = Qh ×  Hbs
Hbb
 × Fwh
Fws
 × Hct [3]
Qb =  
Qr+[Qr (1–Hct)]
Hct
[4]
Fwb =  Wwb – Wdb
Wwb
[5]
EVLW = Qh x Fwh – Qb x Fwb – Qwt [6]
where EVLW is extravascular lung water, Fw is fraction water, b is blood, h is 
homogenate, s is supernatant, Hct is hematocrit, Hb is hemoglobin concentration, 
Ww is wet weight, Wd is dry weight, Q is weight, Q
wt
 is weight of added water, Q
b
 is 
residual blood content in lungs, and Q
r
 is red cell mass of lung.
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General discussion and summary
Adequate assessment of the cardiovascular function in preterm and term infants 
has become an important goal in neonatal medicine. Without reliable information 
on systemic blood flow, systemic vascular resistance, organ blood flow redistribution 
and tissue oxygen delivery, effective treatment of circulatory compromise is not 
possible. In this chapter, we address the need for comprehensive monitoring in 
neonatal intensive care patients and resume the most important findings of our 
research. 
The need for comprehensive hemodynamic monitoring (Section I)
Neonatologists face real challenges to diagnose and treat newborn infants with 
circulatory failure. In general, the key function of the cardiovascular system is to 
preserve an optimal balance between oxygen delivery and oxygen consumption. 
Compensatory mechanisms regulated by the autonomic and peripheral nervous 
system, baroreceptors and hormones are activated in case of circulatory failure [1]. 
The primary mechanism is redistribution of regional blood flow from the low 
priority (non-vital) organs to the high priority (vital) organs. During this phase 
of compensated shock blood pressure normally remains within normal limits. 
When compensating mechanisms fail, progression to hypotension will occur 
(uncompensated shock) and organ blood flow is further diminished leading to 
tissue hypoxia and eventually cell death. As cardiovascular compromise is 
associated with severe morbidity and increased mortality [2-4] it is important to 
recognize and initiate appropriate treatment in the earliest phase of shock. 
Therefore, adequate monitoring of both global and regional blood flow is crucial. 
However, current standard monitoring systems are inaccurate for assessing perfusion 
and more advanced monitoring technologies are therefore warranted [5,6].
 As the neonatal circulation distinguishes itself from the adult circulation in 
many ways, detection of circulatory compromise might even be more difficult. 
Chapter 2 reviews some of the unique cardiovascular aspects of the fetal and 
neonatal circulation. The (preterm) cardiovascular system is characterized by 
morphological and functional myocardial immaturity, with a limited ability to 
increase contractility, a shorter passive ventricular filling phase and impaired 
diastolic function, and a poor tolerance of high systemic vascular resistance [7]. 
Furthermore, major changes in blood flow and systemic/pulmonary vascular 
resistance occur during transition: the parallel, right heart predominant, low 
resistance placental circulation with the existence of fetal channels (open foramen 
ovale, ductus arteriosus) has to change within seconds to minutes into a serial, left 
heart predominant and high systemic vascular resistance circulation after loss of 
the placental circulation and closure of the fetal channels. When adequate 
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transition fails, a condition that is normal in utero becomes pathological after 
birth, putting the neonate at risk for circulatory failure [8]. In addition, maternal 
complications before and during delivery, maternal medication, congenital 
abnormalities and the time of cord clamping may affect transition. 
 Optimal oxygen delivery can only be maintained by adequate perfusion 
pressure and blood flow in the systemic and pulmonary circulation. As blood 
pressure itself is the dependent variable in the product of the interaction between 
both flow and vascular resistance, relying on blood pressure measurements alone 
to estimate circulatory failure and guide treatment might be unhelpful and even 
dangerous [9,10]. Moreover, consensus on normal blood pressure values in (preterm) 
neonates is lacking [11]. Gathering accurate information on global oxygen delivery 
is therefore only possible with simultaneous assessment of systemic blood flow 
(cardiac output) and calculation of systemic vascular resistance (SVR). Yet despite 
adequate oxygen delivery, tissue perfusion may already be impaired in the 
compensated phase of shock in non-vital organs. Estimates of regional blood flow 
and end-organ perfusion are therefore required to enable us to initiate therapy, 
before tissue damage becomes irreversible. In addition, the information gathered 
on cardiac output and SVR is essential to direct treatment, as the circulatory 
derangement could be the result of abnormal CO (usually low systemic flow), 
abnormal SVR, or both. 
 An overview of the currently available (advanced) monitoring systems is listed 
in the second part of Chapter 2. Transthoracic echocardiography is indispensable 
in the neonatal period for detecting congenital cardiac anomalies and it provides 
a wealth of information on cardiac function (including cardiac output) and the 
presence of shunts. However, the method is not always instantly applicable. Over 
the last decade, many cardiac output monitoring devices, with variable degrees of 
invasiveness have become available. They are based on different techniques such 
as Doppler ultrasound, bio-impedance, indicator dilution and arterial pulse 
contour analysis. The feasibility of most of these technologies is limited in 
newborns due to technical restraints, problems with vascular access and the 
inaccuracy of measurements in the presence of shunts [12], although some of them 
might have potential for use in the near future (e.g. electrical velocimetry). 
Choosing the right CO monitoring system can be difficult as there is no device that 
can be applied in all newborns. Non-invasive, easy applicable techniques that 
continuously measure cardiac output (CO) are preferably used, but the current 
methods lack accuracy and precision when compared to more invasive techniques. 
They might be applicable for trend monitoring to detect changes in CO over time. 
For critically ill neonates, invasive techniques with higher accuracy of CO estimates 
might be applied to initiate or adapt treatment. When oxygen consumption 
becomes dependent on oxygen delivery, fractional oxygen extraction will increase, 
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mixed venous saturation will decrease and lactate production will generally rise. 
Measurement of lactate levels and central venous oxygen saturation – as a surrogate 
for mixed venous oxygen saturation – might therefore be helpful, although many 
limitations have to be considered and trend monitoring seems to have more value 
than single measurements. Assessment of regional blood flow and regional tissue 
oxygenation (as estimates of tissue oxygen extraction) using multisite near 
infrared spectroscopy (NIRS) can provide information on redistribution of blood 
flow during the compensated phase of shock [13]. The use of technologies for 
evaluating the microcirculation is still limited but of potential value. 
 With the increasing knowledge of transitional physiology and the availability 
of some of the advanced hemodynamic monitoring techniques mentioned above, 
we investigated to what extent those monitoring systems are currently used in the 
neonatal intensive care units (NICU). The results of this international survey are 
presented in Chapter 3. Respondents mainly originate from western European 
countries. Clinical impression, in combination with (mainly) invasive blood 
pressure measurements, blood gas analysis and lactate levels are still regarded as 
the most important parameters for the assessment and possible treatment of poor 
perfusion. Functional echocardiography is increasingly used by the respondents 
to assess cardiac function, whilst multisite NIRS is sometimes applied in less than 
half of the surveyed centers for the estimation of end-organ perfusion. The use of 
other advanced hemodynamic monitoring systems is limited and restricted to 
research settings, a finding similar to a previous report investigating the use of 
hemodynamic monitoring in preterm infants with hypotension [14]. Possible 
explanations for this abstention in use of those devices  are the lack of validation 
studies of most techniques in neonates, the lack of defined target values to initiate 
therapy and the (sometimes significant) limitations of the devices. Treatment 
protocols for neonatal circulatory failure are available in more than half of the 
centers (with some regional differences) with treatment approaches mainly based 
on applying current knowledge of physiology rather than on blood pressure alone. 
This is in line with the recent recommendations and guidelines to treat circulatory 
instability in critically ill newborns [15,16]. 
The study of an advanced hemodynamic monitoring device (Section II)
Measurement of cardiac output
Neonatal cardiac output monitoring devices should not only be accurate and 
precise, easy to apply, non-invasive, practical and inexpensive, and preferably 
providing continuous information, but also feasible during transition and in the 
presence of shunts. We validated the transpulmonary ultrasound dilution 
technique (TPUD) in two separate animal models for possible use in critically ill 
(pre)term infants. TPUD is an invasive technique using isotonic saline, heated to 
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body temperature, as an indicator that is injected on the venous site of an 
extracorporeal tubing loop situated between any indwelling central venous and 
arterial catheter. Isotonic saline decreases the ultrasound velocity of blood that is 
measured on the arterial site. From the derived ultrasound dilution curve cardiac 
output can be calculated using the Stewart-Hamilton principle. 
 Indicator dilution techniques, irrespective of the indicator used, should meet 
the following conditions: constant blood flow, complete mixing of the indicator 
with blood, only one passage by the arterial detection point, and no or minimal 
loss between the injection and the detection site [17]. Fulfilling the latter two 
conditions might be difficult in NICU patients:
1)  Newborns do have shunts during transition or in the presence of cardiac 
anomalies making the use of TPUD very challenging as the shunting prolongs 
the circulation time of the indicator and distorts the dilution curve, possibly 
effecting the estimation of CO. We assessed the agreement for cardiac output 
measurements between TPUD and measurements of main pulmonary blood 
flow by ultrasonic flow probes (UFP) around the main pulmonary artery in a 
lamb model with an artificially created left-to-right-shunt in Chapter 4. We 
demonstrated that TPUD is reliable for measuring cardiac output in the 
presence of significant shunts over a wide range of cardiac output. The change 
in the dilution curve due to shunting enables the TPUD device to detect and 
calculate the shunt fraction, expressed as pulmonary over systemic blood flow 
ratio (Qp/Qs). In the same shunt model, we found that TPUD is able to detect 
the presence of variable sizes of left-to-right shunts with high sensitivity (100%) 
and specificity (83%). Absolute measurements of Qp/Qs by TPUD were compared 
to Qp/Qs measured by ultrasonic flow probes. Although accuracy was good, 
the precision to quantify Qp/Qs was moderate, especially for the smaller 
shunts. Therefore, we concluded in Chapter 5 that TPUD is able to detect 
shunts with high predictive value, but quantification of the shunt is not 
reliable in its current application. As the ability to detect changes in Qp/Qs 
values is high, TPUD can be used for trend monitoring. 
2)  Neonates admitted to the NICU have a high incidence of respiratory failure 
due to respiratory distress syndrome (RDS), meconium aspiration syndrome or 
pneumonia. The subsequent non-homogeneous pulmonary perfusion in these 
conditions [18] might substantially influence the transit time of the indicator, 
resulting in an overestimation of true cardiac output. In Chapter 7 we 
investigated the influence of lung pathology on the accuracy and precision of 
CO measurements using TPUD in an animal model with induced RDS by 
surfactant wash-out. The degree of lung injury was established by monitoring 
the oxygenation index and by postmortem histological examination. Again, 
CO measured by TPUD was validated against cardiac output measured by UFP. 
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We concluded that TPUD is reliable for measuring CO in patients with 
(progressive) lung injury. 
 Taken these results into account, the transpulmonary ultrasound dilution 
method is a reliable method to measure cardiac output under different neonatal 
conditions and it might be applicable in newborns over a wide range of gestational 
ages and clinical conditions. Its additional ability as a bedside trend monitor to 
detect shunts and track changes in shunt size may be especially useful to evaluate 
changes over time and responses to initiated therapy in preterm infants with 
(patent) ductus arteriosus and in term newborns with persistent pulmonary 
hypertension or cardiac anomalies. Some (technical) limitations of the method 
have to be addressed for the use in clinical practice: first, TPUD is an invasive 
method requiring central (preferably double lumen) venous and arterial catheters 
(umbilically or peripherally inserted) and is provisionally licensed for use in 
preterm infants weighing more than 800 grams. This makes the technique 
unsuitable for monitoring cardiac output immediately during transition in the 
delivery room, in infants admitted to the NICU without central lines or in extreme 
low birth weight infants. However, its use is feasible in most (critically ill) intensive 
care patients. Second, TPUD measures cardiac output intermittently. Changes in 
CO and shunt size can therefore only be detected when repeated measurements 
are performed. At present, technical adaptations are made to measure CO 
continuously with a limited need for calibration. Third, repetitive measurements 
may lead to volume overload especially in patients with the need for fluid 
restriction. We showed in Chapter 4 that the reliability of CO measurements did 
not improve when the mean of 3 instead of 2 injections was used for each session. 
This is in line with previous findings [19]. We therefore recommended to average 
the results of 2 instead of 3 injections of 0.5 mL/kg unless their difference exceeds 
> 10%. In that case 3 injections per session should be used. 
Measurement of fluid status
Obtaining an optimal fluid balance in neonates can be difficult as both fluid 
overload and absolute or relative fluid depletion might impair cardiac function 
due to the immature cardiovascular system. Information on the fluid status is 
required to initiate the proper therapeutic interventions that aim for an adequate 
intravascular volume status while avoiding overzealous fluid administration. 
Static (hemodynamic volumes) and especially dynamic variables derived from 
arterial blood pressure variations during mechanical ventilation (e.g. systolic 
pressure variations and pulse pressure variations) can be used to assess fluid 
responsiveness in adults, but their use is still limited in children and neonates (see 
also Chapter 2) [20,21]. Analysis of the dilution curve from the TPUD device enables 
the calculation of CO, but also of several related hemodynamic volumes. 
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 We described the effect of different interventions on CO and hemodynamic 
volumes in Chapter 6. In the animal model with an artificially created left-to-right 
shunt, changes in cardiac output and hemodynamic volumes (total end diastolic 
volume, central blood volume, and active circulating volume) were observed during 
shunt opening and closure, during progressive hemorrhage, and during volume 
resuscitation and were consistent with expected physiology. We hypothesize that, 
although its clinical utility in neonates is not yet proven and the absolute values of 
the hemodynamic volumes must be interpreted with caution, TPUD seems a promising 
technique that might improve intravascular volumes estimates in critically ill 
newborns, especially when used as a trend monitor. 
 Because lung injury and sepsis are often accompanied by increased permeability 
of the capillaries and pulmonary fluid overload may further impair oxygenation, 
assessment of extravascular lung water (EVLW) could be helpful. In a prototype 
version, TPUD technology can estimate EVLW when used as a double indicator 
method with injection of ice-cold isotonic saline. In Chapter 8 EVLW measurements 
using TPUD were validated against EVLW measurement by the transpulmonary 
double indicator technique and the post-mortem gravimetry (gold standard) in the 
RDS animal model with a wide range of pulmonary edema. Agreement between 
EVLW measured by TPUD and the clinically accepted transpulmonary double 
dilution method was low, probably due the differences in underlying algorithms 
for the calculation of EVLW. The accuracy of TPUD compared to the gold standard 
gravimetric method was good but the method still lacks precision in its current 
prototype. Further adjustment of the algorithm is needed before the technique 
can reliably estimate neonatal EVLW, which might serve as an indicator to restrict 
the use of fluids or to start diuretics. A possible additional limitation for measuring 
EVLW is the use of ice-cold isotonic saline that might lead to a bradycardia 
influencing cardiac output and cerebral blood flow in preterm infants [22].  
 The findings in Section 2 of this thesis support the use of the transpulmonary 
ultrasound dilution technique as a bedside, hemodynamic monitoring device for 
neonates. The next step would be evaluating the bedside clinical use of CO 
measurements by TPUD in neonates. At present, observational studies are in 
progress. Combining the various TPUD variables (cardiac output measurements, 
hemodynamic volumes, presence of shunts and (over time) EVLW measurements) 
will enable us to study neonatal hemodynamics under different clinical conditions. 
 Although we focused on monitoring of the systemic circulation in this thesis, 
we advocate for the simultaneous (and preferably continuous) monitoring of blood 
pressure, systemic and regional blood flow and tissue oxygen delivery. Many 
different methods are available, but most of them lack feasibility for current 
neonatal use. Until more reliable non-invasive and continuous (CO) measurement 
methods are available, we propose integrating clinical and laboratory values 
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(heart rate, blood pressure, arterial oxygen saturation, hemoglobin level, (serial) 
lactate and ScvO
2
) with cardiac output estimates (TPUD), information on cardiac 
function (echocardiography) and regional (cerebral) blood flow (NIRS) to help us 
better understand the underlying pathophysiology of cardiovascular compromise 
in the newborn. In addition, combining repetitive bedside measurements and 
monitoring their dynamic changes over time could be helpful for initiating 
appropriate therapy and evaluating the response to the instituted treatment. 
Knowledge of the technical background and the pitfalls that are associated with 
each monitoring system are of utmost importance, as incorrect interpretation of 
the measured results could lead to initiation of inappropriate therapy and thereby 
increase the risk of injury. Currently, management of circulatory compromise 
depends primarily on experts’ opinions rather than high level of evidence. No 
studies are (yet) available to confirm the assumption that monitoring cardiac 
output or cerebral blood flow is beneficial for reducing mortality in neonates. In 
adults, a goal-directed therapeutic approach using advanced hemodynamic 
monitoring has proven to be of benefit in high risk (surgical) patients, but recent 
trials showed that additional continuous ScvO
2
 and CO monitoring did not 
improve outcome in septic adult patients who were identified in the early phase of 
shock. [23-27]. 
Conclusion
The immaturity of the cardiovascular system and the major changes during 
transition can lead to hemodynamic compromise in neonates with possible 
adverse short- and long-term outcomes. Objective and adequate information on 
systemic blood flow, regional perfusion, and microcirculation by (continuous) 
advanced hemodynamic monitoring will not only provide information of 
cardiovascular function but will guide the clinician to choose the most appropriate 
treatment. The current use of (advanced) hemodynamic monitoring in neonates is 
scarce, mainly due to the limited availability. We validated the transpulmonary 
ultrasound dilution method for neonatal use in an animal model with clinical 
conditions similar to the preterm infant. The technique is reliable for measurements 
of systemic blood flow, detection of (extra-)cardiac shunts, and estimates of 
hemodynamic volume changes, but some limitations have to be recognized. 
Despite the urgent need for advanced hemodynamic monitoring systems in 
neonatal care, it must be clear that the gathered information will not improve the 
patient’s outcome, unless the parameters are interpreted correctly and the initiated 
goal-directed therapy improves outcome by itself. 
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Future perspectives
We recommend the following research directions with regard to the use of 
transpulmonary ultrasound dilution and hemodynamic monitoring in general:
Transpulmonary ultrasound dilution (TPUD):
· Study neonatal hemodynamics using the transpulmonary ultrasound dilution 
device under normal (transition) and pathological conditions (persistent 
ductus arteriosus, persistent pulmonary hypertension, perinatal asphyxia, 
septic shock, congenital (cardiac) anomalies,…) over time to adequately assess 
hemodynamic changes;
· Study the influence of therapeutic agents used for circulatory comprise on 
systemic blood flow and hemodynamic values;
· Validate the algorithm used in the transpulmonary ultrasound dilution 
device to continuously measure cardiac output.
Advanced hemodynamic monitoring:
· Validate the existing continuous and non-invasive monitoring systems in 
clinical practice against the transpulmonary ultrasound dilution method;
· Elucidate cardiovascular (patho)physiology in the neonate by the combined 
use of advanced hemodynamic monitoring systems (on systemic, regional and 
microcirculatory levels);
· Continue the search for non-invasive, continuous, easily applicable and reliable 
hemodynamic monitoring devices for neonatal use.
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Samenvatting, conclusie en toekomstperspectieven 
(summary in Dutch)
Inleiding
Het bewaken (monitoren) van de bloedsomloop (ook wel circulatie genoemd) bij 
kritisch zieke pasgeborenen (neonaten) vormt vaak een grote uitdaging voor het 
behandelend medisch team, mede door de speciale eigenschappen van de neonatale 
circulatie. De circulatie staat in voor de toevoer van zuurstof en voedingsstoffen 
naar de weefsels - al naar gelang hun behoeften - en voor de afvoer van koolstof-
dioxide en afvalstoffen. Het is steeds streven naar een optimale balans tussen de 
zuurstofaanvoer en de zuurstofbehoefte. De zuurstofaanvoer wordt onder andere 
bepaald door de arteriële zuurstofconcentratie in het bloed en het hartminuut-
volume (de hoeveelheid bloed die per minuut door het hart wordt uitgepompt, ook 
wel cardiac output of systemische bloedstroom genoemd). Bij een falende bloeds - 
omloop kan de zuurstofvoorziening van de weefsels in het gedrang komen, 
hetgeen leidt tot celdood en orgaanbeschadiging. (Premature) pasgeborenen met 
een gecompromitteerde circulatie lopen het risico op ernstige darmontsteking, 
hersenbloeding, een gestoorde hersenontwikkeling met op termijn een psycho- 
motore achterstand, en/of overlijden. Bewaking van de circulatie op zowel systeem- 
als weefselniveau (ook wel macro- respectivelijk microcirculatie genoemd) is 
daarom uiterst belangrijk. De belangrijkste doelen van het monitoren zijn: 1) het 
vroegtijdig herkennen van een falende circulatie om orgaanschade en uiteindelijk 
mortaliteit te voorkomen, 2) het tijdig kunnen opstarten van een adequate 
behandeling, 3) het evalueren van de effecten van de ingezette behandeling en 4) 
vanuit wetenschappelijk oogpunt het verwerven van meer inzicht in de circulatie 
waardoor we onze behandelingsstrategieën kunnen verbeteren. 
 De huidige monitoringsystemen – continue registratie van bloeddruk, zuur-
stofverzadiging, hartritme – in combinatie met het lichamelijk onderzoek en 
 laboratoriumtesten zijn niet nauwkeurig genoeg gebleken voor het correct 
diagnosticeren van de (verminderde) circulatie. Het gebruik van (hoofdzakelijk) 
bloeddrukmeting bij de (premature) pasgeborene voor het inschatten van een 
falende bloedsomloop kan zelfs leiden tot een onder- of overbehandeling, met 
mogelijke nadelige bijwerkingen en iatrogene schade tot gevolg. Bloeddruk 
refereert namelijk naar de interactie tussen de bloedstroom en de vaatweerstand. 
Een normale bloeddruk kan dus gepaard gaan met een verminderde doorbloeding 
van de weefsels, terwijl bij een lage bloeddruk de weefselperfusie nog adequaat 
kan zijn. Verder is er geen eenduidigheid over normale bloeddrukwaarden bij 
(premature) pasgeborenen. De huidige aanbevelingen voor het behandelen van 
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een falende circulatie bij zieke pasgeborenen combineren bij voorkeur informatie 
over de bloeddruk, de bloedstroom (naar het lichaam) en het onderliggende pa-
thofysiologisch proces voor het maken van de juiste therapiekeuze. Aanvullende 
informatie over zuurstofaanbod en –verbruik is gewenst door middel van meer 
geavanceerde bewaking op zowel systeem- als weefselniveau. 
Doel van het onderzoek
In een eerste deel van dit proefschrift wordt een overzicht gegeven van  de huidige 
beschikbare en mogelijk toekomstige (geavanceerde) monitoringsystemen voor 
het bewaken van de circulatie (hemodynamiek) bij de pasgeborenen. Tevens wordt 
geïnventariseerd in hoeverre deze methoden al gebruikt worden in de klinische 
praktijk.
 Het focus van het proefschrift is echter gericht op het valideren van de trans- 
pulmonale ultrageluiddilutie methode (TPUD) als hemodynamisch  monitoring- 
systeem voor (premature) pasgeborenen waarbij gebruikt gemaakt wordt van lam-
merenmodellen als surrogaat voor deze patiëntengroep. In het ene diermodel met 
een zelf gecreëerde links-rechts shunt wordt een ductus arteriosus nagebootst (een 
belangrijke bloedvatverbinding tussen de lichaams- en long circulatie tijdens de 
foetale periode en de transitie van foetus naar pasgeborene); in een ander model 
wordt longschade en longoedeem geïnduceerd, vergelijkbaar met een veel 
voorkomend ziektebeeld bij de pasgeborenen. Onderzocht wordt of het inschatten 
van het  hartminuutvolume, het detecteren en kwantificeren van de links-rechts 
shunt, het waarnemen van veranderingen in hemodynamische volumes en het 
meten van het longoedeem met behulp van de TPUD betrouwbaar is. Hiervoor wordt 
 de methode gevalideerd met gebruik van goud standaard referentie methoden. 
Samenvattingen van de studies
Hoofdstuk 2 geeft een inzicht in de cardiovasculaire ontwikkelingsfysiologie van 
de pasgeborene, evenals een overzicht van de bestaande (geavanceerde) 
hemodynamische monitoringsystemen voor de pasgeborenen. De bloedsomloop 
van de (premature) pasgeborene is uniek en onderscheidt zich van ieder ander 
moment in het leven. Het (preterm) hart- en vaatstelsel wordt gekenmerkt door 
morfologische en functionele onrijpheid van de hartspier met een verminderde 
contractiekracht en relaxatiemogelijkheid tot gevolg, evenals een verminderde 
aanpassing aan een verhoogde weerstand (bloeddruk of afterload) of een volume 
overbelasting (preload). Tijdens de transitiefase – geïnitieerd door het doorknippen 
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van  de navelstreng en de eerste ademteugen - vinden  grote veranderingen plaats 
met betrekking tot de pompfunctie van beide hartshelften, de bloedstroom en de 
vaatweerstand in zowel de long- als de lichaamsslagaders. De obligate verbindingen 
(shunts) tussen de lichaams- en longcirculatie aanwezig tijdens het foetale leven 
sluiten kort na de geboorte (de zogenaamde ductus arteriosus en het foramen 
ovale). Foetale, moederlijke en placentaire problemen kunnen daarenboven het 
transitieproces beïnvloeden. Wanneer de normale transitie faalt als gevolg van een 
inadequate aanpassing, aangeboren (hart)afwijkingen, infectie of longaandoenin-
gen en de foetale bloedsomloop persisteert, zal de pasgeborene een verhoogd risico 
hebben op falen van de circulatie met secundaire shock. 
 In het tweede deel van dit hoofdstuk wordt een overzicht gegeven van de 
huidige (en mogelijke toekomstige) beschikbare monitoringsystemen voor pas- 
geborenen. De basisprincipes van de methoden worden kort beschreven, evenals 
hun voor- en nadelen. Monitoringsystemen vereisen een hoge accuratesse en 
nauwkeurigheid: accuraatheid refereert aan de gemiddelde afwijking van repetitieve 
metingen ten opzichte van de referentiemethode, terwijl nauwkeurigheid (precisie) 
de mate van reproduceerbaarheid bij herhaaldelijke metingen weergeeft. Het mag 
duidelijk zijn dat het ideale monitor systeem niet bestaat. Bij voldoende zuurstof-
verzadiging van het bloed en een adequaat hemoglobinegehalte wordt de zuurstof-
toevoer hoofdzakelijk bepaald door het hartminuutvolume. De afgelopen decennia 
zijn er meerdere geavanceerde cardiac output monitoringsystemen ontwikkeld, 
gebruik makend van verschillende technieken, zoals ultrageluid doppler, indicator-
verdunningsmethoden, arteriële polscontour analyse en bio-impedantie. De 
meeste van deze methoden zijn beperkt bruikbaar in pasgeborenen als gevolg van 
technische beperkingen (noodzaak aan grote katheters) en hun gebrek aan 
accuratesse in de aanwezigheid van shunts. Niet-invasieve, makkelijk toepasbare 
technieken met continue cardiac output meting genieten de voorkeur, maar de 
huidige methoden zijn minder accuraat en precies in het weergeven van het hart-
minuutvolume dan de meer invasieve methoden. Ondanks een aantal beperkingen 
met betrekking tot het bepalen van het hartminuutvolume, blijft de (functionele) 
echocardiografie onontbeerlijk voor het uitsluiten van aangeboren hartafwijkingen 
en shunts bij de pasgeborene met circulatoire problemen. Bij onvoldoende zuurstof-
aanvoer zullen de weefsels meer zuurstof aan het bloed proberen te onttrekken, 
vooraleer er overgegaan wordt op een anaerobe stofwisseling. Het herhaaldelijk 
meten van de centraal veneuze zuurstofverzadiging (als maat voor zuurstofver-
bruik) en het lactaat is hiervoor meer informatief dan de absolute waarden. Voor 
het inschatten van de regionale doorbloeding (voornamelijk de hersenen) tijdens 
een periode van (pre)shock kan gebruikt gemaakt worden van bijna-infrarood 
spectroscopie (NIRS). Methoden voor het bepalen van de microcirculatie zijn 
beschikbaar, maar nog niet vlot toepasbaar. Gezien de verminderde mogelijkheden 
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van het (premature) hart om volumeveranderingen op te vangen, worden enkele 
potentiële methoden beschreven om de reactie van het hart op een vochtbolus 
(de zogenaamde vloeistofbolus responsiviteit) te voorspellen, waaronder hemo-
dynamische volumes, polsdruk variaties en het meten van de gemiddelde systeem 
vullingsdruk. 
 Hoofdstuk 3 beschrijft de resultaten van een internationale enquête die het 
huidige gebruik van de hierboven vermelde geavanceerde hemodynamische 
 bewakingsmethoden inventariseert in de neonatale intensive care afdelingen. 
Alle 79 (hoofdzakelijk Europese) neonatologen gaven aan dat ze het lichamelijk 
onderzoek in combinatie met (arteriële) bloeddrukmeting en bepalingen van het 
zuurbase evenwicht en lactaat in het bloed nog steeds het belangrijkste instrument 
vinden om de circulatie van een pasgeborene in te schatten en eventuele 
behandeling op te starten. Met het groeiend inzicht in de ontwikkelingsfysiologie 
en het belang van bloedstroommetingen lijkt er een toename in het gebruik van 
functionele echocardiografie te zijn:  79% van de ondervraagden gebruikten deze 
methode in wisselende mate voor het meten van de hartfunctie, de vullingstoe-
stand en de bloedstroom naar het lichaam toe. NIRS wordt in minder dan de helft 
van de centra soms gebruikt voor het bepalen van de regionale (hersen)door -
bloeding. Andere geavanceerde monitoringtechnieken voor het meten van het 
hartminuutvolume, de vloeistofbolus responsiviteit en de microcirculatie worden 
beperkt gebruikt in onderzoeksverband en nauwelijks in de dagelijkse klinische 
praktijk. Gemiddeld 55% van de neonatologen gaven aan een richtlijn te hebben 
voor het behandelen van pasgeborenen met een falende bloedsomloop variërend 
van 82% in West-Europese landen tot 36% in Zuid-Europa. In overeenstemming 
met de aanbevelingen zijn de behandelingen in de gebruikte protocollen gebaseerd 
op een combinatie van bloedstroom, bloeddruk en onderliggend ziektebeeld. 
 In sectie II exploreren we de mogelijkheden van de invasieve transpulmonale 
ultrageluiddilutie methode als hemodynamisch monitoringsysteem voor pas - 
geborenen met verschillende ziektebeelden. We gebruikten hiervoor 2 dier- 
modellen als surrogaat voor de zieke neonaat. De TPUD gebruikt fysiologisch zout 
verwarmd tot lichaamstemperatuur als indicator, welke wordt geïnjecteerd aan 
de veneuze zijde van een extracorporeel circuit bevestigd tussen de ingebrachte 
centraal veneuze en arteriële katheter. De geïnjecteerde zoutoplossing vermindert 
de ultrageluidsnelheid van het bloed, waardoor het als indicator kan gebruikt 
worden. De hierdoor ontstane verdunningscurve wordt gedetecteerd door een 
sensor aan de arteriële zijde van het circuit. Uit de verdunningscurve kan onder 
andere het hartminuutvolume berekend worden met behulp van de Stewart- 
Hamilton vergelijking. De methode werd reeds gevalideerd in een gezond diermodel, 
evenals in een model met shock als gevolg van verbloeding.
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 Betrouwbaar monitoren van pasgeborenen met persisterende shunts of aan- 
geboren hartafwijkingen is noodzakelijk om eventueel circulatoir falen snel te 
kunnen detecteren en adequaat te kunnen handelen. De meeste indicator dilutie-
methoden zijn onbetrouwbaar gebleken voor het meten van het hartminuut-
volume in de aanwezigheid van shunts. In aanwezigheid van shunts wordt namelijk 
de circulatietijd van de indicator verlengd waardoor er vormveranderingen 
optreden van de verdunningscurve. Hierdoor kan het hartminuutvolume worden 
onderschat. In hoofdstuk 4 valideerden we de TPUD methode in een pasgeboren 
lammerenmodel met een kunstmatig aangelegde ductus arteriosus tussen de 
 lichaamsslagader en de linker longslagader, welke intermitterend werd geopend 
en gesloten. De lammeren werden blootgesteld aan geleidelijke verbloeding om zo 
het circulerend volume en daarmee ook het  hartminuutvolume te beïnvloeden. 
Als referentiemethode werd gebruikt gemaakt van een ultrasonic flow probe – 
bevestigd rondom de longslagader - welke beschouwd wordt als de goud standaard 
voor het meten van het hartminuutvolume in een diermodel. We vonden dat de 
cardiac output metingen met behulp van TPUD betrouwbaar waren in de 
aanwezigheid van een links-rechts shunt ongeacht de hoeveelheid circulerend 
volume. Aangezien voor iedere meetsessie 3 injecties van 1.0 ml/kg zoutoplossing 
worden aanbevolen zou er een risico op overvulling kunnen ontstaan. Wij toonden 
aan dat het middelen van meerdere opeenvolgende injecties geen effect heeft op 
de accuraatheid of precisie van de metingen en adviseren daarom het  gebruik van 
2 injecties per sessies. Enkel indien beide metingen meer dan 10% verschillen zal 
een derde injectie noodzakelijk zijn.
 Aangepaste software stelt het TPUD apparaat in staat om uit de vervormde 
verdunningscurve die ontstaat in de aanwezigheid van shunts, de shuntfractie op 
te sporen en te kwantificeren. Deze wordt weergegeven als de ratio tussen de long-
doorbloeding (Qp) en de lichaamsdoorbloeding (Qs)  - Qp/Qs. In hetzelfde diermodel, 
zoals beschreven in hoofdstuk 4, vonden we dat TPUD in staat is de aanwezigheid 
van verschillende afmetingen van links-rechts shunts te detecteren met een hoge 
sensitiviteit (100%) en specificiteit (83%), hetgeen TPUD een goede screeningsme-
thode maakt voor het diagnosticeren van (links-rechts) shunts. Het bepalen van de 
shuntgrootte door TPUD is accuraat wanneer deze vergeleken wordt met Qp/Qs 
ratio’s gemeten met ultrasonic flow probes, maar het ontbreekt de methode aan 
precisie, met name voor de kleinere shunts. We zijn dan ook van mening dat verdere 
aanpassing van het algoritme noodzakelijk is voordat de TPUD kan worden toegepast 
in de klinische praktijk voor het kwantificeren van shunts zoals geconcludeerd in 
hoofdstuk 5. Aangezien veranderingen in absolute Qp/Qs waarden wel goed te 
detecteren waren, kan overwogen worden TPUD als trendmonitor te gebruiken.
 Het streven naar een optimale vochtbalans kan moeilijk zijn in (premature) 
pasgeborenen gezien zowel volume (over)belasting als volume tekort het hart-
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minuutvolume kunnen beïnvloeden. Vooral bij patiënten met een verhoogde 
capillaire doorlaatbaarheid (het capillair lekkage syndroom) zoals bv bij ernstige 
infecties, postoperatief of tijdens behandeling met de kunstlong-machine, is strikt 
vochtmanagement noodzakelijk om enerzijds ondervulling te voorkomen en 
anderzijds excessieve vochttoediening te vermijden. Neonatologen zouden dus 
kunnen gebaat zijn met extra informatie met betrekking tot de vloeistofstatus van 
hun patiënten. Het toedienen van een vloeistofbolus wordt vaak gezien als een 
eerste stap in de behandeling van een falende circulatie. Het idee is dat deze 
toename van het circulerend volume leidt tot een verhoging van het hartminuut-
volume (de zogenoemde vloeistofbolus responsiviteit). Het blijkt echter dat bij een 
aantal patiënten de extra vloeistofbolus toediening niet het gewenste effect heeft 
op het hartminuutvolume en zelfs kan leiden tot overvulling. Het is dan ook 
belangrijk om parameters te hebben die de respons op de vloeistofbolus kunnen 
voorspellen. Bij volwassen lijken veranderingen in hemodynamische volumes 
betere voorspellers voor vloeistofbolus responsiviteit te zijn dan bijvoorbeeld het 
meten van de centrale veneuze druk. Door middel van analyse van de verdun-
ningscurve kunnen ook verschillende hemodynamische volumes als het totale 
eind-diastolisch volume (TEDV), het centraal bloedvolume (CBV = bloedvolume in 
het hart, longen en grote vaten) en – exclusief voor TPUD – het actief circulerend 
volume (ACV = totale bloedvolume minus het bloedvolume in de microcirculatie) 
berekend worden. In hoofdstuk 6 beschrijven we het effect van shunt opening en 
sluiting, progressieve verbloeding en volume resuscitatie op het hartminuutvolu-
me en deze hemodynamische volumes. We vonden dat de verschillende interventies 
specifieke veranderingen in voornoemde parameters teweegbrachten. Validatie 
van de absolute volumewaarden is niet mogelijk wegens het gebrek aan bestaande 
referentiemethoden. Echter, deze bevindingen suggereren dat hemodynamische 
volumetrie met behulp van TPUD als trendbewaking nuttig kan zijn bij het 
beoordelen van de volumestatus van een pasgeborene.
 Frequent voorkomende longaandoeningen bij pasgeborenen omvatten het 
respiratoire distress syndroom (onder andere als gevolg van een te kort aan 
surfactant), het meconiumaspiratiesyndroom en longontsteking, ziektebeelden 
die vaak gepaard gaan met circulatoire instabiliteit, verhoogde capillaire doorlaat-
baarheid en longvaatovervulling (longoedeem). Bewaking van de circulatie is ook 
bij deze patiënten aangewezen. De doorbloeding van beschadigde longen kan 
inhomogeen zijn waardoor de doorlooptijd van de indicator kan wijzigen, resulterend 
in een vormverandering van de verdunningscurve en dus mogelijk een overschatting 
van het ware hartminuutvolume. In tegenstelling tot andere verdunningstechnieken 
gebruikt TPUD een niet-diffundeerbare indicator waardoor er nagenoeg geen 
 indicatorverlies optreedt in de aanwezigheid van verhoogde capillaire doorlaat-
baarheid en longoedeem. In hoofdstuk 7 onderzochten we de betrouwbaarheid 
502337-L-sub01-bw-Vrancken
191
SUMMARY IN DUTCH
10
van hartminuutvolumemetingen via TPUD in een diermodel met een geïnduceerd 
respiratoir distress syndroom door middel van herhaaldelijke longspoelingen. 
De beoogde longschade werd bevestigd door een toename van de oxygenatie index 
(OI) - een maat voor de intensiteit van beademing - tijdens het experiment (OI 
verhoogd van <10 tot > 40) en door middel van postmortem histologisch onderzoek. 
Hartminuutvolumemetingen door TPUD waren in overeenstemming met de 
gemeten waarden met ultrasonic flow probes, bevestigd rondom de longslagader. 
We concluderen dat de nauwkeurigheid en de precisie van de door TPUD gemeten 
hartminuutvolumes niet worden beïnvloed door matig tot ernstig longlijden en 
dat de techniek betrouwbaar kan worden gebruikt bij pasgeborenen met respiratoir 
falen.
 Longoedeem, ontstaan door longaandoeningen of infectie, kan het kunstmatig 
beademen van pasgeborenen verder bemoeilijken waardoor longschade zou 
kunnen ontstaan/toenemen. Het zou dus wenselijk zijn om de hoeveelheid 
longoedeem (of extravasculair long water (EVLW)) te kunnen meten zodat het 
vochtbeleid kan aangepast worden. EVLW kan ingeschat worden door de TPUD 
methode wanneer deze gebruikt wordt als een dubbel indicatordilutie methode 
met behulp van injectie van ijskoude isotone zoutoplossing. In hoofdstuk 8 werden 
EVLW metingen met behulp TPUD gevalideerd tegen EVLW gemeten door enerzijds 
een transpulmonale dubbel (dye) indicatordilutie techniek en anderzijds postmortem 
gravimetrie (de goud standaard) in het diermodel beschreven in hoofdstuk 7. 
Naast de geïnduceerde longschade ontstond er namelijk ook een enorme toename 
van het longoedeem. De overeenkomst tussen EVLW gemeten door TPUD en de 
transpulmonale dubbel indicatordilutie methode was laag, waarschijnlijk vanwege 
de verschillen in de onderliggende algoritmen voor het berekenen van EVLW van 
beide methoden. Correlatie en nauwkeurigheid van het gemeten EVLW door TPUD 
in vergelijking met de gravimetrische methode was goed, maar de TPUD methode 
lijkt precisie te missen in zijn huidige prototype. Verdere aanpassing van het 
algoritme zal nodig zijn voordat deze techniek betrouwbaar de hoeveelheid 
neonataal EVLW kan inschatten. Een mogelijke extra beperking voor het meten 
van EVLW op deze wijze is het gebruik van de ijskoude isotone zoutoplossing die 
een verlaging van het hartritme kan veroorzaken waardoor kortdurend het hart-
minuutvolume en mogelijk de hersendoorbloeding beïnvloed worden in premature 
baby’s.
 Op basis van de verrichte onderzoeken besluiten we in hoofdstuk 9 dat de 
transpulmonale ultrageluiddilutie methode een betrouwbare en klinisch bruikbare 
methode is voor het meten van het hartminuutvolume bij (zieke) pas- geborenen, 
de detectie van (extra-)cardiale shunts en het meten van veranderingen in 
hemodynamische volumes welke een indicatie zijn voor de vullingstoestand. 
De TPUD methode heeft echter ook zijn beperkingen: 1) het is een invasieve en 
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niet-continue methode die de aanwezigheid van centraal veneuze en arteriële 
katheters vereist. Dit maakt de techniek niet geschikt voor het bewaken van het 
hartminuutvolume tijdens de transitiefase in de verloskamer en bij pasgeborenen 
zonder centrale katheters, 2) gezien de niet-continue meetwijze kunnen veranderingen 
in het hartminuutvolume, hemodynamische volumes en shuntgrootte alleen 
worden gedetecteerd wanneer herhaaldelijke injectiesessies worden uitgevoerd 
met een (beperkt) risico op volumeoverbelasting zoals voorheen beschreven. 
 Een volgende (reeds genomen) stap is het verrichten van klinische studies  met 
de TPUD methode bij (premature) pasgeborenen. Herhaaldelijk meten van het 
hartminuutvolume en andere hemodynamische parameters zal ons inzicht geven 
in hemodynamische veranderingen tijdens het ziekteproces en geeft de mogelijkheid 
om behandelingsmodaliteiten aan te passen. De ontwikkeling van een stroom- 
schema gebaseerd op de verkregen variabelen met therapeutische eindpunten 
(noodzaak aan vulling, inotropie, vasopressoren of vasodilatatoren) zou nuttig 
zijn om behandelingen op te starten, bij te stellen en te individualiseren. 
Conclusie
Circulatoir falen bij de pasgeborenen kan leiden tot zuurstofgebrek in de weefsels 
met orgaanbeschadiging en een verhoogde sterftekans tot gevolg. Het verkrijgen 
van objectieve en accurate informatie over de bloedstroom, de regionale door- 
bloeding en microcirculatie door middel van (continue) geavanceerde hemo- 
dynamische bewakingstechnieken is essentieel om  een optimale behandeling in 
te zetten en bij te sturen. De beperkte toepasbaarheid verhindert het huidige 
gebruik van (geavanceerde) hemodynamische bewakingssystemen in de neonatale 
intensive care. Wij valideerden de transpulmonale ultrageluiddilutie methode in 
een diermodel met vergelijkbare klinische condities als (premature) pasgeborenen 
en vonden de techniek betrouwbaar voor het bewaken van de  macrocirculatie, 
mits de beperkingen van de methode in acht worden genomen. Ondanks de 
dringende behoefte aan geavanceerde hemodynamische bewakings systemen in 
neonatale zorg, mag het duidelijk zijn dat de verzamelde informatie de uitkomst 
van de patiënt niet zal verbeteren, tenzij de gegevens correct geïnterpreteerd 
worden en de ingezette doelgerichte therapie de uitkomst zelf verbetert.
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Het vuurwerk dat 2016 inluidde dooft langzaam uit als ik begin aan deze laatste 
pagina’s. Het glas werd geheven op een nieuw en boeiend jaar, maar ook op het 
afronden van dit proefschrift. Ja, het boekje is er! Eindelijk! Het was een ware 
 (wetenschappelijke) ontdekkingstocht met onverwachte wendingen, een uitermate 
leerrijke ervaring die niet zonder hulp van vele mensen tot stand gekomen zou zijn. 
Aan iedereen die op welke wijze dan ook een bijdrage heeft geleverd aan dit proef- 
schrift: hartelijk dank! Een aantal mensen wil ik graag in het bijzonder noemen.
Prof. dr. H. van der Hoeven, promotor. Beste Hans, onze eerste ontmoeting had 
niets met onderzoek te maken, maar hoe we de patiëntzorg ziekenhuisbreed 
konden verbeteren door decentraal incident melden. Ik had nooit gedacht dat 
enkele jaren later onze wegen opnieuw zouden kruisen op wetenschappelijk vlak. 
Door de uitgezette paden van samenwerking tussen de (kinder)intensive care, onze 
gezamenlijke interesse in hemodynamisch onderzoek en je enorme kennis was 
het evident dat jij de geknipte persoon was om mij mee te begeleiden in dit traject. 
Je hebt met je visie en kritische commentaar een waardevolle bijdrage geleverd 
aan dit manuscript. Met je wetenschappelijke kwaliteiten, je inzet met hart en ziel 
voor de patiëntzorg en je bevlogenheid ben je een voorbeeld voor velen! Ik hoop in 
de toekomst nog met je mogen samen te werken. Dank dat je mijn promotor bent!
Prof. dr. C. Noordam, promotor. Beste Kees, jij hebt me de afgelopen jaren de 
mogelijkheid geboden om me verder te ontwikkelen op professioneel vlak en dit 
onderzoek tot een goed einde te brengen. Er zat veel dynamiek in onze gesprekken 
zonder dat het begrip neonatale circulatie echt veel ter sprake kwam. Ik ben je 
dankbaar voor alle geboden kansen, je brede belangstelling en je vertrouwen! 
Dr. WP. de Boode, copromotor. Beste Willem, jij bent de stuwende kracht achter 
dit project. Alle eer komt jou toe! Je hebt de neonatale hemodynamiek op de 
Nederlandse NICU-kaart gezet. Het enthousiasme, de gedrevenheid en het door-
zettingsvermogen waarmee je dat deed (en doet!), werkte zo aanstekelijk dat ik 
wat graag jouw onderzoek wou voortzetten. Jij hebt me wegwijs gemaakt in het 
dierproevenonderzoek en me wetenschappelijk ontzettend veel bijgebracht. Bovenal 
leerde je me relativeren en dat kwam ongewild goed van pas! Je betrokkenheid is 
ongeëvenaard: altijd beschikbaar voor overleg, om te sparren, (nog maar eens) te 
corrigeren, …  maar ook voor een opbeurend praatje. Je passie voor onderzoek en 
patiënt blijft inspireren. Ik wil je bedanken voor alle steun, en niet alleen op 
 wetenschappelijk vlak! Ik kon me geen betere copromotor wensen! De volgende 
(internationale) hemodynamische uitdagingen zijn al in aantocht. We gaan ervoor! 
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Dr. A. van Heijst, copromotor. Beste Arno, de overtuiging dat ik ooit zou promoveren 
was er bij jou eerder dan bij mij! Ik was toch vooral een clinicus, een praktijk-
gerichte dokter, liever klussend aan bed dan ‘achter een bureau’,… Tot deze 
uitdaging voorbij kwam en ik overstag ging. Je kritische blik, prikkelende vraag-
stellingen en gevatte commentaar zijn dit proefschrift zeker ten goede gekomen. 
Dank voor al die keren dat ik even bij je mocht binnen springen, de kopjes koffie, 
de onderzoekstijd die ik afgelopen jaar kreeg om dit manuscript af te ronden (dat 
ik dat nog eens zou zeggen!) en de onvoorwaardelijke steun op en naast de 
werkvloer. 
Drs. J. Hopman. Beste Jeroen, mijn held wat betreft dataverwerking, data-analyse 
en statistiek! Jij leerde me het belang van het opzetten van een goede database en 
het formuleren van de juiste vraagstellingen. Met veel geduld wist je moeilijke 
begrippen in een begrijpelijke taal uit te leggen, keer op keer. Jouw bijdrage aan 
dit proefschrift was uiterst waardevol. Ik waardeer ontzettend dat je hiervoor tijd 
hebt willen vrijmaken. Ik hoop dat je binnenkort mag genieten van een fraai 
uitzicht op de Waal (en andere wereldse panorama’s) en wens je nog veel mooie 
voorstellingen met het toonkunstkoor.
Dr. K. D. Liem. Beste Djien, neonatoloog met hart en ziel: begeesterd door je vak, 
enorme kennis, leermeester van velen, oneindig geduld, inzet voor onderzoek, 
maar vooral waardering van je patiënten en collega’s. Mijn respect voor jou is 
groot! Dank je wel voor al je adviezen, je correcties en je waardevolle bijdrage aan 
dit proefschrift! Ik kijk er naar uit om de komende jaren nog samen te werken 
(voordat je je energie naar andere meridianen laat leiden)!
Dr. A. Nusmeier. Beste Anneliese, mijn onderzoeksmaatje! We begonnen als groentjes 
op het centraal dierenlaboratorium (CDL), maar onder deskundige begeleiding van 
Willem en Joris en met enige hulp ontpopten we ons tot echte onderzoekers met 
als resultaat dat jij je inmiddels al een paar jaar doctor mag noemen. Dank voor je 
waardevolle input, je luisterend oor en alle gezelligheid. Hopelijk mogen we in de 
toekomst nog samenwerken!
Dr. J. Lemson. Beste Joris, net als een Willem een hemodynamisch onderzoeker in 
hart en nieren: ervaren, toegewijd, doelgericht met een scherpe en kritische blik. 
Dank voor je bijdrage aan dit proefschrift!
Waarde leden van de manuscriptcommissie: Prof. dr. F. Vandenbussche, Prof. dr. D. 
Tibboel en Prof. dr. ir. C. de Korte, veel dank voor het kritisch beoordelen van dit 
proefschrift. 
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Dit (dierexperimenteel) onderzoek was niet mogelijk geweest zonder gewaardeerde 
inzet van velen. Mijn dank gaat in het bijzonder uit naar de medewerkers van het 
centraal dierenlaboratorium: beste Alex, Wilma, Maikel en Jeroen, jullie excellente 
vaardigheden en expertise waren onmisbaar. Steeds paraat, meedenkend en 
inventief in acute situaties. Het was een voorrecht met jullie te mogen werken! 
Beste Jan, adequate data-aquisitie en -verwerking is de basis van ieder onderzoek. 
Dank voor de vele dagen aan onze zijde in het CDL, de nauwkeurige registraties en 
je nooit aflatende hulp wanneer ik weer eens iets anders bedacht om te analyseren. 
Beste Paul en Sandeep, het aanleggen van een aorto-pulmonale shunt is geen 
 neonatologenspel. Dank voor jullie deskundige hulp. Beste Benno, het was leuk 
met je samen te werken in het CDL. Inspirerend ook om te zien hoe vlot jij je 
 promotietraject hebt doorlopen! Beste Monika, dank voor je professionele beoordeling 
van alle microscopische preparaten. Beste Luc, jij hebt me wegwijs gemaakt in 
wereld van de enquêtes en surveys! Je inhoudelijke en praktische input was erg 
waardevol. Beste Ton, jouw statistische hulp was meer dan welkom. Dank voor je 
snelle reacties en grondige data-analyses. Beste Sue, je taalkundige correcties als 
native speaker waren meer dan welkom. Dank!
Dear Nikolai, this research would not have been possible without your tremendous 
work and support. It was a great pleasure to validate the transpulmonary ultrasound 
dilution technique for neonatal use. Thank you for all the inspiring discussions, 
your inexhaustible enthusiasm and your quick replies. I hope we can continue our 
scientific journey! And no matter what, there is always time to tango!
Beste vrienden-neonatologen, ik prijs me gelukkig om jullie collega te zijn! Het is 
fantastisch om in zo een inspirerend team te mogen werken. Ons werk is 
gevarieerd, uitdagend, grensverleggend, maar ook heftig, acuut en emotioneel 
met de nodige ethische dilemma’s. Het voelt goed om te weten dat je op elk uur van 
de dag (en nacht) bij elkaar terecht kan! Gelukkig is er naast het serieuze werk ook 
ruimte voor de nodige humor, grappen en (culinaire) ontspanning. Dank jullie wel 
voor alle ruimte die ik kreeg om dit proefschrift af te ronden, maar vooral voor 
alle steun en belangstelling tijdens mijn onvrijwillig verlof. Djien – topneonatoloog, 
ongeëvenaard geduld en behendigheid, steeds op zoek naar nieuwe uitdagingen; 
Arno - the Boss, ECMO-specialist, fietstochtjes voor all4small en levensgenieter; 
Viola – intake matters, Duitse klasse, de laatste loodjes promovenda!; Willem – 
Mister Hemodynamiek, betrokkenheid, familieman, cabaretier; Katerina – follow 
up, brede blik op ziekenhuisorganisatie, gezelligheid; René – patient centraal, 
ruwe bolster, blanke pit, culinair genieten; Maresa – CRM ten top, spraakwaterval, 
masterchef taartenbakken; Marije – duizendpoot, onderwijs over de grenzen heen, 
multitasken als de beste; Tim – Master-Mind, internationale top-designer (van 
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simulatie apparatuur), music maestro; Mayke – gedreven, grote betrokkenheid, 
leuke babbels, Lieshout boven! Mathijs – leergierig, humor, taalvirtuoos eindelijk 
fellow. Femke, Ronny, Robin, Ellen, Marlies en Tessa – bedankt voor jullie bijdrage en 
gezelligheid de afgelopen jaren. Het was fantastisch jullie in ons team te hebben. 
Verpleegkundigen, teamleiders, arts-assistenten, nurse practioners, physician 
assistants, paramedici en medisch maatschappelijk werksters: het is een waar 
genoegen om met jullie op deze afdeling te mogen werken. Dank voor jullie 
professionele ondersteuning, gezonde teamspirit en inzet, voor de (nachtelijke) 
babbels, de grappen en grollen en de leuke uitjes. Mede dankzij jullie heeft deze 
Belg zich snel thuis gevoeld in het land van broodje kroket en drop. Ellen, Marian, 
Willie en Rinie,…  dank voor alles. Secretaresses, jullie dagelijkse ondersteuning 
is onmisbaar! In het bijzonder noem ik hier Corrie en Heidi, dank voor al jullie 
inzet bij de totstandkoming van dit proefschrift. Theo en Wouter, fijn om altijd op 
iemand te kunnen rekenen als de apparatuur het weer eens laat afweten. 
Beste collegae Werner, van Hoessel, de Boer en Boersma, beste Lenny en Renate, 
dank voor al jullie goede zorgen tijdens mijn onverwachte “sabbatical”. Vertrouwen 
in je behandelaars is positief gecorreleerd met het genezingsproces, daar ben ik 
zeker van!   
Mijn paranimfen: 
Beste Berty, mijn neonatologiemaatje van het eerste uur! Gezelligheid op en vooral 
naast de werkvloer: samen op huizenjacht, op verkenning door Nijmegen en 
omstreken, lekker kokkerellen, ontelbare kletsmomenten bij kopjes koffie,… . 
Inmiddels heb je nieuwe (professionele) horizonten verkend, maar lang leve sociale 
media waardoor de babbeluurtjes gebleven zijn! Super dat je vandaag hier als 
paranimf naast me staat. Dank voor je vriendschap! Ik wens je heel veel geluk met 
Guusje in Deventer en veel werkplezier als arts voor verstandelijk gehandicapten.
Beste Patricia, hechte vriendschap voor het leven! In goede en minder goede 
tijden… Je drukke agenda herhaaldelijk helemaal schoonvegen, verse broodjes om 
6.30 u, verrassende weekendjes weg en peptalk à volonté… ik zal het nooit vergeten! 
Dank voor je onvoorwaardelijke steun! Het is niet meer dan logisch dat jij vandaag 
hier getuige bent van mijn promotie! We delen niet alleen onze passie voor 
geneeskunde, maar ook voor lekker eten en reizen, hetgeen duidelijk werd toen 
ik even op bezoek kwam tijdens je avontuur met Artsen zonder Grenzen in 
Mozambique. Ik hoop dat we onze wereldse en culinaire ontdekkingstochten nog 
lang mogen continueren. 
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Beste (ex-)Leuvenaren: er waren eens 4 meiden en een kotmadam… Inmiddels zijn 
we uitgegroeid tot een bijzondere vriendenclub met 15 leden verspreid over België 
en Nederland. Onze contacten zijn misschien beperkt, maar daarom zeker niet 
minder waardevol. Dank voor alle afleiding, ontspanning, wandelingen in de 
Ardennen of aan zee, vriendschap en zoveel meer. Ik kijk uit naar ons 20-jarig 
 jubileum-weekend! Het wordt ongetwijfeld feest!
Beste familie/vrienden, het is goed om weten dat er altijd mensen voor je klaar 
staan! We hebben al heel wat intense momenten beleefd, meestal met een lach, 
soms met een traan. Af en toe lijkt Nijmegen o zo ver. Na alle drukte van de afgelopen 
jaren hoop ik dat er weer meer tijd over is voor fietstochten, zwempartijtjes, 
cappuccino’s en babbels! Dank dat jullie er zijn.
Lieve mam, samen met pap heb je me de mogelijkheid gegeven om te studeren en 
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